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GENERAL INTRODUCTION1
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The aging society
As wisdom and experience come with age, old adults are of significant value to their families, 
local communities, and to society in general. Today, populations in most countries show a 
substantial increase in longevity, resulting in an increased proportion of old adults aged 
over 65 worldwide [1]. The personal and societal value of extending life, however, seems to 
heavily depend on whether those added years are spent in good health or are compromised 
by disease and disability. Unfortunately, the number and severity of clinical conditions 
steadily increases with age [2]. According to the World Health Organisation, it therefore 
remains a sustained challenge to ‘not only add years to life, but to also add health to years’.
‘Healthy aging’ vs. ‘geriatric aging’
Even ‘healthy aging’ results in the accumulation of physiological, psychological, and social 
changes over time. For example, the loss of muscle fibres leads to an annual reduction in 
leg strength of 1-2% after age 50 [3]. Brain volume shrinks by 5% per decade after age 40, 
resulting in a brain tissue loss of up to 20% by age 80[4]. When the degree of decline in 
physical and/or psychological functioning exceeds the degree of decline expected based on 
the aging process alone, old adults are usually referred to geriatricians or other specialists 
with expertise in the treatment of geriatric conditions and diseases [2]. Typical geriatric 
conditions include sarcopenia, delirium, weight loss, cognitive impairment, osteoporosis, 
and recurrent falls. Such conditions are often characterized by multiple aetiological 
factors and interacting pathogenetic pathways [5]. Geriatric patients can thus be defined 
as a vulnerable segment of old adults, in whom the presence of a minor condition may 
eventually result in a catastrophe. For example, a mild infection in geriatric patients may 
cause confusion, which could lead to a fall, and result in a hip fracture. ‘Geriatric aging’ 
can therefore be conceptualized as the natural aging process accompanied by multiple co-
morbidities that require specialized geriatric care to slow functional decline.
Study population of the present thesis
The experimental studies (Chapters 3-5) examine geriatric patients recruited from the 
MC Slotervaart hospital in Amsterdam between 2014 and 2017. They visited the geriatric 
diagnostic dayclinic for a comprehensive evaluation of physical, cognitive, and psychological 
function. Geriatric patients visiting the geriatric department present with a mean age of 
approximately 80 years and an average life expectancy of about 4 years. This characterization 
is based on many years of descriptive data collected at the MC Slotervaart hospital.
Cognitive impairment in the geriatric population
A major cause of disability in geriatric patients results from the presence of cognitive 
impairment, as it affects memory, thinking, behaviour, emotions, and/or perceptions [6]. 
Population studies report prevalence rates of cognitive impairment ranging between 
5% and 29% in community-dwelling old adults aged over 65 [7], and the presence of 
cognitive impairment is often considered as a precursor to the development of dementia. 
In fact, approximately 10-15% of old adults with diagnosed cognitive impairment yearly 
develop dementia [7]. Because geriatric patients are usually considerably older than 65, 
prevalence and conversion rates are certainly higher in this population. Over the years, 
several terms have been introduced to define the transitional state between normal aging 
and the development of dementia. ‘Benign senescence forgetfulness’ was one of the first 
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descriptors of this transition state, and was considered as a manifestation of the normal 
aging process [8]. Later, the Canadian Study of Health and Aging introduced the term 
‘cognitive impairment no dementia’, which refers to cognitive impairment of insufficient 
severity to constitute dementia [9]. Since 1997, this concept has been refined and is 
nowadays recognized as a pathological condition, i.e., not a manifestation of normal aging, 
and is widely known as ‘Mild Cognitive Impairment’ (MCI) [10]. MCI involves the evolution of 
cognitive impairment in one or more cognitive domains (e.g., memory, executive and visuo-
spatial function) beyond the expected decline based on an individual’s age and education. In 
MCI, the impairment is not severe enough to compromise daily life or to meet the criteria for 
dementia [10]. Nevertheless, clinicians and researchers still use various terms and criteria 
to define cognitive impairment. In this thesis, the umbrella term ‘cognitive impairment’ is 
used to refer to those definitions, unless studies specified the disease (e.g., MCI).
Gait characteristics as indicators of cognitive impairment
Even though there is no cure yet to reverse cognitive neurodegeneration, tailored inter-
ventions (e.g., medication, psychotherapy, psychoeducation, environmental modifications, 
physical activity) can slow disease progression and reduce symptoms [6]. The effectiveness 
of disease-modifying interventions is greatest in early phases of cognitive impairment and 
decreases with disease progression [11]. The identification of cognitive impairment in early 
stages is therefore crucial. Current models use demographic, genomic, vascular, behavioural, 
neurological and neuropsychological variables to predict dementia-related pathology [12]. 
Because those models insufficiently discriminate patients at-risk from patients not at-risk 
(Area Under the Curve ranging from AUC=0.50 to AUC=0.87) [13], there is a need for extra 
markers. In addition to usual predictors, the present thesis studied gait characteristics 
as potential non-invasive indicators of cognitive impairment in geriatric patients.
Experimental, neuroscientific, and behavioural evidence for the relationship 
between gait and cognitive impairment
Motor and cognitive functions were initially considered two distinct entities. This view 
originated from the ‘mind-body’ dualism: a philosophical view that advocates that mental 
phenomena are not physical and that the body and mind are two distinct features [14]. 
Nowadays, studies from multiple scientific fields emphasize the inter-relatedness between 
motor and cognitive functions. For example, the brain works better and the risk to develop 
neurodegenerative disorders decreases with an increase in physical fitness [15, 16]. 
Similarly, neurodegenerative disorders such as dementia and Parkinson’s disease often 
cause severe weight loss [17].
The inter-relatedness between motor and cognitive functions is also reflected in human 
walking. Walking involves the execution of goal-directed actions, and is thus a process 
which heavily relies on memory and on executive function to anticipate and interpret the 
environment and behaviour of others. In this process, gait and cognition show distinct 
patterns of associations [18, 19]. For example, recent studies showed that information 
processing was associated with gait rhythm, fine motor speed with tandem walking, and 
executive function with gait speed [19]. Neuro-imaging studies confirmed the link between 
gait and cognition by showing that walking utilizes brain areas that are responsible for 
executive, memory, and visuo-spatial functions, as well as motor areas such as the motor 
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cortex, the cerebellum, and the basal ganglia [20]. Brain areas involved in gait and cognitive 
function thus partly overlap and changes in gait can therefore be expected with the onset 
of cognitive impairment. White matter damage may be the underlying common cause 
of the concurrent changes in gait and cognition, as white matter tracts connect all those 
cortical and sub-cortical inputs. Indeed, smaller brain volumes and white matter lesions 
have been associated with MCI and dementia [21], but also with decline in global cognition 
in cognitively healthy old adults [22]. This white matter damage in turn has been associated 
with gait dysfunction (gait speed of <0.5 m/s), even in old adults free from dementia [23].
Perhaps the most explicit observation illustrating the connection between gait and cognition 
comes from motor-cognitive dual-task studies. During a dual-task, individuals perform a 
cognitive and a motor task simultaneously. Two decades ago, Lundin-Olssen and colleagues 
reported that 80% of frail old adults who stopped walking while talking experienced at 
least one fall in the next six months, in contrast to only 24% of old adults who were able 
to concurrently walk and talk without stopping [24]. The results showed that the motor 
and cognitive tasks (partly) rely on the same cognitive resources, and that attention should 
be allocated to both tasks. The change in performance from single- to dual-task walking 
reflects the degree of motor-cognitive interference and is referred to as ‘dual-task cost’ 
(DTC). Because patients with a cognitive impairment have limited cognitive capacities, DTC 
in patients with cognitive impairment or dementia is usually higher than in age-matched 
controls [25-29], depending on the nature and difficulty of the cognitive task [30]. Because 
a cognitively demanding task while walking places an additional stressor to the brain, 
dual-task walking has the potential to reveal subtle cognitive impairment in the brain that 
remains invisible with single-task walking. Methods incorporating dual-task paradigms 
therefore have become the reference method for assessing interactions between motor and 
cognitive functions.
The gait-cognition link in light of the ‘loss of complexity’ theory
Because geriatric patients show degradation in multiple interacting systems, the gait-
cognition link could be placed in a theoretical framework to better understand the coupling 
and coordination between elements of the aging neuro-musculo-skeletal system (NMSS) 
(i.e., gait and cognition). To this idea, a key-phenomenon of the aging NMSS was considered, 
namely the ‘loss of complexity’ (LOC). The LOC theory is derived from the field of non-linear 
dynamics and suggests that even healthy aging is associated with a (neuro)physiological 
breakdown of system elements that causes a loss of overall complexity [31]. Physiologic 
systems exist at molecular, subcellular, cellular, organ, and systemic levels, in which a 
healthy physiological system is characterized by complex networks of control mechanisms 
that allow individuals to flexibly adapt to unpredictable situations in daily life [31]. The 
original studies that recognized and quantified the complexity of physiological systems 
(instead of focussing on mean values of discrete physiological variables) were in the 
field of cardiology. The results underscored that a normal sinus rhythm in heartbeats in 
healthy young adults were not strictly regular but instead revealed with a complex type 
of variability [32, 33]. With natural aging, a degeneration in tissues and organs leads to a 
progressive loss of complexity in physiological systems, resulting in a decreased ability 
to adapt to physiological stress. This loss of complexity is unavoidable and even present 
in healthy aging [31]. Additional physiological deterioration is marked by an even greater 
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loss of complexity. For example, declines due to sensory impairment [34] and frailty [35] 
resulted in a reduced complexity of postural fluctuations. Similarly, fallers (who generally 
present with physiological declines in sensory and neuromuscular functions [36]) were 
characterized by a loss of gait complexity [37, 38]. In the present thesis, it was postulated 
that physiological decline caused by cognitive impairment was also reflected in gait 
function. A loss of gait complexity would be characterized by an increase in gait regularity 
and predictability [39], outcomes that will be clarified in the paragraphs below.  
The dynamic nature of walking: what’s in someone’s gait?
Researchers have been using gait speed extensively as a comprehensive index of old adults' 
locomotor performance [40]. A ubiquitous observation from previous studies is an age-
related slowing of gait speed. Even ‘healthy aging’ is associated with a slowing of habitual 
gait speed of as much as 16% per decade after the age of 60 [41-43]. A gait speed below 1.0 
m/s signifies potential clinical conditions such as mobility impairment, recurrent falling, 
a loss of independence, and possibly poor cognitive function. In addition, gait slowing 
has been associated with hospitalization and even mortality [44]. The value of measuring 
gait speed in old adults is therefore increasingly endorsed and gait speed has even been 
proposed as the ‘sixth vital sign’ [45] and a test used in geriatric clinics [40, 46].
The original observation of the relationship between gait slowing and cognitive impairment 
was reported nearly two decades ago. The data showed that a slow gait speed in the oldest-
old preceded cognitive impairment 3 years later, with old adults who developed cognitive 
impairment vs. those who remained cognitively stable walking 0.69 m/s and 0.95 m/s at 
baseline, respectively [47]. Similarly, Buracchio and colleagues reported an acceleration in 
gait slowing up to 12.1 years before cognitive impairment became clinically manifested 
[48]. More recently, multiple studies confirmed those initial findings, and highlighted the 
potential of a slow gait speed as a precursor of MCI and dementia in initially healthy old 
adults who were recruited from the community [49-51]. Gait speed expressed in one of its 
elements, such as stride time and stride time variability (assessed with the Coefficient of 
Variation), have also been linked to cognitive impairment, in which a higher stride time 
variability was associated with future decline in memory and executive functioning [52], 
and with the development of MCI [53, 54]. A meta-analysis underscored that higher stride 
time variability represented a motor phenotype of MCI, with patients with vs. without MCI 
presenting with a stride time variability of 3.8±6.7% and 2.0±1.8%, respectively [55]. Most of 
the above studies were performed in relatively young old adults (age ranging from 65-75) 
recruited from the community. Less is known, however, about geriatric populations who are 
older and present with many co-morbidities.
In addition to gait speed as a summary index of mobility, fine-grained, dynamic gait 
outcomes describe features of gait not apparent in gait speed. The quantification of such 
gait dynamics can be achieved when walking is viewed as a dynamic task. Indeed, walking 
requires continuous interactions between body segments, the body and the environment, 
and necessitates both, anticipatory and reactive responses. For example, when one 
walks from point A to point B, we are able to adapt our gait to a variety of unexpected 
circumstances. We can easily manage to walk on different surfaces, anticipate to upcoming 
traffic, and avoid obstacles that block the road, while controlling and coordinating our 
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moving body parts such as our legs, arms, trunk, and the head [56]. Old adults are even 
more challenged to control and coordinate moving body parts [57], as they experience a 
loss of muscle strength, and a reduction in the ability to detect and process sensory as 
well as proprioceptive information [58]. Apart from individuals with severe cognitive and/or 
physical dysfunction, even old adults are able to flexibly adapt to all kind of circumstances. 
Yet, our steps are not independent of each other but instead depend on previous as well as 
on steps we anticipate to make. For example, when we stumble, the length of our next step 
will be larger in order to compensate for this ‘miss-step’. Previous steps may unravel why 
this compensation was successful or unsuccessful. Similarly, patients can walk very slowly 
but highly stable or very fast but highly unstable, and everything in between. Analysing 
time-dependent fluctuations, i.e., how gait evolves over time, may unravel the cause of slow 
gait in terms of gait coordination and reactions to perturbations [38, 39, 56, 59-61]. The 
time-series correlation between the constituent events of gait can reveal underlying gait 
disorders or pathologies. Using traditional gait measures such as gait speed and (coefficient 
of variation of) stride time may mask the temporal interdependence between successive 
steps, as those measures simply average step-related information over time. In summary, 
the quantification of time-dependent fluctuations during walking potentially increases our 
understanding of the relationship between gait and cognitive impairment, and may help to 
underpin the neural control of gait.
Tools and concepts to quantify gait dynamics
Dynamical systems theory provides tools and concepts to quantify time-dependent 
fluctuations during walking [38, 39, 59, 60, 62, 63]. A continuous monitoring of a patients’ 
gait pattern is required to capture those time-dependent fluctuations. There are a variety 
of ways to continuously monitor gait (e.g., optoelectric systems), but the advantage of 
accelerometry is that walking remains relatively unconstrained and can be measured 
outside laboratory settings over long walking distances and durations [64]. Because the 
regulation of balance during walking is known to be reflected in acceleration signals of the 
lower trunk (because of its proximity to the body’s center of mass) [65], trunk accelerations 
can accurately reflect center of mass behaviour during gait [64]. From trunk acceleration 
signals, dynamic gait outcomes can be computed that quantify time-dependent fluctuations 
and patterns throughout the gait cycle [38, 39, 59, 60, 62, 63]. For example, the Index of 
Harmonicity reflects gait smoothness [62], autocorrelation procedures are used to examine 
gait regularity and symmetry [59], and the maximal Lyapunov exponent can be computed 
as an indicator of gait stability [66]. In this thesis, the term ‘gait dynamics’ is used to refer 
to such dynamic aspects of walking. In general, gait dynamics are indicative of overall gait 
coordination, adaptability, and the ability to respond to perturbations.
There is a limited number of studies that examined gait dynamics in patients with cognitive 
impairment. Patients with dementia compared with age-matched controls present with 
high gait variability and low gait stability [67]. Another study reported low gait variability 
and irregular trunk acceleration patterns in dementia patients [68]. With respect to other 
conditions, gait dynamics discriminated young and old adults [69], individuals with and 
without a clinical condition [70, 71], and fallers and non-fallers [37, 38, 72-74]. Healthy old 
adults (aged 46-75) had a less variable, more predictable, and less symmetrical gait as 
compared to healthy young adults (aged 18-45). Patients with a flexed posture presented 
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with a more variable, and less regular trunk accelerations as compared to patients with a 
normal posture [70]. Studies concerned with gait dynamics in relation to fall-status showed 
that a high fall risk was associated with a less smooth and less stable gait [73], with a more 
variable and less stable gait [74], and with less gait complexity [37, 38]. Gait dynamics thus 
showed potential to identify clinical as well as non-clinical conditions.
A multivariate approach 
Because of the high number of comorbidities, a multivariate approach is necessary to 
examine the link between gait and cognition in geriatric patients. As mentioned before, 
geriatric conditions are often characterized by multiple aetiological factors and interacting 
pathogenetic pathways [5]. Those geriatric conditions are likely to be inter-related. For 
example, conditions that are typically present in geriatric patients are known to interact with 
gait performance, such as a flexed posture [70], muscle weakness [75], and polypharmacy 
[76]. Also, gait characteristics tend to correlate with one another. For instance, gait speed 
highly correlates with stride time. While gait speed and stride time individually may have 
limited power in the identification of cognitive impairment, the combination of these two 
measures can be substantially higher. In addition to the fact that statistical assumptions 
are not met, performing univariate analyses for each individual outcome could mask 
clusters / dependencies in the data. Therefore, multivariate analyses were performed using 
Partial Squares Discriminant Analyses (PLS-DA) [77] in chapter 3 and 4. PLS-DA combines 
features from Principal Component Analysis and usual regression analysis. Covariance 
structures are modelled, and underlying latent clusters are extracted.
Objectives of the thesis
Most of the existing literature on the relationship between gait and cognitive impairment is 
concerned with relatively young and healthy old adults, while our sample of geriatric patients 
is older and presents a high number of co-morbidities known to interact with gait function. 
In addition, previous studies predominantly focussed on gait speed as indicator of cognitive 
impairment, while fine-grained, dynamic gait outcomes potentially increase the specificity of 
the gait-cognition link, and may help to underpin the neural control of walking. Therefore, the 
main objective of this thesis was to increase our understanding of the relationship between 
gait and cognition in geriatric patients. To this aim, multivariate analyses were used to study 
multiple gait outcomes in relation to cognitive status. Ultimately, gait characteristics could 
serve as non-invasive indicators of cognitive impairment in this vulnerable population. To 
achieve this main goal, sub-objectives were twofold: (1) to characterize the gait pattern 
of geriatric patients with and without cognitive impairment, as compared to younger and 
healthier old adults, and (2) to examine whether and how gait characteristics can contribute 
to the identification and/or prediction of cognitive impairment and falls. It was hypothesized 
that geriatric patients with cognitive impairment presented with a slower, more regular 
and less complex gait pattern as compared to cognitive intact geriatric patients. In 
addition, it was expected that gait outcomes derived from an extensive gait analysis 
could add to usual diagnostics to identify and/or predict cognitive impairment and falls.
Figure 1 illustrates the gait protocol and measures that were used in Chapters 3-5. In 
addition to usual screening procedures at the MC Slotervaart hospital, patients walked for 
3-minutes, during single- and dual-tasking. Trunk accelerations in Anterior-Posterior (AP), 
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Medio-Lateral (ML), and Vertical (V) signals were derived from an IPod touch 4G. The figure 
shows an example of a raw acceleration signal in AP direction, from which trunk outcomes, 
i.e., gait dynamics, were calculated in 3D. Considering the explorative nature of the studies, 
multiple gait outcomes were quantified. While all outcomes reflect the dynamic nature of 
walking, they quantify different aspects of the gait pattern, using different properties of the 
acceleration signal (e.g., amplitude, frequency, time-scales, phase-space).
Figure 1. The gait protocol and measures that were used in Chapters 3-5. In addition to usual screening 
procedures at the MC Slotervaart hospital, patients walked for 3-minutes, during single- and dual-tasking. 
Trunk accelerations in Anterior-Posterior (AP), Medio-Lateral (ML), and Vertical (V) signals were derived 
from an IPod touch 4G. The figure shows an example of a raw acceleration signal in AP direction, from 
which trunk outcomes, i.e., gait dynamics, were calculated in 3D.
Outline of the thesis
To obtain an overview of the existing literature concerned with the relationship between gait 
characteristics and cognitive impairment in old adults, chapter 2 systematically reviewed 
evidence from longitudinal studies that revealed associations between baseline gait function 
and future cognitive decline. Chapter 3 studied the contribution of an extensive cognitive- and 
gait evaluation in the classification accuracy of fallers and non-fallers. Chapter 4 examined 
gait characteristics and their discriminative power in healthy old controls, and in geriatric 
patients with- and without cognitive impairment. The gait outcomes that revealed with the 
highest discriminative power were studied in a prospective design in chapter 5. This pilot 
study investigated how baseline gait outcomes correlated with future cognitive decline.
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Early identification of individuals at risk for cognitive decline may 
facilitate the selection of those who benefit most from interventions. 
Current models predicting cognitive decline include neuropsycho-
logical and/or biological markers. Additional markers based on 
walking ability might improve accuracy and specificity of these mod-
els because motor and cognitive functions share neuroanatomical 
structures and psychological processes. We reviewed the relation-
ship between walking ability at one point of (mid)life and cognitive 
changes at follow-up. A systematic literature search identified 20 
longitudinal studies. The average follow-up time was 4.5 years. Gait 
speed quantified walking ability in most studies (n=18). Additional 
gait measures (n=4) were step frequency, variability and step-length. 
Despite methodological weaknesses, results revealed that gait slow-
ing (0.68-1.1 m/sec) preceded cognitive decline and the presence of 
dementia syndromes (maximal odds and hazard ratios of 10.4 and 
11.1, respectively). The results indicate that measures of walking 
ability could serve as additional markers to predict cognitive decline. 
However, gait speed alone might lack specificity. We recommend 
gait analysis, including dynamic gait parameters, in clinical evalu-
ations of patients with suspected cognitive decline. Future studies 
should focus on examining the specificity and accuracy of various 
gait characteristics to predict future cognitive decline. 
Keywords: Dementia, cognitive impairment, biomarker, gait, MCI, 
prediction models
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INTRODUCTION
Rationale
The increase in the number of old adults nearly parallels the incidence of age-associated 
dementia worldwide [1, 2]. Data suggest that the pathophysiological processes of dementia 
may start several years or even decades before the eventual diagnosis [3, 4]. Patients 
progress from a preclinical phase during which the disease might have already started 
in the brain without overt clinical symptoms, followed by a period characterized by the 
presence of Mild Cognitive Impairments (MCI), culminating in a diagnosis of dementia [5]. 
In the absence of a cure, key strategies of disease management include early diagnosis, 
delaying disease onset, and a slowing of disease progression [6, 7]. Therefore, identifying 
markers that predict dementia is a major subject of current interest [8, 9]. 
Prediction of dementia is often studied in the context of MCI [10], which is a transitional state 
between a cognitively intact condition and dementia [11]. Patients with MCI have cognitive 
dysfunctions beyond those expected as a result of normal aging, yet the level of impairment 
is not severe enough to compromise the ability to perform activities of daily living [12]. 
Even though the published values vary, a recent review analysing population data (> 300 
participants) estimated the prevalence of MCI to range from 16 to 20% in patients over 
age 60. Approximately 10 to 15% of these patients develop dementia annually [13]. This 
conversion rate is high, making it important to differentiate between patients who will 
develop dementia and those who will remain cognitively fit. Early identification of patients at 
risk for dementia might help to select those individuals who would benefit most from future 
interventions to delay disease onset and slow the progression of neurodegeneration [14].
 
Biomarkers in prediction models for dementia
Biomarkers are used to identify pre-dementia symptoms and can be broadly classified 
as (1) cognitive markers (test scores measuring cognitive functioning such as memory 
and executive function) and (2) biological markers (such as measures derived from 
cerebrospinal fluid and brain imaging). The most accurate predictors are memory tasks 
measuring long-delay free recall [15-19], the cerebrospinal fluid (CSF) markers Aβ1–42/t-
tau ratio [15, 20-22], and volumes of the hippocampal and entorhinal cortices [15, 20, 23-
25]. However, single predictors seem to be insufficiently sensitive to predict conversion 
from MCI to dementia. Therefore, prediction models ultimately employ a combination of 
markers [26]. Nevertheless, such predictions are far from perfect, as age, duration of follow-
up, subtype of MCI diagnosis, degree of cognitive decline (early versus late stage of MCI), 
and outcome (e.g., AD, mixed dementia) all seem to affect conversion rates [16]; [27]; [28]. 
For example, a recent study showed that both neuropsychological assessment and MRI 
variables can predict conversion to AD with 63% to 67% classification accuracy in patients 
with MCI both younger and older than 75, while CSF biomarkers reached this rate only in 
patients younger than 75 years old [16]). A systematic review about risk prediction models 
for dementia concluded that sensitivity and specificity values vary broadly between studies, 
(Area Under the Curve ranging from AUC = 50 to AUC = 87). In particular, specificity is low in 
numerous prediction models [29], complicating the clinical use of such models. 
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Taken together, these observations show that it remains a persistent challenge and should 
be a research priority to develop dementia prediction models that ultimately employ 
a combination of markers to differentiate between old adults who will and who will not 
develop dementia. Current prediction models show low to moderate predictive ability with 
large variability, making it necessary to explore new markers. A possible candidate is motor 
function, in which walking ability may serve as a potential marker in the prediction of 
cognitive decline [30-32]. 
Walking ability as a predictor of cognitive decline
The original observation of a correlation between motor and cognitive impairments was 
reported nearly two decades ago. The data suggested that motor slowing (e.g., low walking 
speed) precedes cognitive decline in healthy older adults [33], a finding substantiated by 
the relationship between reductions in gait function and the development of dementia [34]. 
Numerous cross-sectional and longitudinal studies have recently confirmed these initial 
findings [35-38].
Viewing walking as a complex task could increase its validity to serve as a marker for 
early cognitive decline. Indeed, imaging and brain stimulation studies suggest that higher 
brain centres are involved in the planning and execution of normal human locomotion [39] 
and balance [40, 41]. The widespread network of brain areas that control walking involves 
regions responsible for attentional, executive and visuospatial functions as well as areas 
needed to perform and control motor tasks, such as the cerebellum, basal ganglia and 
motor cortex [42]. Thus, there is an overlap between areas that control walking and areas 
that control cognitive functioning, explaining the relationship between dementia-related 
pathology and gait dysfunction. The co-occurrence of decline in both cognitive and gait 
function favours a ‘common-cause’ mechanism [43]. There is considerable evidence for 
the role of white matter damage in age-related cognitive decline and dementia [44, 45]. 
In addition, reduced grey and white matter volumes in multiple brain regions and white 
matter hyperintensities are associated with gait dysfunction (gait speed of <0.5 m/s) in old 
adults free from dementia [46]. 
Perhaps the simplest demonstration of the interrelationship between gait and cognition 
comes from dual task studies in, which subjects perform a walking and cognitively 
demanding task concurrently [47]. ‘Dual task cost’, i.e., the magnitude of deterioration in 
gait performance measured during single vs. dual tasking, arises from the two interfering 
tasks competing for the same cortical resources [48]. It is noteworthy that dual task costs 
are often higher in cognitively impaired compared to cognitively intact elderly [48-51]. 
The effects of decline in cognition on walking are especially expressed in the slowing of 
gait. A ubiquitous observation from cross-sectional studies is the reduction of gait speed 
in patients with MCI [52-54] and dementia [37, 38, 51, 55]. In addition to gait speed, spatial 
variability and stride time variability (STV) tend to increase in patients with MCI [56, 57]. 
However, for the time being, most studies have cross-sectional designs and are restricted to 
gait speed as a measure of walking ability.
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Aims
The co-occurrence of gait dysfunction and decline in cognitive function as derived from 
cross-sectional studies suggests that measures of walking ability could serve as a marker 
in the identification of individuals at risk to develop dementia. To verify the possibility that 
gait dysfunction precedes cognitive decline, we set the aim of the present review to scope 
evidence from longitudinal studies that assessed whether or not there is a relationship 
between walking ability at one point of (mid)life and cognitive decline years later. In addition, 
we critically evaluate and discuss methodologies used to determine this relationship and to 
formulate recommendations for future studies to expand the preclinical phase of dementia. 
METHODS
Scoping review
A scoping review method was adopted to explore the depth of evidence for the putative 
role of walking ability in the prediction of cognitive decline. A scoping review provides an 
appropriate method to systematically scan and evaluate evidence within a specific area 
of research and to identify gaps in the existing literature, allowing variation in methods 
between studies selected for inclusion [58, 59]. 
Literature search
A systematic literature search was performed for studies published from 1980 till May 
2015 in PubMed and Embase using keywords specific to Embase thesaurus (EMtree) and 
to PubMed in the form of Medical Subject Headings (Mesh), combined with non-specific 
terms. We used a cognitive term (cognitive decline, MCI, cognitive impairment, dementia), 
combined it with a walking term (gait, walking, locomotion, motor performance, motor 
slowing), and terms representing a longitudinal study design (follow-up, longitudinal, long-
term, prospective, cohort, predict). Filters further focused the search by removing various 
clinical conditions. Figure 1 presents the syntax. 
Inclusion, exclusion criteria
The inclusion criteria were specified as followed: (1) Quantitative gait analysis 
measurements at baseline, (2) Study populations consisting of older adults with a mean 
age of 65 or older with significant cognitive decline or cognitive decline clinically diagnosed 
(e.g., MCI, dementia, Alzheimer’s disease) at follow-up, (3) a longitudinal study design, and 
(4) English as publication language. The exclusion criteria were specified as followed: 1) 
Cognitive impairment with clinical diagnosis other than related to dementia (e.g., Multiple 
Sclerosis, Huntington’s disease, and Parkinson’s disease), 2) animal research, and 3) case 
studies. Duplicates and reviews were removed. Two reviewers were involved in the literature 
search and independently selected studies for in- and exclusion. Disagreement between the 
researchers was discussed until they reached consensus.   
Data analysis
The literature revealed two types of studies investigating the relationship between walking 
ability and future cognitive decline, which are presented separately in the review: 1) 
longitudinal studies that examined associations between baseline walking ability and 
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within-person change in cognition at follow-up (with most results presented as beta-
values) and 2) longitudinal studies that established risk estimates for cognitive decline at 
follow-up, with measures of walking ability as predictors (with most results presented as 
hazard ratios or odds ratios).
RESULTS
Literature search
The literature search revealed 431 studies of which after screening for title and abstract, 
50 were assessed for eligibility by full-text analysis. Finally, 20 articles met the criteria for 
inclusion. A flowchart of the literature search and selection process is presented in figure 1.
Figure 1. Syntax of literature search and selection process.
Study characteristics
Studies included in the current review were heterogeneous in terms of number of 
participants (ranging from 52 to 2776), age (> 60 to > 80) and length of follow-up (ranging 
from 2 to 9 years) and are based on data from 24,368 participants. Retention rate was 71% 
between baseline and follow-up measurement (n = 19 studies), with mortality accounting 
for most of the attrition. Two studies (10%) were sex-homogeneous (Table 2; Ref. 2 & 14) 
and sixteen studies (80%) showed large age ranges (> 10 years) or high standard deviations 
from the mean age (> 3 years). Patients were cognitively healthy at baseline in most studies 
(n = 17). Three studies included patients with pre-dementia syndromes at baseline [60-
62]. Statistical models were adjusted for cofounding variables grossly representing the 
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following domains: sociodemographic (age, sex, education, gender), behavioural (physical 
activity, smoking), clinical conditions (heart disease, stroke, diabetes mellitus, hypertension, 
osteoporosis, arthritis, depression and pain), visual functioning (visual acuity), health-
related (BMI, blood pressure) and genetic factors (APOE ε4 allele). 
Measures of walking ability and cognitive function
Walking ability was mainly quantified using gait speed (n = 18 studies; 90%), either measured 
over a certain distance or by the completion of a bidirectional walk. Only a few studies (n 
= 3, Table 1; Ref 2 & 8 and Table 2; Ref 9) quantified walking by other gait characteristics 
such as step frequency, stride length, cadence, stance time, swing time and double support 
time. One study assessed multiple aspects of walking as revealed by factor analysis, namely 
pacing (loading on gait speed and step length), rhythm (loading on cadence and timing 
measures) and variability (loading on stride length variability and swing time variability) 
[63]. For the assessment of cognition as main outcome at follow-up, four studies (20%) used 
measures of global mental state (assessed by mini mental state examination (MMSE) or 
modified versions) (Table 1; Ref 1, 2, 4 & 5), four studies (20%) used measures of specific 
cognitive functions (e.g., memory, executive functioning and processing speed) (Table 1; Ref 
3, 6, 7 & 8), and twelve studies (60%) used diagnoses of dementia syndromes (e.g., dementia, 
AD, MCI, vascular dementia) (Table 2; Ref 1, 2, 3, 4, 6, 8, 9, 10, 11, 12, 13 & 14). Cognitive 
state at baseline was assessed using various measurement instruments to indicate global 
mental state, such as the MMSE, and guidelines to indicate dementia syndromes, such as 
DSMM IV and clinical dementia rating (CDR) scale.
The relationship between walking ability and future cognitive decline
Longitudinal studies that examined associations between baseline walking ability and 
within-person change in cognition at follow-up
Table 1 presents the eight studies that determined the relative association between baseline 
walking ability and within-subject change in cognition at follow-up (n = 9,984). Baseline 
walking ability was quantified with gait speed in five studies (62.5%) with a mean habitual 
gait speed of 1.00 m/s (n = 7,532) measured on a straight course with distances ranging 
from 2.5 meters to 7 meters. The other three studies could not serve as a reference because 
the authors reported gait speed as ranges instead of a mean value (Ojagbemi et al., 2015) or 
used walking tasks involving a turn that slows gait and would bias the data in the present 
patient description (Alfaro-Acha et al., 2007; Katsumata et al., 2011). 
Standardized beta-coefficients were reported as outcome measure with positive values 
indicating a yearly increase or preservation of cognition in relation to a unit higher gait 
performance at baseline, and negative values indicating a yearly decline in cognition in 
relation to a unit lower gait performance at baseline. For example, a unit increase in time to 
walk 8-feet predicts 0.21 points decline in MMSE score per year (β = -0.21, [64]. One study 
reported estimated test scores on mental state to indicate cognitive decline in relation to 
baseline waking ability and found an increase of 2.00 and 2.31 in square root of number of 
errors in the Japanese version of the MMSE, for slow and fast TUG time respectively [65]. All 
associations were relative to baseline walking ability of the reference group. 
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With respect to studies using measures of mental state as main outcome, slow gait speed at 
baseline was associated with decline in MMSE score at follow-up (β = -0.21, p < 0.01) (Table 
1; Ref 1). In addition, longer step length in men at baseline was associated with preserved 
MMSE score at follow-up (β = 0.162, p < 0.05) (Table 2; Ref 2). Furthermore, faster gait speed 
at baseline correlated with preserved MMSE score at follow-up, but only under fast speed 
instructions (β = 0.038, p < 0.05) (Table 1; Ref 4). Finally, longer time to complete the TUG 
test was associated with decline in the Japanese version of the MMSE (p = 0.03) (Table 
1; Ref 5). With respect to studies using measures of specific cognitive functions as main 
outcomes (n=4), faster gait speed at baseline was associated with preservation of executive 
functioning (β = 0.036, p < 0.01; β = 0.060, p < 0.01) (Table 1; Ref 3 & 6), memory (β = 0.031, 
p < 0.05; β = 1.24, p < 0.01) (Table 1; Ref 3 & 7), processing speed (β = 0.025, p < 0.05) [36] 
and visuospatial functioning (β = 0.042, p < 0.05) (Table 1; Ref 6) at follow-up. In addition to 
gait speed, impaired pacing at baseline was associated with a decline in the digit symbol 
test and letter fluency task (both relying on executive functioning) at follow up (β= -0.73, p 
< 0.001 and β = -0.46, p < 0.001, respectively) (Table 1; Ref 8). Impaired rhythm at baseline 
was associated with decline in memory at follow-up (β = -0.15, p < 0.05) (Table 1; Ref 8). 
In summary, slow gait speed (under habitual and fast speed instructions) at baseline 
was related to decline in global mental state, executive function, memory performance, 
processing speed and visuospatial function, after a mean follow-up period of 4.3 years. 
Shorter step length in men and longer time to complete the TUG test at baseline were 
associated with decline in measures of global mental state at follow-up. Impaired rhythm 
at baseline was associated with decline in memory functioning and impaired pacing with 
decline in executive functioning at follow-up. The results indicate that slow gait speed 
precedes decline in mental state as well as in specific cognitive functions. Although there 
is limited evidence for gait characteristics other than gait speed, the results signify that 
dysfunctions in those characteristics also precede cognitive decline.
Longitudinal studies that established risk estimates for cognitive decline, with 
measures of walking ability as predictors 
Table 2 summarizes 14 studies that examined the relative risk for cognitive decline, 
predicted by walking ability at baseline (n = 14,384). Participants developed dementia (43%), 
Alzheimer’s disease (29%), vascular dementia (14%), MCI (7%) or other diagnosed cognitive 
impairment (50%), in which some studies examined multiple syndromes. Mean baseline 
gait speed of participants who remained free from significant cognitive decline at follow-up 
was 1.11 m/s, based on four studies providing this information (n = 2,921). In contrast, mean 
baseline gait speed of participants who developed dementia, MCI and cognitive impairment 
was respectively 0.8 m/s (n = 2631), 0.91 m/s (n = 204) and 0.68 m/s (n = 85). The other 
seven studies either used gait speed ranges, gait variability, pace or rhythm measures, 
or did not distinct between cognitive subgroups. Gait speed was measured over walking 
distances ranging from 2.5 meters to 9 meters. 
Outcomes are presented as risk ratios (hazard ratio, odds ratio or relative hazard). Odds 
ratios (OR) were reported most often, with values above one signifying a higher relative 
risk compared to the reference group. For example, patients with slow versus fast gait 
speed at baseline were 2.28 times more likely to be diagnosed with dementia at follow-up 
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[66]. Second, hazard ratios (HR) were reported with values < 1.0 indicating a risk reduction 
in cognitive decline with better gait performance at baseline and values > 1.0 indicating 
increased risk at cognitive decline predicted from gait performance at baseline, both 
proportionally to a comparison group. For example, patients with motoric cognitive risk 
(MCR) syndrome had an 11-fold risk (HR = 11.1) to develop dementia at any given point 
in time [60]. One study reported a relative hazard of 1.57 [67], meaning that patients with 
slower gait speed at baseline were 1.57 times more likely to have developed dementia after 
7 years compared to the reference group. Another study reported a transition point in the 
acceleration of gait speed decline 12.1 years prior to cognitive decline [68], indicating that 
changes in gait were already visible 12.1 years prior to significant cognitive decline. 
With respect to studies using dementia as main outcome, slow gait speed at baseline was 
related to an increased risk for dementia at follow-up (OR = 2.28, p < 0.05; RH = 1.57, p < 0.05; 
HR = 2.72, p < 0.05; OR = 5.6; OR = 10.4; HR = 0.79, p < 0.001; HR = 0.78, p < 0.01; OR = 1.61, 
p < 0.05) (Table 2; Ref 1, 2, 11-14, respectively). Also, impaired rhythm and high variability 
at baseline were related to increased risks for dementia at follow-up (HR = 1.48, p < 0.05 
and HR = 1.37, p < 0.05, respectively) (Table 2; Ref 10). In addition to studies examining 
the risk for dementia, several studies revealed that slow gait speed at baseline was also 
related to increased risk for Alzheimer’s disease (OR = 3.38, p < 0.05; HR = 0.81, p < 0.01) 
(Table 2; Ref 1 & 13) as well as vascular dementia (HR = 11.10, p < 0.001) (Table 2; Ref 11) at 
follow-up. Note that in some studies patients were diagnosed with MCI at baseline (Table 2), 
explaining the large risk ratios [38, 61, 62]. Impaired pacing was also related to increased 
risk for vascular dementia (HR = 1.61, p < 0.05) (Table 1; Ref 10). The risk for significant 
cognitive impairments other than dementia syndromes at follow-up was determined using 
various definitions, for example > 3 points decline in MMSE score, > 0.5 points at the CDR 
scale, and more than 9 points decline in digit symbol substitution test (DSST) score. All 
studies concluded that slow gait speed at baseline predicted a significant increase in risk 
for cognitive impairment at follow-up. One study found shorter step length to be related to 
increased risk for cognitive decline and found higher risks for step length compared to gait 
speed and for gait under fast speed instructions compared to habitual gait speed [69]. 
In summary, slow gait speed at baseline was related to an increased risk for dementia, 
Alzheimer’s disease, and significant cognitive decline as defined in specific studies, after 
a mean follow-up period of nearly 5 years. In addition, poor gait rhythm and high gait 
variability were related to increased risk for dementia, and worse performance on the pace 
factor was related to increased risks for vascular dementia. Altogether, the longitudinal 
data shows that slowed gait speed appears before cognitive decline is detected. Despite 
the limited number of studies reporting on other gait characteristics, the results of these 
studies point in the same direction. 
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DISCUSSION
The present scoping review aimed to examine the relationship between walking ability and 
future cognitive decline. The main finding supported the hypothesis that walking ability 
at baseline, independent of gait characteristic, has the potential to predict future cognitive 
decline through (1) an association between poor walking ability at baseline and within-
person decline in cognition at follow-up and (2) a higher risk for cognitive impairment/
dementia with poor walking ability at baseline as predictor variable. We provide an in-depth 
analysis of methodological inequalities between studies and synthesize the information 
into one key recommendation, i.e., clinicians should add walking ability as a quantitative 
and simple preclinical measurement to the array of tests used to predict cognitive decline 
in old adults. 
The analyses of the longitudinal studies, with a mean follow-up period of 4.3 years, that 
examined associations between baseline walking ability and within-person change in 
cognition at follow-up (Table 1) revealed that slow gait speed (1.00 m/s) at baseline preceded 
decline in global mental state as well as in specific cognitive functions. A role for walking 
ability in the prediction of cognitive decline is supported by the finding that slower gait 
speed at baseline predicted increased risks for diagnostic outcomes related to dementia, 
after a mean follow-up period of nearly 5 years (Table 2). Mean baseline gait speed of old 
adults who developed dementia, MCI and cognitive impairment was respectively 0.8 m/s (n 
= 2631), 0.91 m/s (n = 204) and 0.68 m/s (n = 85), in contrast to mean baseline gait speed 
of participants who remained free from significant cognitive decline (1.11 m/s). Mean gait 
speed values are far beneath standard values of 1.15 [70], 1.22 (Hortobágyi et al., 2015), and 
1.30 m/s [71] reported previously. In contrast, a mean gait speed of 1.00 m/s or lower is often 
used as a cut-off point for high risks for negative health outcomes such as hospitalization 
and death [72]. To rule out frailty, a reference of > 0.90 m/s is used [73]. Together, subject and 
gait characteristics suggest that the results are relevant to older adults who are cognitively 
healthy at baseline, mostly not frail, but less fit than healthy older adults. (Table 2). 
Walking ability in the prediction of cognitive decline
Gait speed is most often used to evaluate the relationship between walking ability and future 
cognitive decline. This finding is not unexpected because gait speed is associated with many 
adverse health and clinical outcomes in healthy and mobility-impaired old adults [72, 74]. 
Slowing of habitual gait speed represents an important characteristic of reduced physical 
capacity as a result of the aging process, with slowing of gait speed up to 16% per decade 
in individuals over 60 [66, 71, 75]. A possible explanation for slow gait speed preceding 
the development of cognitive decline is that it may represent a marker of lesions in the 
brain resulting from pathophysiological changes related to cognitive decline. Age-related 
cognitive decline and dementia have been associated with white matter damage [44, 45]. 
This damage in white matter volumes in turn has been found to affect gait speed (gait speed 
of <0.5 m/s), even in older adults free from dementia [46]. Thus, slowing of gait speed might 
be an early indicator of the presence of brain lesions. An additional explanation for the 
association between slow gait speed and cognitive decline may be found in the relationship 
between muscle strength and slow gait speed. Loss of muscle strength has been associated 
with high levels of inflammatory markers, low levels of corticosteroids and high oxidative 
32
Table 1. Walking ability in the prediction of cognitive decline: longitudinal studies that examined associations 
between baseline walking ability and within-person change in cognition at follow-up.
To be continued on the next page
 
Author, Year Study No. of 
partici-
pants 
Follow-
up 
(years) 
Base-line 
age 
Baseline gait 
 (mean ± SD) 
Baseline cognition Follow-up 
cognition 
Main results Change in cognition  
(in relation to baseline 
gait)   
Alfaro-Acha 
et al., 2007 
[64] 
Hispanic 
Established 
Population for 
the Epide-
miological 
Study of the 
Elderly 
1218 7 >65 Timed 8-feet walk 
(s):  
7.7±6.4 
MMSE:  
26.5±2.9 
N.A. Subjects in the lowest 8-foot walk time quartile 
(≥9s) had greater cognitive decline over 7 years 
than those in the highest quartile (<4s) (p<0.001).  
A unit increase in walk time predicts 0.21 points 
decline in MMSE score per year.   
Timed 8-feet walk: 
β (SE) MMSE:  
-0.21 (0.06)** 
 
Auyeung et 
al., 2011 [79] 
 
  
 
General 
Population of 
Older Chinese 
1514 
men 
 
 
 
1223 
women 
4 
 
 
 
 
4 
 
 
 
>65 Gait speed (m/s): 
1.04±0.21 
Step length (m): 
0.58±0.07 
Gait speed: 
0.94±0.19 
Step length: 
0.51±0.07 
 
MMSE: 
27.4±2.25 
 
 
 
25.8±2.80 
 
 
N.A. 
 
 
 
 
 
 
 
Shorter step length in men was associated with a 
lower MMSE score after 4 years (p<0.05).  
A unit increase in step length predicts 0.162 points 
increase in MMSE score per year. 
Step length men: 
β (95% CI) MMSE: 
0.162 (0.013, 0.309)* 
 
Gale et al., 
2014 [36] 
The English 
Longitudinal 
Study of 
Ageing 
2654 6 60-90 Gait speed (m/s): 
0.92±0.27 
 
 
 
 
 
EFa: 
19.57(5.85) 
Verbal memoryb: 
9.53(3.13) 
Proc speedc: 
18.8(5.50) 
EFa:  
19.03(6.28) 
Verbal memoryb: 
9.21(3.34) 
Proc speedc: 
17.57(5.45) 
Slower gait speed at baseline was associated with 
cognitive decline at follow-up in all domains 
(p<0.01; p=0.015; p=0.038 respectively).  
A unit increase in gait speed is associated with 
0.036, 0.031 and 0.025 less decline in cognitive 
functioning per year, respectively.    
Gait speed: 
β (SE) EF:  
0.036(0.013)**  
β (SE) verbal memory: 
0.031(0.013)* 
β (SE) proc speed:  
0.025(0.012)* 
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed (m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
 
MMSE: 
N.A. 
> 3 points decline 
in MMSE score 
Slow gait at fast speed was a predictor of cognitive 
decline over 3 years (p<0.021).  
A unit increase in gait speed was associated with 
0.038 less decline in MMSE score per year.  
Gait speed: 
β (SE) MMSE: 
0.038(0.016)* 
Katsumata et 
al., 2011 [65] 
Keys To 
Optimal 
Cognitive 
Aging (KOCOA) 
Project 
192 3 >80 - Fast or normal 
TUG time (<14s) 
- Slow TUG time 
(>14s) 
 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
Slow TUG time was associated with decline in 
JMMSE functioning after 3 years (p=0.03) but was 
only cross-sectional associated with EF and 
memory.  
An increase of 2.00 and 2.31 in square root of 
number of errors in the JMMSE, for slow and fast 
TUG time respectively.   
Estimated test score global 
cognitive functioning:  
Slow TUG (95% CI): 
2.00(1.85,2.15) 
Normal TUG (95% CI): 
2.31(2.08,2.55)  
Mielke et al., 
2013 [96] 
Mayo Clinic 
Study of Aging 
1158 4 70-89 Gait speed: 
1.09 (95% CI 
0.95,1.27) 
 
 
 
 
 
 
 
 
Memoryd:  
0.21(-0.39,0.86) 
Languagee: 
0.26(-0.30,0.82)  
EFf: 
0.34(-0.26,0.83) 
Visuospatialg: 
0.26(-0.38,0.80) 
Global cognitionh: 
0.30(-0.25,0.90) 
Memoryd:  
N.A. 
Languagee: 
N.A.  
EFf: 
N.A. 
Visuospatialg: 
N.A. 
Global cognitionh: 
N.A. 
A faster gait speed at baseline was associated with 
less cognitive decline in the following domains (EF 
p=0.001, visuospatial p=0.013, global cognition 
p=0.001).  
A 1 m/s increase in gait speed was associated with 
a 0.060, 0.042 and 0.049 higher z-score in cognitive 
domains per year, respectively. 
  
Gait speed: 
β (SE) EF: 
0.060 (0.016)** 
β (SE) visuospatial: 
0.042 (0.017)* 
β (SE) global: 
0.049 (0.013)** 
 
Ojagbemi et 
al., 2015 
[97] 
Ibada  study of 
aging (ISA) 
1042 2 >65 Gait speed 
N.A.  
Gait quartiles 
 
 
 
 
10-word delayed 
recall test: 
N.A.  
10-word delayed 
recall test: 
11.49±0.32 
A slower baseline gait speed was independently 
associated with poorer follow-up cognition (p=-
0.001).  
The slowest gait category (>6.52s 3m) had 1.24 less 
words recalled at follow-up, compared to the fastest 
gait category (<4.82s 4m). 
Gait speed: 
β (95% CI) recall test: 
1.24 (0.48,2.00)** 
 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Impaired pace and rhythm scores predicted 
cognitive decline in memory (p=0.02), digit symbol 
(p<0.001) and letter fluency (p<0.001).  
A 1 point increase in rhythm was associated with 
0.15 points decrease in memory per year.   
A 1 point increase in pace score was associated 
with 0.73 and 0.46 decrease in digit symbol and 
letter fluency per year, respectively.   
Rhythm factor: 
β (95% CI) memory: 
-0.15(-0.28,-0.02)* 
Pace factor: 
β (95% CI) digit symbol: 
-0.73(-1.15,-0.31)*** 
β (95% CI) letter fluency: 
-0.46(-0.82,-0.11)*** 
 
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05.  
a. EF measured with animal naming b. Measured with intermediate and delayed recall c. Measured with the letter cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction  
tasks and the Auditory Verbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial  
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of)  
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available. 
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Author, Year Study No. of 
partici-
pants 
Follow-
up 
(years) 
Base-line 
age 
Baseline gait 
 (mean ± SD) 
Baseline cognition Follow-up 
cognition 
Main results Change in cognition  
(in relation to baseline 
gait)   
Alfaro-Acha 
et al., 2007 
[64] 
Hispanic 
Established 
Population for 
the Epide-
miological 
Study of the 
Elderly 
1218 7 >65 Timed 8-feet walk 
(s):  
7.7±6.4 
MMSE:  
26.5±2.9 
N.A. Subjects in the lowest 8-foot walk time quartile 
(≥9s) had greater cognitive decline over 7 years 
than those in the highest quartile (<4s) (p<0.001).  
A unit increase in walk time predicts 0.21 points 
decline in MMSE score per year.   
Timed 8-feet walk: 
β (SE) MMSE:  
-0.21 (0.06)** 
 
Auyeung et 
al., 2011 [79] 
 
  
 
General 
Population of 
Older Chinese 
1514 
men 
 
 
 
1223 
women 
4 
 
 
 
 
4 
 
 
 
>65 Gait speed (m/s): 
1.04±0.21 
Step length (m): 
0.58±0.07 
Gait speed: 
0.94±0.19 
Step length: 
0.51±0.07 
 
MMSE: 
27.4±2.25 
 
 
 
25.8±2.80 
 
 
N.A. 
 
 
 
 
 
 
 
Shorter step length in men was associated with a 
lower MMSE score after 4 years (p<0.05).  
A unit increase in step length predicts 0.162 points 
increase in MMSE score per year. 
Step length men: 
β (95% CI) MMSE: 
0.162 (0.013, 0.309)* 
 
Gale et al., 
2014 [36] 
The English 
Longitudinal 
Study of 
Ageing 
2654 6 60-90 Gait speed (m/s): 
0.92±0.27 
 
 
 
 
 
EFa: 
19.57(5.85) 
Verbal memoryb: 
9.53(3.13) 
Proc speedc: 
18.8(5.50) 
EFa:  
19.03(6.28) 
Verbal memoryb: 
9.21(3.34) 
Proc speedc: 
17.57(5.45) 
Slower gait speed at baseline was associated with 
cognitive decline at follow-up in all domains 
(p<0.01; p=0.015; p=0.038 respectively).  
A unit increase in gait speed is associated with 
0.036, 0.031 and 0.025 less decline in cognitive 
functioning per year, respectively.    
Gait speed: 
β (SE) EF:  
0.036(0.013)**  
β (SE) verbal memory: 
0.031(0.013)* 
β (SE) proc speed:  
0.025(0.012)* 
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed (m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
 
MMSE: 
N.A. 
> 3 points decline 
in MMSE score 
Slow gait at fast speed was a predictor of cognitive 
decline over 3 years (p<0.021).  
A unit increase in gait speed was associated with 
0.038 less decline in MMSE score per year.  
Gait speed: 
β (SE) MMSE: 
0.038(0.016)* 
Katsumata et 
al., 2011 [65] 
Keys To 
Optimal 
Cognitive 
Aging (KOCOA) 
Project 
192 3 >80 - Fast or normal 
TUG time (<14s) 
- Slow TUG time 
(>14s) 
 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
Slow TUG time was associated with decline in 
JMMSE functioning after 3 years (p=0.03) but was 
only cross-sectional associated with EF and 
memory.  
An increase of 2.00 and 2.31 in square root of 
number of errors in the JMMSE, for slow and fast 
TUG time respectively.   
Estimated test score global 
cognitive functioning:  
Slow TUG (95% CI): 
2.00(1.85,2.15) 
Normal TUG (95% CI): 
2.31(2.08,2.55)  
Mielke et al., 
2013 [96] 
Mayo Clinic 
Study of Aging 
1158 4 70-89 Gait speed: 
1.09 (95% CI 
0.95,1.27) 
 
 
 
 
 
 
 
 
Memoryd:  
0.21(-0.39,0.86) 
Languagee: 
0.26(-0.30,0.82)  
EFf: 
0.34(-0.26,0.83) 
Visuospatialg: 
0.26(-0.38,0.80) 
Global cognitionh: 
0.30(-0.25,0.90) 
Memoryd:  
N.A. 
Languagee: 
N.A.  
EFf: 
N.A. 
Visuospatialg: 
N.A. 
Global cognitionh: 
N.A. 
A faster gait speed at baseline was associated with 
less cognitive decline in the following domains (EF 
p=0.001, visuospatial p=0.013, global cognition 
p=0.001).  
A 1 m/s increase in gait speed was associated with 
a 0.060, 0.042 and 0.049 higher z-score in cognitive 
domains per year, respectively. 
  
Gait speed: 
β (SE) EF: 
0.060 (0.016)** 
β (SE) visuospatial: 
0.042 (0.017)* 
β (SE) global: 
0.049 (0.013)** 
 
Ojagbemi et 
al., 2015 
[97] 
Ibadan study of 
aging (ISA) 
1042 2 >65 Gait speed 
N.A.  
Gait quartiles 
 
 
 
 
10-word delayed 
recall test: 
N.A.  
10-word delayed 
recall test: 
11.49±0.32 
A slower baseline gait speed was independently 
associated with poorer follow-up cognition (p=-
0.001).  
The slowest gait category (>6.52s 3m) had 1.24 less 
words recalled at follow-up, compared to the fastest 
gait category (<4.82s 4m). 
Gait speed: 
β (95% CI) recall test: 
1.24 (0.48,2.00)** 
 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Impaired pace and rhythm scores predicted 
cognitive decline in memory (p=0.02), digit symbol 
(p<0.001) and letter fluency (p<0.001).  
A 1 point increase in rhythm was associated with 
0.15 points decrease in memory per year.   
A 1 point increase in pace score was associated 
with 0.73 and 0.46 decrease in digit symbol and 
letter fluency per year, respectively.   
Rhythm factor: 
β (95% CI) memory: 
-0.15(-0.28,-0.02)* 
Pace factor: 
β (95% CI) digit symbol: 
-0.73(-1.15,-0.31)*** 
β (95% CI) letter fluency: 
-0.46(-0.82,-0.11)*** 
 
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05.  
a. EF measured with animal naming b. Measured with intermediate and delayed recall c. Measured with the letter cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction  
tasks and the Auditory Verbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial  
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of)  
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available. 
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Table 1. Continued
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05. 
a. EF measured with animal naming b. Measured with intermediate and delayed recall c. Measured with the letter 
cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction 
tasks and the Auditory Verbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective 
Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial 
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence 
interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of) 
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available.
 
Author, Year Study No. of 
partici-
pants 
Follow-
up 
(years) 
Base-line 
age 
Baseline gait 
 (mean ± SD) 
Baseline cognition Follow-up 
cognition 
Main results Change in cognition  
(in relation to baseline 
gait)   
Alfaro-Acha 
et al., 2007 
[64] 
Hispanic 
Established 
Population for 
the Epide-
miological 
Study of the 
Elderly 
1218 7 >65 Timed 8-feet walk 
(s):  
7.7±6.4 
MMSE:  
26.5±2.9 
N.A. Subjects in the lowest 8-foot walk time quartile 
(≥9s) had greater cognitive decline over 7 years 
than those in the highest quartile (<4s) (p<0.001).  
A unit increase in walk time predicts 0.21 points 
decline in MMSE score per year.   
Timed 8-feet walk: 
β (SE) MMSE:  
-0.21 (0.06)** 
 
Auyeung et 
al., 2011 [79] 
 
  
 
General 
Population of 
Older Chinese 
1514 
men 
 
 
 
1223 
women 
4 
 
 
 
 
4 
 
 
 
>65 Gait speed (m/s): 
1.04±0.21 
Step length (m): 
0.58±0.07 
Gait speed: 
0.94±0.19 
Step length: 
0.51±0.07 
 
MMSE: 
27.4±2.25 
 
 
 
25.8±2.80 
 
 
N.A. 
 
 
 
 
 
 
 
Shorter step length in men was associated with a 
lower MMSE score after 4 years (p<0.05).  
A unit increase in step length predicts 0.162 points 
increase in MMSE score per year. 
Step length men: 
β (95% CI) MMSE: 
0.162 (0.013, 0.309)* 
 
Gale et al., 
2014 [36] 
The English 
Longitudinal 
Study of 
Ageing 
2654 6 60-90 Gait speed (m/s): 
0.92±0.27 
 
 
 
 
 
EFa: 
19.57(5.85) 
Verbal memoryb: 
9.53(3.13) 
Proc speedc: 
18.8(5.50) 
EFa:  
19.03(6.28) 
Verbal memoryb: 
9.21(3.34) 
Proc speedc: 
17.57(5.45) 
Slower gait speed at baseline was associated with 
cognitive decline at follow-up in all domains 
(p<0.01; p=0.015; p=0.038 respectively).  
A unit increase in gait speed is associated with 
0.036, 0.031 and 0.025 less decline in cognitive 
functioning per year, respectively.    
Gait speed: 
β (SE) EF:  
0.036(0.013)**  
β (SE) verbal memory: 
0.031(0.013)* 
β (SE) proc speed:  
0.025(0.012)* 
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed (m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
 
MMSE: 
N.A. 
> 3 points decline 
in MMSE score 
Slow gait at fast speed was a predictor of cognitive 
decline over 3 years (p<0.021).  
A unit increase in gait speed was associated with 
0.038 less decline in MMSE score per year.  
Gait speed: 
β (SE) MMSE: 
0.038(0.016)* 
Katsumata et 
al., 2011 [65] 
Keys To 
Optimal 
Cognitive 
Aging (KOCOA) 
Project 
192 3 >80 - Fast or normal 
TUG time (<14s) 
- Slow TUG time 
(>14s) 
 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
Slow TUG time was associated with decline in 
JMMSE functioning after 3 years (p=0.03) but was 
only cross-sectional associated with EF and 
memory.  
An increase of 2.00 and 2.31 in square root of 
number of errors in the JMMSE, for slow and fast 
TUG time respectively.   
Estimated test score global 
cognitive functioning:  
Slow TUG (95% CI): 
2.00(1.85,2.15) 
Normal TUG (95% CI): 
2.31(2.08,2.55)  
Mielke et al., 
2013 [96] 
Mayo Clinic 
Study of Aging 
1158 4 70-89 Gait speed: 
1.09 (95% CI 
0.95,1.27) 
 
 
 
 
 
 
 
 
Memoryd:  
0.21(-0.39,0.86) 
Languagee: 
0.26(-0.30,0.82)  
EFf: 
0.34(-0.26,0.83) 
Visuospatialg: 
0.26(-0.38,0.80) 
Global cognitionh: 
0.30(-0.25,0.90) 
Memoryd:  
N.A. 
Languagee: 
N.A.  
EFf: 
N.A. 
Visuospatialg: 
N.A. 
Global cognitionh: 
N.A. 
A faster gait speed at baseline was associated with 
less cognitive decline in the following domains (EF 
p=0.001, visuospatial p=0.013, global cognition 
p=0.001).  
A 1 m/s increase in gait speed was associated with 
a 0.060, 0.042 and 0.049 higher z-score in cognitive 
domains per year, respectively. 
  
Gait speed: 
β (SE) EF: 
0.060 (0.016)** 
β (SE) visuospatial: 
0.042 (0.017)* 
β (SE) global: 
0.049 (0.013)** 
 
Ojagbemi et 
al., 2015 
[97] 
Ibadan study of 
aging (ISA) 
1042 2 >65 Gait speed 
N.A.  
Gait quartiles 
 
 
 
 
10-word delayed 
recall test: 
N.A.  
10-word delayed 
recall test: 
11.49±0.32 
A slower baseline gait speed was independently 
associated with poorer follow-up cognition (p=-
0.001).  
The slowest gait category (>6.52s 3m) had 1.24 less 
words recalled at follow-up, compared to the fastest 
gait category (<4.82s 4m). 
Gait speed: 
β (95% CI) recall test: 
1.24 (0.48,2.00)** 
 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Impaired pace and rhythm scores predicted 
cognitive decline in memory (p=0.02), digit symbol 
(p<0.001) and letter fluency (p<0.001).  
A 1 point increase in rhythm was associated with 
0.15 points decrease in memory per year.   
A 1 point increase in pace score was associated 
with 0.73 and 0.46 decrease in digit symbol and 
letter fluency per year, respectively.   
Rhythm factor: 
β (95% CI) memory: 
-0.15(-0.28,-0.02)* 
Pace factor: 
β (95% CI) digit symbol: 
-0.73(-1.15,-0.31)*** 
β (95% CI) letter fluency: 
-0.46(-0.82,-0.11)*** 
 
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05.  
a. EF measured with animal naming b. Me sured with intermediate and delayed recall c. Measured with the letter cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction  
tasks and the uditory erbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial  
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of)  
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available. 
 
Author, Year Study No. of 
partici-
pants 
Follow-
up 
(years) 
Base-line 
age 
Baseline gait 
 (mean ± SD) 
Baseline cognition Follow-up 
cognition 
Main results Change in cognition  
(in relation to baseline 
gait)   
Alfaro-Acha 
et al., 2007 
[64] 
Hispanic 
Established 
Population for 
the Epide-
miological 
Study of the 
Elderly 
1218 7 >65 Timed 8-feet walk 
(s):  
7.7±6.4 
MMSE:  
26.5±2.9 
. . Subjects in the lowest 8-foot walk time quartile 
(≥9s) had greater cognitive decline over 7 years 
than those in the highest quartile (<4s) (p<0.001).  
A unit increase in walk time predicts 0.21 points 
decline in MMSE score per year.   
Timed 8-feet walk: 
β (SE) MMSE:  
-0.21 (0.06)** 
 
Auyeung et 
al., 2011 [79] 
 
  
 
General 
Population of 
Older Chinese 
1514 
men 
 
 
 
1223 
women 
4 
 
 
 
 
4 
 
 
 
>65 Gait speed (m/s): 
1.04±0.21 
Step length (m): 
0.58±0.07 
Gait speed: 
0.94±0.19 
Step length: 
0.51±0.07 
 
MMSE: 
27.4±2.25 
 
 
 
25.8±2.80 
 
 
N.A. 
 
 
 
 
 
 
 
Shorter step length in men was associated with a 
lower MMSE score after 4 years (p<0.05).  
A unit increase in step length predicts 0.162 points 
increase in MMSE score per year. 
Step length men: 
β (95% CI) MMSE: 
0.162 (0.013, 0.309)* 
 
Gale et al., 
2014 [36] 
The English 
Longitudinal 
Study of 
Ageing 
2654 6 60-90 Gait speed (m/s): 
0.92±0.27 
 
 
 
 
 
EFa: 
19.57(5.85) 
Verbal memoryb: 
9.53(3.13) 
Proc speedc: 
18.8(5.50) 
EFa:  
19.03(6.28) 
Verbal memoryb: 
9.21(3.34) 
Proc speedc: 
17.57(5.45) 
Slower gait speed at baseline was associated with 
cognitive decline at follow-up in all domains 
(p<0.01; p=0.015; p=0.038 respectively).  
A unit increase in g it speed is ssociated with 
0.036, 0.031 and 0.025 less decline in cognitiv  
functioning per year, respectively.    
Gait speed: 
β (SE) EF:  
0.036(0.013)**  
β (SE) verbal memory: 
0.031(0.013)* 
β (SE) proc speed:  
0.025(0.012)* 
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed (m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
 
MMSE: 
N.A. 
> 3 points decline 
in MMSE score 
Slow gait at fast speed was a predictor of cognitive 
decline over 3 years (p<0.021).  
A unit increase in gait speed was associated with 
0.038 less decline in MMSE score per year.  
Gait speed: 
β (SE) MMSE: 
0.038(0.016)* 
Katsumata et 
al., 2011 [65] 
Keys To 
Optimal 
Cognitive 
Aging (KOCOA) 
Project 
192 3 >80 - Fast or normal 
TUG time (<14s) 
- Slow TUG time 
(>14s) 
 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
Slow TUG time was associated with decline in 
JMMSE functioning after 3 years (p=0.03) but was 
only cross-sectional associated with EF and 
memory.  
An increase of 2.00 and 2.31 in square root of 
number of errors in the JMMSE, for slow and fast 
TUG time respectively.   
Estimated test score global 
cognitive functioning:  
Slow TUG (95% CI): 
2.00(1.85,2.15) 
Normal TUG (95% CI): 
2.31(2.08,2.55)  
Mielke et al., 
2013 [96] 
Mayo Clinic 
Study of Aging 
1158 4 70-89 Gait speed: 
1.09 (95% CI 
0.95,1.27) 
 
 
 
 
 
 
 
 
Memoryd:  
0.21(-0.39,0.86) 
Languagee: 
0.26(-0.30,0.82)  
EFf: 
0.34(-0.26,0.83) 
Visuospatialg: 
0.26(-0.38,0.80) 
Global cognitionh: 
0.30(-0.25,0.90) 
Memoryd:  
N.A. 
Languagee: 
N.A.  
EFf: 
N.A. 
Visuospatialg: 
N.A. 
Global cognitionh: 
N.A. 
A faster gait speed at baseline was associated with 
less cognitive decline in the following domains (EF 
p=0.001, visuospatial p=0.013, global cognition 
p=0.001).  
A 1 m/s increase in gait speed was associated with 
a 0.060, 0.042 and 0.049 higher z-score in cognitive 
domains per year, respectively. 
  
Gait speed: 
β (SE) EF: 
0.060 (0.016)** 
β (SE) visuospatial: 
0.042 (0.017)* 
β (SE) global: 
0.049 (0.013)** 
 
Ojagbemi et 
al., 2015 
[97] 
Ibadan study of 
aging (ISA) 
1042 2 >65 Gait speed 
N.A.  
Gait quartiles 
 
 
 
 
10-word delayed 
recall test: 
N.A.  
10-word delayed 
recall test: 
11.49±0.32 
A slower baseline gait speed was independently 
associated with poorer follow-up cognition (p=-
0.001).  
The slowest gait category (>6.52s 3m) had 1.24 less 
words recalled at follow-up, compared to the fastest 
gait category (<4.82s 4m). 
Gait speed: 
β (95% CI) recall test: 
1.24 (0.48,2.00)** 
 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Impaired pace and rhythm scores predicted 
cognitive decline in memory (p=0.02), digit symbol 
(p<0.001) and letter fluency (p<0.001).  
A 1 point increase in rhythm was associated with 
0.15 points decrease in memory per year.   
A 1 point increase in pace score was associated 
with 0.73 and 0.46 decrease in digit symbol and 
letter fluency per year, respectively.   
Rhythm factor: 
β (95% CI) memory: 
-0.15(-0.28,-0.02)* 
Pace factor: 
β (95% CI) digit symbol: 
-0.73(-1.15,-0.31)*** 
β (95% CI) letter fluency: 
-0.46(-0.82,-0.11)*** 
 
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05.  
a. EF measured with animal naming b. Measured with intermediate and delayed recall c. Measured with the letter cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction  
tasks and the Auditory Verbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial  
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of)  
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available. 
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Author, Year Study No. of 
partici-
pants 
Follow-
up 
(years) 
Base-line 
age 
Baseline gait 
 (mean ± SD) 
Baseline cognition Follow-up 
cognition 
Main results Change in cognition  
(in relation to baseline 
gait)   
Alfaro-Acha 
et al., 2007 
[64] 
Hispanic 
Established 
Population for 
the Epide-
miological 
Study of the 
Elderly 
1218 7 >65 Timed 8-feet walk 
(s):  
7.7±6.4 
MMSE:  
26.5±2.9 
N.A. Subjects in the lowest 8-foot walk time quartile 
(≥9s) had greater cognitive decline over 7 years 
than those in the highest quartile (<4s) (p<0.001).  
A unit increase in walk time predicts 0.21 points 
decline in MMSE score per year.   
Timed 8-feet walk: 
β (SE) MMSE:  
-0.21 (0.06)** 
 
Auyeung et 
al., 2011 [79] 
 
  
 
General 
Population of 
Older Chinese 
1514 
men 
 
 
 
1223 
women 
4 
 
 
 
 
4 
 
 
 
>65 Gait speed (m/s): 
1.04±0.21 
Step length (m): 
0.58±0.07 
Gait speed: 
0.94±0.19 
Step length: 
0.51±0.07 
 
MMSE: 
27.4±2.25 
 
 
 
25.8±2.80 
 
 
N.A. 
 
 
 
 
 
 
 
Shorter step length in men was associated with a 
lower MMSE score after 4 years (p<0.05).  
A unit increase in step length predicts 0.162 points 
increase in MMSE score per year. 
Step length men: 
β (95% CI) MMSE: 
0.162 (0.013, 0.309)* 
 
Gale et al., 
2014 [36] 
The English 
Longitudinal 
Study of 
Ageing 
2654 6 60-90 Gait speed (m/s): 
0.92±0.27 
 
 
 
 
 
EFa: 
19.57(5.85) 
Verbal memoryb: 
9.53(3.13) 
Proc speedc: 
18.8(5.50) 
EFa:  
19.03(6.28) 
Verbal memoryb: 
9.21(3.34) 
Proc speedc: 
17.57(5.45) 
Slower gait speed at baseline was associated with 
cognitive decline at follow-up in all domains 
(p<0.01; p=0.015; p=0.038 respectively).  
A unit increase in gait speed is associated with 
0.036, 0.031 and 0.025 less decline in cognitive 
functioning per year, respectively.    
Gait speed: 
β (SE) EF:  
0.036(0.013)**  
β (SE) verbal memory: 
0.031(0.013)* 
β (SE) proc speed:  
0.025(0.012)* 
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed (m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
 
MMSE: 
N.A. 
> 3 points decline 
in MMSE score 
Slow gait at fast speed was a predictor of cognitive 
decline over 3 years (p<0.021).  
A unit increase in gait speed was associated with 
0.038 less decline in MMSE score per year.  
Gait speed: 
β (SE) MMSE: 
0.038(0.016)* 
Katsumata et 
al., 2011 [65] 
Keys To 
Optimal 
Cognitive 
Aging (KOCOA) 
Project 
192 3 >80 - Fast or normal 
TUG time (<14s) 
- Slow TUG time 
(>14s) 
 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
Slow TUG time was associated with decline in 
JMMSE functioning after 3 years (p=0.03) but was 
only cross-sectional associated with EF and 
memory.  
An increase of 2.00 and 2.31 in square root of 
number of errors in the JMMSE, for slow and fast 
TUG time respectively.   
Estimated test score global 
cognitive functioning:  
Slow TUG (95% CI): 
2.00(1.85,2.15) 
Normal TUG (95% CI): 
2.31(2.08,2.55)  
Mielke et al., 
2013 [96] 
Mayo Clinic 
Study of Aging 
1158 4 70-89 Gait speed: 
1.09 (95% CI 
0.95,1.27) 
 
 
 
 
 
 
 
 
Memoryd:  
0.21(-0.39,0.86) 
Languagee: 
0.26(-0.30,0.82)  
EFf: 
0.34(-0.26,0.83) 
Visuospatialg: 
0.26(-0.38,0.80) 
Global cognitionh: 
0.30(-0.25,0.90) 
Memoryd:  
N.A. 
Languagee: 
N.A.  
EFf: 
N.A. 
Visuospatialg: 
N.A. 
Global cognitionh: 
N.A. 
A faster gait speed at baseline was associated with 
less cognitive decline in the following domains (EF 
p=0.001, visuospatial p=0.013, global cognition 
p=0.001).  
A 1 m/s increase in gait speed was associated with 
a 0.060, 0.042 and 0.049 higher z-score in cognitive 
domains per year, respectively. 
  
Gait speed: 
β (SE) EF: 
0.060 (0.016)** 
β (SE) visuospatial: 
0.042 (0.017)* 
β (SE) global: 
0.049 (0.013)** 
 
Ojagbemi et 
al., 2015 
[97] 
Ibadan study of 
aging (ISA) 
1042 2 >65 Gait speed 
N.A.  
Gait quartiles 
 
 
 
 
10-word delayed 
recall test: 
N.A.  
10-word delayed 
recall test: 
11.49±0.32 
A slower baseline gait speed was independently 
associated with poorer follow-up cognition (p=-
0.001).  
The slowest gait category (>6.52s 3m) had 1.24 less 
words recalled at follow-up, compared to the fastest 
gait category (<4.82s 4m). 
Gait speed: 
β (95% CI) recall test: 
1.24 (0.48,2.00)** 
 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Impaired pace and rhythm scores predicted 
cognitive decline in memory (p=0.02), digit symbol 
(p<0.001) and letter fluency (p<0.001).  
A 1 point increase in rhythm was associated with 
0.15 points decrease in memory per year.   
A 1 point increase in pace score was associated 
with 0.73 and 0.46 decrease in digit symbol and 
letter fluency per year, respectively.   
Rhythm factor: 
β (95% CI) memory: 
-0.15(-0.28,-0.02)* 
Pace factor: 
β (95% CI) digit symbol: 
-0.73(-1.15,-0.31)*** 
β (95% CI) letter fluency: 
-0.46(-0.82,-0.11)*** 
 
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05.  
a. EF measured with animal naming b. Measured with intermediate and delayed recall c. Measured with the letter cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction  
tasks and the Auditory Verbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial  
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of)  
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available. 
 
Author, Year Study No. of 
partici-
pants 
Follow-
up 
(years) 
Base-line 
age 
Baseline gait 
(mean ± SD) 
Baseline cognition Follow-up 
cognition 
Main results Change in cognition  
(in relation to baseline 
gait)   
Alfaro-Acha 
et al., 2007 
[64] 
Hispanic 
Established 
Population for 
the Epide-
miological 
Study of the 
Elderly 
1218 7 >65 Timed 8-feet walk 
(s):  
7.7±6.4 
MMSE:  
26.5±2.9 
. . Subjects in the lowest 8-foot walk time quartile 
(≥9s) had greater cognitive decline over 7 years 
than those in the highest quartile (<4s) (p<0.001).  
A unit increase in walk time predi ts 0.21 points 
decline in MMSE score per year.   
Timed 8-feet walk: 
β (SE) MMSE:  
-0.21 (0.06)** 
 
Auyeung et 
al., 2011 [79] 
 
  
 
General 
Population of 
Older Chinese 
1514 
men 
 
 
 
1223 
women 
4 
 
 
 
 
4 
 
 
 
>65 Gait speed (m/s): 
1.04±0.21 
Step length (m): 
0.58±0.07 
Gait speed: 
0.94±0.19 
Step length: 
0.51±0.07 
 
MMSE: 
27.4±2.25 
 
 
 
25.8±2.80 
 
 
N.A. 
 
 
 
 
 
 
 
Shorter step length in men was associated with a 
lower MMSE score after 4 years (p<0.05).  
A unit increase in step length predicts 0.162 points 
increase in MMSE score per year. 
Step length men: 
β (95% CI) MMSE: 
0.162 (0.013, 0.309)* 
 
Gale et al., 
2014 [36] 
The English 
Longitudinal 
Study of 
Ageing 
2654 6 60-90 Gait speed (m/s): 
0.92±0.27 
 
 
 
 
 
EFa: 
19.57(5.85) 
Verbal memoryb: 
9.53(3.13) 
Proc speedc: 
18.8(5.50) 
EFa:  
19.03(6.28) 
Verbal memoryb: 
9.21(3.34) 
Proc speedc: 
17.57(5.45) 
Slower gait speed at baseline was associated with 
cognitive decline at follow-up in all domains 
(p<0.01; p=0.015; p=0.038 respectively).  
A unit increase in g it speed is ssociated with 
0.036, 0.031 and 0.025 less decline in cognitiv  
functioning per year, respectively.    
Gait speed: 
β (SE) EF:  
0.036(0.013)**  
β (SE) verbal memory: 
0.031(0.013)* 
β (SE) proc speed:  
0.025(0.012)* 
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed (m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
 
MMSE: 
N.A. 
> 3 points decline 
in MMSE score 
Slow gait at fast speed was a predictor of cognitive 
decline over 3 years (p<0.021).  
A unit increase in gait speed was associated with 
0.038 less decline in MMSE score per year.  
Gait speed: 
β (SE) MMSE: 
0.038(0.016)* 
Katsumata et 
al., 2011 [65] 
Keys To 
Optimal 
Cognitive 
Aging (KOCOA) 
Project 
192 3 >80 - Fast or normal 
TUG time (<14s) 
- Slow TUG time 
(>14s) 
 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
 
JMMSE: N.A 
EF: N.A 
Memory: N.A 
 
Slow TUG time was associated with decline in 
JMMSE functioning after 3 years (p=0.03) but was 
only cross-sectional associated with EF and 
memory.  
An increase of 2.00 and 2.31 in square root of 
number of errors in the JMMSE, for slow and fast 
TUG time respectively.   
Estimated test score global 
cognitive functioning:  
Slow TUG (95% CI): 
2.00(1.85,2.15) 
Normal TUG (95% CI): 
2.31(2.08,2.55)  
Mielke et al., 
2013 [96] 
Mayo Clinic 
Study of Aging 
1158 4 70-89 Gait speed: 
1.09 (95% CI 
0.95,1.27) 
 
 
 
 
 
 
 
 
Memoryd:  
0.21(-0.39,0.86) 
Languagee: 
0.26(-0.30,0.82)  
EFf: 
0.34(-0.26,0.83) 
Visuospatialg: 
0.26(-0.38,0.80) 
Global cognitionh: 
0.30(-0.25,0.90) 
Memoryd:  
N.A. 
Languagee: 
N.A.  
EFf: 
N.A. 
Visuospatialg: 
N.A. 
Global cognitionh: 
N.A. 
A faster gait speed at baseline was associated with 
less cognitive decline in the following domains (EF 
p=0.001, visuospatial p=0.013, global cognition 
p=0.001).  
A 1 m/s increase in gait speed was associated with 
a 0.060, 0.042 and 0.049 higher z-score in cognitive 
domains per year, respectively. 
  
Gait speed: 
β (SE) EF: 
0.060 (0.016)** 
β (SE) visuospatial: 
0.042 (0.017)* 
β (SE) global: 
0.049 (0.013)** 
 
Ojagbemi et 
al., 2015 
[97] 
Ibadan study of 
aging (ISA) 
1042 2 >65 Gait speed 
N.A.  
Gait quartiles 
 
 
 
 
10-word delayed 
recall test: 
N.A.  
10-word delayed 
recall test: 
11.49±0.32 
A slower baseline gait speed was independently 
associated with poorer follow-up cognition (p=-
0.001).  
The slowest gait category (>6.52s 3m) had 1.24 less 
words recalled at follow-up, compared to the fastest 
gait category (<4.82s 4m). 
Gait speed: 
β (95% CI) recall test: 
1.24 (0.48,2.00)** 
 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Memoryi:  
N.A. 
Digit symbol:  
N.A. 
Letter fluency: 
N.A. 
Digit Span: 
N.A. 
Impaired pace and rhythm scores predicted 
cognitive decline in memory (p=0.02), digit symbol 
(p<0.001) and letter fluency (p<0.001).  
A 1 point increase in rhythm was associated with 
0.15 points decrease in memory per year.   
A 1 point increase in pace score was associated 
with 0.73 and 0.46 decrease in digit symbol and 
letter fluency per year, respectively.   
Rhythm factor: 
β (95% CI) memory: 
-0.15(-0.28,-0.02)* 
Pace factor: 
β (95% CI) digit symbol: 
-0.73(-1.15,-0.31)*** 
β (95% CI) letter fluency: 
-0.46(-0.82,-0.11)*** 
 
NOTE. ***p < 0.001, **p < 0.01, *p < 0.05.  
a. EF measured with animal naming b. Measured with intermediate and delayed recall c. Measured with the letter cancelation task d. Wechsler Memory Scale-Revised Logical Memory and Visual Reproduction  
tasks and the Auditory Verbal Learning task e. Boston naming test and category fluency f. Free and Cued Selective Reminding Test g. Picture completion and block design h. Global cognitive test scores i. Trial  
making test B and Digit Symbol Substitution subtest. SD= standard deviation, SE= standard error, CI= confidence interval, SD= standard deviation, EF= executive functioning, (J)MMSE= (Japanese version of)  
the Mini Mental State Examination, proc. Speed= processing speed, TUG= Timed Up and Go, N.A.= not available. 
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Table 2. Walking ability in the prediction of cognitive decline: longitudinal studies that established risk 
estimates for cognitive decline, with measures of walking ability as predictors.
To be continued on the next page
 
Author, 
Year 
Study No. of 
parti-
cipants 
Follow-
up 
(years) 
Age  Baseline 
gait (by 
final 
diagnosis)  
Baseline 
cognition 
Clinical decline or diagnosis at 
follow-up (cognitive measure)  
Main results Change in cognition 
(in relation to 
baseline gait)   
Abellan van 
Kan et al., 
2012 
[66] 
The EPIDOS-
Toulouse Cohort 
647 7 >75 Gait speed 
(m/s): 
CH:  
0.9±0.2 
Dementia:  
0.8±0.2 
CH: SPMSQ 
>8 
AD:  
National Institute of Neurological 
and Communicative 
Disorders/Alzheimer’s Disease 
and Related Disorders 
Association 
Dementia: DSMM IV 
Gait speed decline was an independently associated factor for 
subsequent dementia and AD as a continuous (m/s) and as a 
categorical variable (p<0.05). 
Continuous gait speed: 
OR (95% CI) 
dementia: 
2.28(1.32,3.94)* 
OR (95% CI) AD: 
3.38(1.80,6.33)* 
Categorical gait speed: 
OR (95% CI) 
dementia: 
2.38(1.28,4.43)* 
Abbott et 
al., 2004 
[67]  
The Honolulu-
Asia Aging Study 
2257 7 71-
93 
Timed 10 
feet walk: 
N.A. 
CH:  
CASI >74 
Dementia:  
DSMM III 
Men who walked 10 feet in > 6 seconds, incidence was 
20.2/1000 person-years compared with 13.1 per 1000 person 
years for those with gait times of 3 seconds or less.  
Timed 10 feet walk: 
RH (95% CI) 
dementia: 
1.57(0.77,3.21)*  
Buracchio et 
al., 2010 
[98] 
Oregon Brain 
Aging Study 
(OBAS) 
204 9 >65 Gait speed 
(m/s): 
CH: 
0.96±0.23 
MCI:  
0.91±0.24 
 
 
 
CH: 
MMSE ≥24, 
CDR=0, no 
depression 
(GDS) 
MCI:  
CDR ≥0.5 
The decrease in gait speed accelerated by 0.02 m/s/year 
(p<0.001) occurring 12.1 years prior to the onset of MCI. 
Approximately 14 years prior to diagnosis in men, and 6 years in 
women.  
 
Change point  
Years (95% CI): 
Men:  
14.2(8.7,UNK) 
Women: 
6.0(4.6,9.5) 
Combined: 
12.1(8.1,UNK) 
Camicioli et 
al., 1998 
[33]  
Oregon Brain 
Aging Study 
85 3 >65 
 
Timed 30-
feet walk 
(s):  
CH: 9.6±2.3 
IC: 13.2±4.5 
CH: 
CDR=0 
Impaired cognition:  
CDR: >0.5 
Patients who developed cognitive impairments had longer time 
to walk 30 feet at baseline compared to patients who remained 
cognitively intact (p<0.001). Every 1-second increase was 
associated with an increased odds of cognitive impairment of 
1.26 (p = 0.05). 
 
Timed 30-feet walk: 
OR (95% CI) IC: 
1.26(1.01,1.6)* 
  
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed 
(m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
CH: 
MMSE: 
N.A. 
Significant cognitive decline:  
> 3 points decline in MMSE 
score 
 
Participants in the slowest quartile of usual (<1.08m/s) and ‘dual 
task’ speed (<0.81) were more likely to develop SCD (p=0.019 
and p=0.024). Participants in the third (1.49-1.30m/s) as well as 
fourth (<1.30m/s) quartile of fast speed were more likely to 
develop SCD (p=0.005 and p=0.002). All compared to the fastest 
gait quartile.  
Usual gait speed: 
OR (95%CI)  
(<1.08) SDC: 
2.32(1.15–4.90)* 
Fast gait speed: 
OR (95% CI)  
(third) SCD: 
2.71(1.35–5.46)** 
OR (95% CI)  
(fourth) SGD: 
3.17(1.50–6.68)** 
Dual-task gait speed: 
OR (95% CI)  
(<0.81) SCD: 
2.08(1.10–3.93)* 
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Author, 
Year 
Study No. of 
parti-
cipants 
Follow-
up 
(years) 
Age  Baseline 
gait (by 
final 
diagnosis)  
Baseline 
cognition 
Clinical decline or diagnosis at 
follow-up (cognitive measure)  
Main results Change in cognition 
(in relation to 
baseline gait)   
Abellan van 
Kan et al., 
2012 
[66] 
The EPIDOS-
Toulouse Cohort 
647 7 >75 Gait speed 
(m/s): 
CH:  
0.9±0.2 
Dementia:  
0.8±0.2 
CH: SPMSQ 
>8 
AD:  
National Institute of Neurological 
and Communicative 
Disorders/Alzheimer’s Disease 
and Related Disorders 
Association 
Dementia: DSMM IV 
Gait speed decline was an independently associated factor for 
subsequent dementia and AD as a continuous (m/s) and as a 
categorical variable (p<0.05). 
Continuous gait speed: 
OR (95% CI) 
dementia: 
2.28(1.32,3.94)* 
OR (95% CI) AD: 
3.38(1.80,6.33)* 
Categorical gait speed: 
OR (95% CI) 
dementia: 
2.38(1.28,4.43)* 
Abbott et 
al., 2004 
[67]  
The Honolulu-
Asia Aging Study 
2257 7 71-
93 
Timed 10 
feet walk: 
N.A. 
CH:  
CASI >74 
Dementia:  
DSMM III 
Men who walked 10 feet in > 6 seconds, incidence was 
20.2/1000 person-years compared with 13.1 per 1000 person 
years for those with gait times of 3 seconds or less.  
Timed 10 feet walk: 
RH (95% CI) 
dementia: 
1.57(0.77,3.21)*  
Buracchio et 
al., 2010 
[98] 
Oregon Brain 
Aging Study 
(OBAS) 
204 9 >65 Gait speed 
(m/s): 
CH: 
0.96±0.23 
MCI:  
0.91±0.24 
 
 
 
CH: 
MMSE ≥24, 
CDR=0, no 
depression 
(GDS) 
MCI:  
CDR ≥0.5 
The decrease in gait speed accelerated by 0.02 m/s/year 
(p<0.001) occurring 12.1 years prior to the onset of MCI. 
Approximately 14 years prior to diagnosis in men, and 6 years in 
women.  
 
Change point  
Years (95% CI): 
Men:  
14.2(8.7,UNK) 
Women: 
6.0(4.6,9.5) 
Combined: 
12.1(8.1,UNK) 
Camicioli et 
al., 1998 
[33]  
Oregon Brain 
Aging Study 
85 3 >65 
 
Timed 30-
feet walk 
(s):  
CH: 9.6±2.3 
IC: 13.2±4.5 
CH: 
CDR=0 
Impaired cognition:  
CDR: >0.5 
Patients who developed cognitive impairments had longer time 
to walk 30 feet at baseline compared to patients who remained 
cognitively intact (p<0.001). Every 1-second increase was 
associated with an increased odds of cognitive impairment of 
1.26 (p = 0.05). 
 
Timed 30-feet walk: 
OR (95% CI) IC: 
1.26(1.01,1.6)* 
  
Deshpande 
et al., 2009 
[84] 
The InCHIANTI 
study 
584 3 >65 Gait speed 
(m/s): 
Usual: 
1.23±0.26 
Fast: 
1.49±0.33 
Dual-task: 
0.98±0.28 
CH: 
MMSE: 
N.A. 
Significant cognitive decline:  
> 3 points decline in MMSE 
score 
 
Participants in the slowest quartile of usual (<1.08m/s) and ‘dual 
task’ speed (<0.81) were more likely to develop SCD (p=0.019 
and p=0.024). Participants in the third (1.49-1.30m/s) as well as 
fourth (<1.30m/s) quartile of fast speed were more likely to 
develop SCD (p=0.005 and p=0.002). All compared to the fastest 
gait quartile.  
Usual gait speed: 
OR (95%CI)  
(<1.08) SDC: 
2.32(1.15–4.90)* 
Fast gait speed: 
OR (95% CI)  
(third) SCD: 
2.71(1.35–5.46)** 
OR (95% CI)  
(fourth) SGD: 
3.17(1.50–6.68)** 
Dual-task gait speed: 
OR (95% CI)  
(<0.81) SCD: 
2.08(1.10–3.93)* 
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Ho et al., 
2001 
[99] 
General 
Population of 
Older Chinese 
988 3 >70 Timed  
16-feet 
walk (s): 
11.2±5.76 
CH: 
CAPEe: 
Score >8 
Impaired cognition: 
CAPEe: 
Score ≤7 
Slow 16-feet gait time, was a predictor of cognitive impairment 
in men and women (p<0.05). Every 1-second increase was 
associated with an increased odds of cognitive impairment of 
1.03 in women and 1.06 in men (p = 0.05).  
 
Timed 16-feet walk: 
OR (95% CI) IC: 
women: 
1.03(1.0,1.07)*  
men: 1.06(0.98,1.15)* 
Inzitari et 
al., 2007 
[100] 
Health Aging 
and Body 
Composition 
Study 
2776 5 70-
79 
Gait speed: 
N.A.  
Gait 
quartiles  
CH: 
DSST: 
37±0.29 
Impaired cognition:  
DSST <31.2±0.5  
 
Participants with a relatively slow gait speed (<1.05m/s) were 
more likely to decline in DSST (>9 points) compared to 
participants with a high gait speed (≥1.35m/s) (p=0.01).  
 
Gait speed: 
OR (95% CI) IC: 
1.74(1.21,2.51)** 
 
Marquis et 
al., 2002 
[101] 
The Oregon 
Brain Aging 
Study 
108 6 >65 Time 30 
feet walk 
(steps/s): 
CH: 
1.73±0.31 
PCI: 
1.66±0.42 
CH: 
MMSE ≥24 
PCI:  
CDR ≥0.5 
 
Time to walk 30 feet contributed independently to the time of 
onset PCI.  
A 1-second increase in time to walk 30 feet increased risk of 
1.14 times of developing PCI (p=0.09). 
 
 
Timed 30-feet walk: 
HR PCI: 
1.14* 
Taniguchi et 
al., 2012 
[69] 
 
General 
Population of 
Older Japanese 
266 
men 
 
 
 
400 
women 
2.7 
 
>70 Gait speed, 
step length, 
step 
frequency: 
N.A.  
Gait tertiles 
CH: 
MMSE ≥24 
Impaired cognition:  
> 3 points in MMSE 
 
Men in the slowest gait tertile of fast speed were 4.42 times as 
likely to develop cognitive decline compared to men in the 
fastest gait tertile (p<0.01) for step length. 
 
Women in the slowest gait tertile at usual gait speed were 2.43 
(p<0.05) times for gait speed and 5.76 (p<0.01) times for step 
length as likely to develop cognitive impairment compared to 
women from the fastest gait tertile. At fast gait speed, these risks 
are 2.45 (p<0.05) and 3.18 (p<0.01) for respectively gait speed 
and step length.  
 
 
Fast gait speed: 
Step length: 
OR (95% CI) IC: 
4.42(1.65,11.84)** 
 
Usual gait speed: 
OR (95% CI) IC: 
Gait speed: 
2.43(1.03,5.72)* 
Step length: 
5.76(2.15,15.44)** 
Fast gait speed: 
OR (95% CI) IC: 
Step length: 
3.18(1.35,7.49)** 
Gait speed: 
2.45(1.02,5.89)* 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
 
 
 
 
 
 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
CH: 
N.A.  
Dementia:  
DSMM, IV 
AD:  
DSMM, IV + neuroimaging 
Vascular dementia:  
DSMM, IV + neuroimaging 
A 1 point increase on baseline rhythm and variability factor 
scores was associated with increased risk of dementia with 1.48 
(p=0.03) and 1.37 (p=0.02) respectively and a 1 point increase on 
baseline pace was associated with an increased risk of vascular 
dementia with 1.60 (p=0.02).   
 
Rhythm:  
HR (95% CI) 
dementia: 
1.48(1.03,2.14)* 
Variability: 
HR (95% CI) 
dementia: 
1.37(1.05,1.78)* 
Pace: 
HR (95% CI) vascular: 
1.60(1.06,2.41)* 
Verghese et 
al., 2013 
[38] 
Einstein Aging 
Study 
767 3 >70 Gait speed 
(m/s): 
N.A. 
 
MCR: 
IC, slow gait, 
intact IADL 
and no 
dementia 
(DSMM, IV)  
Not-MCR 
AD:  
DSMM, IV 
Vascular dementia:  
DSMM IV + neuroimaging 
 
Participants with MCR were at higher risk of developing 
dementia (p=0.013) and vascular dementia (p<0.001). 
 
Gait speed: 
HR (95% CI) 
dementia: 
2.72 (1.24,5.97)* 
HR (95% CI) vascular: 
11.10(4.00,30.82)*** 
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Ho et al., 
2001 
[99] 
General 
Population of 
Older Chinese 
988 3 >70 Timed  
16-feet 
walk (s): 
11.2±5.76 
CH: 
CAPEe: 
Score >8 
Impaired cognition: 
CAPEe: 
Score ≤7 
Slow 16-feet gait time, was a predictor of cognitive impairment 
in men and women (p<0.05). Every 1-second increase was 
associated with an increased odds of cognitive impairment of 
1.03 in women and 1.06 in men (p = 0.05).  
 
Timed 16-feet walk: 
OR (95% CI) IC: 
women: 
1.03(1.0,1.07)*  
men: 1.06(0.98,1.15)* 
Inzitari et 
al., 2007 
[100] 
Health Aging 
and Body 
Composition 
Study 
2776 5 70-
79 
Gait speed: 
N.A.  
Gait 
quartiles  
CH: 
DSST: 
37±0.29 
Impaired cognition:  
DSST <31.2±0.5  
 
Participants with a relatively slow gait speed (<1.05m/s) were 
more likely to decline in DSST (>9 points) compared to 
participants with a high gait speed (≥1.35m/s) (p=0.01).  
 
Gait speed: 
OR (95% CI) IC: 
1.74(1.21,2.51)** 
 
Marquis et 
al., 2002 
[101] 
The Oregon 
Brain Aging 
Study 
108 6 >65 Time 30 
feet walk 
(steps/s): 
CH: 
1.73±0.31 
PCI: 
1.66±0.42 
CH: 
MMSE ≥24 
PCI:  
CDR ≥0.5 
 
Time to walk 30 feet contributed independently to the time of 
onset PCI.  
A 1-second increase in time to walk 30 feet increased risk of 
1.14 times of developing PCI (p=0.09). 
 
 
Timed 30-feet walk: 
HR PCI: 
1.14* 
Taniguchi et 
al., 2012 
[69] 
 
General 
Population of 
Older Japanese 
266 
men 
 
 
 
400 
women 
2.7 
 
>70 Gait speed, 
step length, 
step 
frequency: 
N.A.  
Gait tertiles 
CH: 
MMSE ≥24 
Impaired cognition:  
> 3 points in MMSE 
 
Men in the slowest gait tertile of fast speed were 4.42 times as 
likely to develop cognitive decline compared to men in the 
fastest gait tertile (p<0.01) for step length. 
 
Women in the slowest gait tertile at usual gait speed were 2.43 
(p<0.05) times for gait speed and 5.76 (p<0.01) times for step 
length as likely to develop cognitive impairment compared to 
women from the fastest gait tertile. At fast gait speed, these risks 
are 2.45 (p<0.05) and 3.18 (p<0.01) for respectively gait speed 
and step length.  
 
 
Fast gait speed: 
Step length: 
OR (95% CI) IC: 
4.42(1.65,11.84)** 
 
Usual gait speed: 
OR (95% CI) IC: 
Gait speed: 
2.43(1.03,5.72)* 
Step length: 
5.76(2.15,15.44)** 
Fast gait speed: 
OR (95% CI) IC: 
Step length: 
3.18(1.35,7.49)** 
Gait speed: 
2.45(1.02,5.89)* 
Verghese et 
al., 2007 
[63] 
Einstein 
Ageing Study 
 
 
 
 
 
 
399 5 >70 Gait factors: 
Pace 
Rhythm  
Variability 
CH: 
N.A.  
Dementia:  
DSMM, IV 
AD:  
DSMM, IV + neuroimaging 
Vascular dementia:  
DSMM, IV + neuroimaging 
A 1 point increase on baseline rhythm and variability factor 
scores was associated with increased risk of dementia with 1.48 
(p=0.03) and 1.37 (p=0.02) respectively and a 1 point increase on 
baseline pace was associated with an increased risk of vascular 
dementia with 1.60 (p=0.02).   
 
Rhythm:  
HR (95% CI) 
dementia: 
1.48(1.03,2.14)* 
Variability: 
HR (95% CI) 
dementia: 
1.37(1.05,1.78)* 
Pace: 
HR (95% CI) vascular: 
1.60(1.06,2.41)* 
Verghese et 
al., 2013 
[38] 
Einstein Aging 
Study 
767 3 >70 Gait speed 
(m/s): 
N.A. 
 
MCR: 
IC, slow gait, 
intact IADL 
and no 
dementia 
(DSMM, IV)  
Not-MCR 
AD:  
DSMM, IV 
Vascular dementia:  
DSMM IV + neuroimaging 
 
Participants with MCR were at higher risk of developing 
dementia (p=0.013) and vascular dementia (p<0.001). 
 
Gait speed: 
HR (95% CI) 
dementia: 
2.72 (1.24,5.97)* 
HR (95% CI) vascular: 
11.10(4.00,30.82)*** 
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Waite et al., 
2005 
[62] 
The Sydney 
Older Persons 
Study 
630 3 and 6 >75 5 meter-
returned 
walk time: 
N.A. gait 
quartiles 
CH Dementia  
Preclinical 
phase 
Dementia:  
DSMM IV + CDR 
Impaired cognition: mild or 
moderate dysfunction in 
cognition, insufficient for 
dementia 
PreEP:  
Slowed 5 meter-returned walk + 
(bradykinesia, tremor and/or 
rigidity). 
Those with cognitive impairment in combination with gait and 
motor slowing (preEP) were the most likely to dement over the 
3- and 6-year period compared to CH elderly. 
Sensitivity levels are high (80.4%) but specificity levels low 
(36.9%) 
 
5-meter returned walk: 
OR (95% CI) 
dementia: 
over 6 years: 
5.6(2.5,12.6) 
over 3 years: 
10.4(3.6,30.6) 
Wang et al., 
2006 
[61] 
Adult Changes in 
Thought 
(ACT) study 
2288 6 >65 Timed to 
walk 10 
feet: 
N.A. gait 
quartiles 
CH:  
CASI >86 
MCI:  
CASI ≤90 
Dementia and AD:  
DSMM IV + National Institute of 
Neurological and 
Communicative Diseases and 
Stroke–Alzheimer’s Disease and 
Related Disorders Association 
 
Better performance of 10-feet timed walk at baseline was 
associated with less risk of dementia (p<0.001) and AD (p<0.01), 
per 1 point increase in test score. In MCI patients, better gait 
performance was associated with lower risk of dementia 
(p<0.01). 
Timed 10-feet walk: 
HR (95% CI) 
dementia: 
0.79(0.70,0.89)*** 
HR (95% CI) AD: 
0.81(0.71,0.94)** 
HR (95% CI) dementia 
with MCI at baseline: 
0.78(0.66,0.91)** 
Welmer et 
al., 2014 
[102] 
Swedish 
National study 
on Aging and 
Care in 
Kungsholmen 
1985 6 >60 Gait speed: 
1.1±0.4 
CH: 
1.2±0.3 
Dementia: 
0.8±0.3 
CH: 
MMSE >24 
Dementia: 
DSMM IV 
 
Each SD slower baseline gait speed increased the likelihood of 
incident dementia.  
Slowing of gait speed appears to occur secondary to slowing of 
processing speed in the path leading to dementia. 
Gait speed: 
OR (95% CI) 
dementia: 
1.61(1.31,1.98)* 
 
NOTE. ***p<0.001, ** p<0.01, *p<0.05.   
SE= standard error , SD= standard deviation, CI= confidence interval , RH = relative hazard, OR= odds ratio, HR= hazard ratio, AD= Alzheimer’s disease, IC= impaired cognition, MCI= mild cognitive impairment, PCI= persistent cognitive impairment, SPMSQ= short portable mental status questionnaire, CASI= cognitive 
abilities screening instrument, DSMM= diagnostic and statistical manual of mental disorders, CH= cognitively healthy, CDR= clinical dementia rating scale, GDS= geriatric depression scale, MCR= motoric cognitive risk syndrome, preEP= pre-extrapyramidal features, MMSE= Mini Mental State Examination, CAPE= 
clifton assessment procedure for the elderly, DSST= digit symbol substitution test, IADL= instrumental activities of daily living,  SCD= significant cognitive decline, UNK= unknown, N.A.= not available.
NOTE. ***p<0.001, ** p<0.01, *p<0.05.  
SE= standard error , SD= standard deviation, CI= confidence interval , RH = relative hazard, OR= 
odds ratio, HR= hazard ratio, AD= Alzheimer’s disease, IC= impaired cognition, MCI= mild cognitive 
impairment, PCI= persistent cognitive impairment, SPMSQ= short portable mental status questionnaire, 
CASI= cognitive abilities screening instrument, DSMM= diagnostic and statistical manual of mental 
disorders, CH= cognitively healthy, CDR= clinical dementia rating scale, GDS= geriatric depression scale, 
MCR= motoric cognitive risk syndrome, preEP= pre-extrapyramidal features, MMSE= Mini Mental State 
Examination, CAPE= clifton assessment procedure for the elderly, DSST= digit symbol substitution test, 
IADL= instrumental activities of daily living,  SCD= significant cognitive decline, UNK= unknown, N.A.= 
not available. 
Table 2. Continued
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Waite et al., 
2005 
[62] 
The Sydney 
Older Persons 
Study 
630 3 and 6 >75 5 meter-
returned 
walk time: 
N.A. gait 
quartiles 
CH Dementia  
Preclinical 
phase 
Dementia:  
DSMM IV + CDR 
Impaired cognition: mild or 
moderate dysfunction in 
cognition, insufficient for 
dementia 
PreEP:  
Slowed 5 meter-returned walk + 
(bradykinesia, tremor and/or 
rigidity). 
Those with cognitive impairment in combination with gait and 
motor slowing (preEP) were the most likely to dement over the 
3- and 6-year period compared to CH elderly. 
Sensitivity levels are high (80.4%) but specificity levels low 
(36.9%) 
 
5-meter returned walk: 
OR (95% CI) 
dementia: 
over 6 years: 
5.6(2.5,12.6) 
over 3 years: 
10.4(3.6,30.6) 
Wang et al., 
2006 
[61] 
Adult Changes in 
Thought 
(ACT) study 
2288 6 >65 Timed to 
walk 10 
feet: 
N.A. gait 
quartiles 
CH:  
CASI >86 
MCI:  
CASI ≤90 
Dementia and AD:  
DSMM IV + National Institute of 
Neurological and 
Communicative Diseases and 
Stroke–Alzheimer’s Disease and 
Related Disorders Association 
 
Better performance of 10-feet timed walk at baseline was 
associated with less risk of dementia (p<0.001) and AD (p<0.01), 
per 1 point increase in test score. In MCI patients, better gait 
performance was associated with lower risk of dementia 
(p<0.01). 
Timed 10-feet walk: 
HR (95% CI) 
dementia: 
0.79(0.70,0.89)*** 
HR (95% CI) AD: 
0.81(0.71,0.94)** 
HR (95% CI) dementia 
with MCI at baseline: 
0.78(0.66,0.91)** 
Welmer et 
al., 2014 
[102] 
Swedish 
National study 
on Aging and 
Care in 
Kungsholmen 
1985 6 >60 Gait speed: 
1.1±0.4 
CH: 
1.2±0.3 
Dementia: 
0.8±0.3 
CH: 
MMSE >24 
Dementia: 
DSMM IV 
 
Each SD slower baseline gait speed increased the likelihood of 
incident dementia.  
Slowing of gait speed appears to occur secondary to slowing of 
processing speed in the path leading to dementia. 
Gait speed: 
OR (95% CI) 
dementia: 
1.61(1.31,1.98)* 
 
NOTE. ***p<0.001, ** p<0.01, *p<0.05.   
SE= standard error , SD= standard deviation, CI= confidence interval , RH = relative hazard, OR= odds ratio, HR= hazard ratio, AD= Alzheimer’s disease, IC= impaired cognition, MCI= mild cognitive impairment, PCI= persistent cognitive impairment, SPMSQ= short portable mental status questionnaire, CASI= cognitive 
abilities screening instrument, DSMM= diagnostic and statistical manual of mental disorders, CH= cognitively healthy, CDR= clinical dementia rating scale, GDS= geriatric depression scale, MCR= motoric cognitive risk syndrome, preEP= pre-extrapyramidal features, MMSE= Mini Mental State Examination, CAPE= 
clifton assessment procedure for the elderly, DSST= digit symbol substitution test, IADL= instrumental activities of daily living,  SCD= significant cognitive decline, UNK= unknown, N.A.= not available.
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stress [76, 77], which in turn are strongly related to cognitive decline [78]. Slow gait speed 
might thus represent a hallmark for a loss of muscle strength, resulting from the early 
pathophysiological changes in the process of cognitive decline. Taken these observations 
together, a plausible assumption is that physical impairment is one of the core features in 
the development of cognitive decline. Therefore, gait speed may be a useful proxy in the 
prediction of cognitive decline in old adults.
 
While gait speed is an important marker of mobility and cognitive function, focusing on gait 
speed alone might be overly simplistic. Explaining, when gait was expressed in one of its 
elements (step length), the relation with cognitive decline in women was stronger than with 
gait speed [69]. Furthermore, step length in men correlated with future cognitive decline, 
while the association between gait speed and cognitive decline remained non-significant 
[79]. Thus, the relationship between gait slowing and future cognitive decline is presumably 
strengthened when gait speed is expressed in its more specific elements. 
A more comprehensive gait analysis that moves beyond gait speed, including dynamic 
metrics of gait (e.g., gait smoothness, regularity, stability; [37, 51]0]), could increase the 
specificity of the relationship with future cognitive decline. For example, studies included 
in the present review showed that pace, rhythm and variability of gait were uniquely related 
to decline in specific cognitive functions and types of dementia [80]. Because comorbidities 
and other conditions (e.g., low back pain, osteoarthritis, medication) and their detrimental 
effects on gait speed are common in older adults, dynamic metrics of gait compared with gait 
velocity might be more sensitive to predict cognitive decline. For example, cross-sectional 
studies showed that indices of gait variability have the potential to distinguish between 
fallers and non-fallers [81, 82], age-groups [83], and patients with different conditions [37, 
50, 51]. Therefore, measures of gait variability and stability could possibly strengthen the 
gait cognition link. 
The type of gait test in terms of speed instructions or dual tasking can also affect the 
sensitivity of the prediction of cognitive decline. Compared with habitual gait speed and 
gait speed during 'walking-while-talking' in 660 old adults aged over 65, only fast gait speed 
(1.49 m/s) was associated with cognitive decline at 3-year follow-up [84]. However, the speed 
of the gait test may interact with gender because step length at maximum walking speed 
predicted cognitive decline in men but not in women during a median follow-up of 2.7 
years in the 16.5% of the originally cognitively intact 853 old adults age over 70 [69]. While 
intuitively it seems attractive to propose that fast vs. habitual gait speed is more effective in 
predicting cognitive decline, additional longitudinal studies are needed that assess variants 
of gait tests along the continuum of gait challenges. One way to improve the interpretation 
of dual-task performance is to measure performance in each single task and also in the dual 
task condition and determine whether or not the decline in gait speed during dual tasking 
is caused by insufficient cognitive recourses or rather by an over-allocation of resources to 
the cognitive task [85]. In addition, gait might be differentially affected by the complexity 
and type of the dual task [50]. Considering these observations, the relationship between 
walking ability and future cognitive decline is likely to be influenced by speed instructions 
as well as by the type of cognitive task.
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Methodological considerations
Studies included in the present scoping review were heterogeneous in terms of number of 
participants, age, duration of follow-up, and measures used to indicate walking ability and 
cognitive state. In some cases, assessable information was inconsistent and/or incomplete. 
For example, it appeared difficult to interpret the exact size of the effect on cognitive 
function because absolute or ´ net´ change in cognitive decline when measured at follow-up 
was rarely reported. Predictions reached significant values whereas effects sizes appeared 
to be small, which might be the result of a large number of participants included. 
 
In addition to methodological considerations regarding interpretation of clinical relevance, 
critical notes with respect to measures indicating walking ability and cognitive function 
needs to be addressed. For example, some studies used a very short distance, such as 8 
feet, to indicate gait speed. Considering acceleration and deceleration phases, this distance 
might be too short to measure gait speed [86]. In addition, measures of global mental state 
were often used to indicate baseline cognitive state as well as to determine cognitive decline 
at follow-up. However, the MMSE has been proposed solely suitable as a screening tool 
to indicate whether patients need further cognitive testing [87]. Thus, measures of MMSE 
optimally should be expanded with more specific neuropsychological testing. Despite such 
methodological limitations, the results converge towards a consensus that measures of 
walking ability could serve as a marker in the prediction of cognitive decline. 
Public health priority
The composition of accurate markers in the prediction of cognitive decline/dementia is 
crucial to select those individuals who might benefit most from intervention strategies. 
Evidence from longitudinal studies show that the presence of vascular risk factors, 
including for example diabetes, high blood pressure, smoking, high cholesterol and being 
overweight increases the risk for developing dementia later in life [88, 89]. Additionally, 
physical activity and individualized diet reduce the risk for dementia [90-93]. Modifying 
vascular risk factors by adopting a healthy lifestyle might thus preserve cognitive functions 
and/or postpone dementia. As a result, several large-scale prevention studies target 
vascular and lifestyle related risk factors, aiming to develop multi-domain interventions 
to prevent cognitive decline among older adults: the Finnish Geriatric Intervention Study 
to Prevent Cognitive Impairment and Disability (FINGER), the Prevention of Dementia by 
Intensive Vascular Care (PreDIVA), the Multi-domain Alzheimer Preventive Trial (MAPT) and 
the European Dementia Prevention Initiative (EDPI) project. In summary, the effectiveness 
of interventions to slow the process of neurodegenerations starts with the selection of 
individuals at risk for cognitive decline, emphasizing the need to improve current dementia 
prediction models.
Limitations and recommendations
A possible limitation of our review is that we excluded studies that used observational 
gait analysis, which reduced the number of studies included in the review. However, sub-
clinical gait abnormalities might be underestimated by observational gait analysis in the 
absence of quantitative methods [94]. Furthermore, the included studies may have suffered 
from the ‘survival effect’, meaning people who reached vs. those who dropped out were 
healthier at baseline. Such a bias tends to underestimate how accurately walking ability 
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can predict cognitive decline in the future. We also note the limitation that only 4 studies 
reported results separately for men and women. Therefore, we cannot be totally sure that 
the conclusions are not biased by combined analysis for men and women, supporting 
future studies to take into account sex-differences. Moreover, it is worth mentioning 
that the present study exclusively examined the relationship between walking ability 
and future cognitive decline, while the literature has shown more variables that predict 
cognitive decline, and that are also correlates of walking ability (such as medication use, 
diabetes and obesity). Therefore, prediction models should employ a combination of 
variables. Finally, the large heterogeneity between studies made it impossible to make a 
direct comparison between studies by means of a quantitative meta-analysis. Although 
we did not perform a meta-analysis but rather qualitatively discussed the results, the 
literature was searched systematically.
The results imply that there is an urgent need to examine the relationship between various 
gait characteristics on the one hand, and specific cognitive functions and dementia 
syndromes on the other hand. While there is a clear conceptual basis for the sensitivity of 
for example measures of gait variability in the prediction of cognitive decline, as derived 
from cross-sectional studies, longitudinal evidence is currently lacking. In addition, there 
is a need to develop guidelines that standardize administration, instructions, and distances 
for tests assessing walking ability [95]. Considering measures of cognitive state, consistent 
and specific measures could increase clinical interpretation, as for now the MMSE is 
mostly used to indicate and to rule out cognitive decline, while the MMSE has found to 
be unsuitable for such purposes. Finally, the types of task in terms of speed or dual task 
seem to influence the relationship between walking ability and future cognitive decline. It 
remains to be seen whether more vs. less challenging gait tests actually predict cognitive 
decline more accurately, as for now the longitudinal data are inconclusive. 
Conclusions
It is a health priority to improve dementia prediction models. The present scoping review 
aimed to determine the relationship between walking ability at baseline and future 
cognitive state. The results emerging from 20 studies demonstrated that gait slowing 
preceded cognitive decline in mental state, specific cognitive functions and syndromes 
related to dementia, and support the hypothesis that measures of walking ability could 
serve as a marker in the prediction of cognitive decline. Therefore, we recommend to include 
quantitative gait analysis in the clinical routine evaluation of individuals with suspected 
cognitive decline. Future research should reduce methodological inequalities and specify 
the relationship between various gait characteristics and specific cognitive functions and 
dementia syndromes. The next step would be to examine whether the incorporation of 
walking ability in dementia prediction models actually increases disease prediction and 
classification accuracy.
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GAIT DYNAMICS TO OPTIMIZE FALL RISK 
ASSESSMENT IN GERIATRIC PATIENTS 
ADMITTED TO AN OUTPATIENT 
DIAGNOSTIC CLINIC
Fall prediction in geriatric patients remains challenging because the 
increased fall risk involves multiple, interrelated factors caused by 
natural aging and/or pathology. Therefore, we used a multi-factorial 
statistical approach to model categories of modifiable fall risk factors 
among geriatric patients to identify fallers with highest sensitivity 
and specificity with a focus on gait performance. Patients (n = 61, age 
= 79; 41% fallers) underwent extensive screening in three categories: 
(1) patient characteristics (e.g., handgrip strength, medication use, 
osteoporosis-related factors) (2) cognitive function (global cognition, 
memory, executive function), and (3) gait performance (speed-related 
and dynamic outcomes assessed by tri-axial trunk accelerometry). 
Falls were registered prospectively (mean follow-up 8.6 months) 
and one year retrospectively. Principal Component Analysis (PCA) 
on 11 gait variables was performed to determine underlying gait 
properties. Three fall-classification models were then built using 
Partial Least Squares–Discriminant Analysis (PLS-DA), with separate 
and combined analyses of the fall risk factors. PCA identified ‘pace’, 
‘variability’, and ‘coordination’ as key properties of gait. The best 
PLS-DA model produced a fall classification accuracy of AUC=0.93. 
The specificity of the model using patient characteristics was 60% 
but reached 80% when cognitive and gait outcomes were added. The 
inclusion of cognition and gait dynamics in fall classification models 
reduced misclassification. We therefore recommend assessing 
geriatric patients’ fall risk using a multi-factorial approach that 
incorporates patient characteristics, cognition, and gait dynamics.
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INTRODUCTION
Approximately 30% of all old adults aged 65 or older experience a fall at least once a year. 
Falls are associated with pain, functional impairments, morbidity, psychological side 
effects, and even mortality [1]. Preventing falls therefore remains a health care priority and 
early identification of individuals at risk is the first step in fall prevention. Older compared 
with younger adults are more likely to fall due to age-related declines in sensory, cognitive, 
and neuromuscular function, leading to an impaired gait [2]. Consequently, impaired gait 
and balance, in addition to demographic characteristics (e.g., gender, age, anthropometry, 
polypharmacy), are related to falls in community dwelling adults [3]. 
Age-related slowing of gait is the most documented gait outcome, with habitual gait 
speed slowing by 16% per decade after age 60 [4-6]. A gait speed below 1.0 m/s signifies 
potential clinical or sub-clinical impairment, such as mobility impairments, recurrent 
falling, loss of independence and institutionalization [4]. While most studies are concerned 
with gait speed as main mobility outcome, gait speed alone may lack sufficient specificity 
because multiple age- and clinical conditions also induce gait slowing (e.g., low back pain, 
osteoarthritis, and Parkinson’s disease). In addition to gait speed, a variety of measures 
can quantify the dynamic nature and time-dependent variations of gait, such as detrended 
fluctuation analysis [7], sample entropy [8], harmonic ratio [9] and index of Harmonicity [10], 
reflecting the presence of long range correlations, gait predictability, gait symmetry, and 
gait smoothness, respectively. Each of these gait dynamics reflect a unique characteristic of 
gait and can be considered as complementary to each other. However, some gait measures 
are inter-related [11]. For instance, the coefficient of variation of stride time increases as 
gait speed decreases [12]. Factor analysis takes these inter-relations into account and 
reduces the dimensionality of the gait data by identifying underlying clusters of gait 
characteristics. Previous studies identified such gait clusters, reflecting different aspects of 
gait performance related to speed, variability, rhythm, coordination [13-16]. Hence, extracting 
properties of gait can provide fundamental insights into the meaning of gait function. 
With respect to falling, accuracy of fall prediction models increases when characteristics 
of gait are included [17, 18]. For example, gait smoothness prospectively discriminated 
fallers from non-fallers in community dwelling old adults with a sensitivity of 68.8 % and a 
specificity of 84.2% [18]. In addition, the accuracy of fall prediction models based on clinical 
tests commonly used in fall risk assessments such as questionnaires, handgrip strength, 
and neuropsychological tests, increased by 0.14 when comprehensive gait analysis was 
added (AUC from 0.68 to 0.82, sensitivity: 70%; specificity: 81% [17]). 
The accuracy of fall prediction models may be population-dependent and may not be 
generalizable to patients admitted to geriatric outpatient clinics. Geriatric patients are 
referred based on general or specific decline by a general practitioner, and are typically 
characterized by a combination of physical, psychological, and social problems. Hence, 
these patients can be considered vulnerable and present with an increased risk for adverse 
events such as falling, hospitalization, and ultimately death [19]. Geriatric outpatients thus 
differ from age-matched controls recruited from the community, and multiple comorbidities 
profoundly affect gait. Geriatric patients do not only walk slower than the clinical threshold 
355
of 1.0 m/s [4, 20], but chronic conditions also modify gait dynamics. For example, 50% of 
geriatric patients use polypharmacy, which increases the risk for falls [21, 22]. Also, nearly 
50% of geriatric patients suffer from osteoporotic vertebral fractures, a condition associated 
with an increase in thoracic kyphosis, decrease in gait stability, and increased fall risk [23, 
24]which may be caused by osteoporotic vertebral fractures (VFs. Moreover, up to 30% of 
geriatric patients above age 60 present with sarcopenia, which is also associated with gait 
slowing and an increased fall risk [25]. Finally, the prevalence of cognitive impairment 
ranges from 22-71% in old adults above age 65 [26] and contributes to slow gait, increased 
gait variability, decreased gait stability, and increased fall risk [27]. 
Geriatric patients can thus be characterized by a unique set of variables that increases 
their risk for a fall. Hence, one approach to identify fallers is by grouping fall risk factors 
into categories, e.g., demographic characteristics typically assessed in clinical practice, 
cognitive function, as well as detailed gait performance, and use a multi-factorial data 
analysis method. Such an approach would allow us to examine the role of each factor in fall 
risk. Subsequently, it facilitates the development of personalized interventions strategies 
to modify medication [22], cognition [28], and physical activity levels [6]. The latter 
interventions can be considered crucial to fall-prone, geriatric patients. The present study 
therefore aims to statistically model categories of fall risk factors that identify geriatric 
fallers with the highest sensitivity and specificity, with a focus on gait. To this aim, we 
pursued two complementary objectives: (1) to identify unique gait properties by extracting 
underlying clusters from 11 gait measures and remove redundancies in these measures 
using factor analysis and (2) to examine if the sensitivity and specificity of a fall risk model 
improves when adding first cognitive measures to demographics, and adding then gait 
factors identified by the factors analysis. We hypothesized that different gait measures sum 
into the key features of gait, related to speed and dynamics. Because comorbidities are 
known to significantly affect geriatric patients’ gait performance, we expect that sensitivity, 
specificity or both will increase fall classification when gait properties are added to the 
statistical model. 
METHODS
Study Population
The present study included 61 patients (41 women and 20 men) of a database of patients 
that visited the geriatric dayclinic of the MC Slotervaart Hospital, Amsterdam between 2011 
and 2013 [23, 29, 30]. Patients were admitted to the dayclinic based on a medical referral 
by a general practitioner and underwent extensive screening for physical, psychological, 
and cognitive functions. All outcome measures except for gait function, hand grip strength, 
and fall status were part of standard procedures at the diagnostic geriatric dayclinic of the 
MC Slotervaart hospital. Inclusion criteria were: age 70 or older. Exclusion criteria were: (1) 
Inability to walk for at least three minutes without a walking aid, (2) inability to speak and 
understand the Dutch language, and (3) having mobility disability caused by neurological or 
orthopaedic conditions, limiting function in one or both legs. The Medical Ethical Committee 
of the MC Slotervaart Hospital approved the study protocol. Written informed consent was 
obtained from all participants or their legal representatives. 
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Outcome Measures
Determination of Fall Status
A fall was defined as unintentionally coming to rest on the ground, floor, or other lower 
level [31]. Patients were interviewed retrospectively about the number of falls over the past 
year. Also, falls were prospectively registered with a ‘fall calendar’, for which patients were 
contacted monthly up to 12 monthly by telephone follow-up, with a minimum of 6 months. 
For patients with an MMSE-score below 24, fall history was obtained from a caregiver. 
A patient was classified as ‘faller’ when one or more falls occurred retrospectively or 
prospectively. Because the purpose of the present study was to examine (modifiable) factors 
involved in fall risk, we aimed to include the whole spectrum of fallers, including retro- and 
prospective fallers. Therefore, the study design was essentially cross-sectional.
Patient Characteristics
Demographic information including age, gender, and body mass index (BMI) were recorded. 
Maximal grip strength of the dominant hand [32], was quantified with a Jamar hand-
held dynamometer (average of 3 trials). The number of comorbidities was categorized 
with the Charlson Comorbidity Index (CCI) [33]. Medications were classified according to 
the Anatomical Therapeutic Chemical (ACT) codes (WHO, 2013) and quantified as the total 
number of ‘Fall Risk Increasing Drugs’ (FRIDs), including psychotropic and diuretic drugs 
[22]. Lateral X-rays of the thoracic spine were analyzed to determine the degree of thoracic 
kyphosis, indicated by the Cobb angle between the superior endplate of the second thoracic 
vertebra and the inferior endplate of the twelfth thoracic vertebra [23]. Finally, fall risk was 
assessed according to the Longitudinal Aging Study Amsterdam (LASA) fall risk profile [34]. 
Cognitive Function
Global cognition was assessed with the Mini Mental State Examination (MMSE) with scores 
below 24 denoting cognitive impairment [35]. The 7-minute screen [36] was administered 
to assess memory and executive function using the Benton’s Temporal Orientation (BTO), 
the Enhanced Cued Recall (ECR), the animal verbal fluency and the clock drawing test. 
Gait Performance
All patients walked 160 meters at habitual speed on an 80-meter long hallway. A tri-axial 
accelerometer (87x45x14 mm; sample frequency 100 Hz; Dynaport® MiniMod, McRoberts 
BV, The Hague, the Netherlands) was attached to the lower back at the level of the third 
lumbar spine segment to measure medio-lateral (ML) and anterior-posterior (AP) trunk 
accelerations. Vertical (V) acceleration signals were not analysed because peaks in these 
signals sometimes showed clipping and were therefore unreliable. Acceleration signals 
were analysed with custom-made software in MATLAB (version 2014b; The MathWorks, Inc). 
Except for the calculation of the Sample Entropy, the signals were corrected for horizontal 
tilt and low-pass filtered with a 2nd order Butterworth filter with a cut-off frequency of 15 
Hz. Outliers due to turns were removed from the data using a median filter. We determined 
11 gait outcomes, reflecting different and complementary gait properties.
Walking speed was calculated by dividing distance walked by the time. Peak accelerations 
from AP signals were used to detect time indices of left and right foot contacts. Mean and 
coefficient of variation (CV) of stride times were computed from the time interval between 
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two consecutive ipsilateral foot contacts. Step consistency was quantified by the standard 
deviation (SD) of the relative phase between sequential ipsilateral indices of foot contact 
[37]. Higher SD of the relative phase implies a more inconsistent gait pattern. Long-range 
correlations between strides were quantified by the scaling exponent α using detrended 
fluctuation analysis [7]. A value of 0.5 ≥ α ≥ 1 suggests the presence of long-range 
correlations and signifies that future fluctuations in strides are more accurately predicted 
by previous fluctuations. 
The Root Mean Square (RMS) of the AP and ML acceleration quantified the variability in 
the magnitude of the trunk accelerations. The Index of Harmonicity (IH) was computed 
to examine the smoothness (frequency content) of the signal, using spectral analysis. 
Perfect smooth trunk accelerations would reveal an IH of 1 [10]. To quantify the degree of 
predictability of trunk acceleration time series, the Sample Entropy (SEn) was calculated 
[38]. A complete predictable (periodic) signal will adopt a SEn of 0, with a larger SEn 
representing a less predictable gait. 
Statistical Analysis
Principal Component Analysis (PCA) with a Varimax rotation and Kaiser normalization was 
performed on the 11 gait variables to determine underlying gait properties, and to reduce the 
dimensionality of the data to unique factors. The number of extracted principal components 
(PC’s) was determined by analysing the scree plot which reveals the percentage explained 
variance by each component (usually referred as ‘factor scores’). PC’s with eigenvalues 
larger than 1 were considered eligible for inclusion in the final model. The regression 
coefficients of the extracted PC’s were then used for further analyses [14]. 
To examine the contribution of different fall risk factors, three Partial Least Squares 
Discriminant Analyses (PLS-DA) were performed using the PLS_toolbox for MatLab (version 
3.7.1; Eigenvector Research Inc.). PLS-DA combines PCA and regression analysis and can 
handle data consisting of a large number of independent, highly collinear, inter-related 
variables with relatively few observations (subjects) [39]. Note that such a handling of 
multicollinearity is important, in particular with respect to gait outcomes (e.g., gait speed 
and stride time are highly correlated [40]). In the PLS-DA analyses, patient characteristics, 
cognitive and gait measures represented the independent variables (X), and fall-status the 
categorical, dependent variable (Y). The analysis seeks to find underlying latent variables 
(LV’s) to investigate fundamental relations between the matrices X and Y by modelling the 
covariance structures in these two spaces, and removing common variance. All variables 
were normalized to unit variance. The optimal number of LV’s was determined using the scree 
plot and defined at the level where a plateau phase in the goodness of prediction (Q2) was 
reached [39]. Cross-validation was performed using venetian-blind (number of data-splits: 7).
Three models were developed based on: (1) only patient characteristics, (2) patient 
characteristics and cognitive function, and (3) patient characteristics, cognitive function, 
and the regression coefficients derived from the factor analysis; the gait factors. Outcome 
measures of the PLS-DA included scores (individual patient’s observations) and weights 
(contribution of fall risk factors to the model), quantifying the relationship between fall risk 
factors and fall status. The variance explained reflected how variables are clustered within 
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each LV. Classification accuracy of the models was quantified as sensitivity, specificity, 
and area under the curve (AUC) based on Youden’s criterion, and visualized with receiving 
operating characteristic (ROC) curves, with an AUC of 1 representing a perfect fit. 
RESULTS
Patient characteristics
Table 1 shows characteristics for fallers (mean age 80.2±4.7) and non-fallers (78.8±5.1).
Falls
Retrospective fall data was registered from all 61 patients during the interview. From six 
patients, follow-up fall calendar data was obtained for less than 6 months, because patients 
changed address, or withdrawn from participation and did not want to be contacted any 
longer. The mean follow-up duration was 8.6 months. Twenty-five patients were classified 
as fallers (41%); 18 retrospective fallers, 19 prospective fallers, and 12 patients fell during 
the last year as well as during follow-up. 
Table 1. Patient characteristics for fallers and non-fallers (mean ± SD).
Gait Analysis
Three PC’s with eigenvalues > 1 and absolute factor loadings > 0.4 explained 67.50% of 
the total variance of the 11 gait measures. PC1 reflected measures related to gait speed, 
stride times, and the amplitude of trunk accelerations and was labelled ‘pace’. PC2 and PC3 
represented measures related to gait variability and coordination respectively, and were 
labelled ‘variability’ and ‘coordination’ (Table 2). These three identified gait components 
were then used for the PLS-DA analyses below.
 
 
 Variable Fallers  
(n = 25)   
Non-fallers  
(n = 36) 
 Patient characteristics   
 Body Mass Index (kg/m2) 27.7 ± 4.2 26.0 ± 3.5  
 Handgripa (Newton) 23.7 ± 8.0 27.2 ± 8.8*  
 Charlson Comorbidity Indexb  1.6 ± 1.4 1.3 ± 1.2  
 Longitudinal Aging Study Amsterdam fall risk profiled 8.0 ± 1.2 2.4 ± 0.4*  
 Cobb Anglec (degrees) 52.0 ± 14.5 50.0 ± 12.7  
 Fall Risk Increasing Drugsb (number) 1.3 ± 1.2 1.3 ± 1.4  
        
 Cognition       Scale 
 Mini Mental State Examinationa 23.1 ± 4.8 23.8 ± 3.7 0 - 30 
 Benton’s Temporal Orientation testb 19.2 ± 6.4 10.0 ± 3.3 0 - 113 
 Enhanced Cued Recall testa 11.7 ± 4.1 10.4 ± 5.0 0 - 16 
 Clock Drawing testa 10.1 ± 2.5 10.6 ± 2.5 0 - 14 
 Verbal Fluency testa 13.3 ± 1.5 14.1 ± 0.9 0 - 40 
* p < 0.05. 
a. A higher score indicates better performance. b. A higher score indicates worse performance. 
c. Values above >50 affect postural control. d. A score of ≥ 8 points indicates an increased risk 
for recurrent falling. 
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The PLS-DA Models
Table 3 and Figure 1 show the results of the three PLS-DA models. Model 1 included 3 LV’s, 
model 2 also included 3 LV’s, and 5 LV’s were extracted for model 3. Note that in all models, 
LV1 explains most of the variance in the independent variables (X) and falls (Y), followed 
by LV2 and by LV3, but based on the Q2 criteria, five LV’s were included. Classification 
accuracy of the first model with patient characteristics increased from 0.86 to 0.90 (AUC) 
when cognitive measures were added. Model accuracy further increased from 0.90 to 0.93 
(AUC) when the principal gait components derived were subsequently added. In particular 
specificity increased in the second model from 60% to 72% and reached 80% when gait 
measures were included.
Figure 1. Receiving Operating Characteristic - curves for the three fall classification models. Model 1 = Patient 
characteristics; Model 2 = Patient characteristics + cognitive outcomes; Model 3 = Patient characteristics + 
cognitive outcomes + gait outcomes. AUC = Area Under the Curve.
Table 2. Loadings of the gait variables (eigenvalue 
>1 and absolute loadings > 0.4) as revealed by PCA 
with Varimax Rotation.
 
Gait measures Pace Variability Coordination 
Walking Speed -.848   
Root Mean Square AP -.844   
Root Mean Square ML -.820   
Index of Harmonicity ML  .791   
Stride Time  .748   
CV Stride Time  .583  .435  
Step Consistency   .781  
Long range correlations  -.774  
Sample Entropy AP   .677  
Sample Entropy ML    .850 
Index of Harmonicity AP    .512 
 CV = Coefficient of Variation; AP = Anterior-Posterior;  
 ML = Medio-Lateral.  
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Table 3. Characteristics of the three PLS-DA models: Number of latent variables, variance explained in X 
(fall risk factors) and Y (fall-status), and classification accuracy of fallers and non-fallers.
Table 4 presents the amount of explained variance per independent variable of each 
included LV of the final model (model 3). The results signify that X-variables are clustered 
within the LV’s. Motor performance (gait components and handgrip strength) and the LASA 
were mainly presented in LV1, cognitive function in LV2 and LV3, and patient characteristics 
in LV4 and LV5.
Biplots of the final model provide 
a graphical representation of the 
Y-variable (falls) and weights of 
the X-variables (patient charac-
teristics, cognitive outcomes, and 
gait outcomes) with respect to the 
LV’s (Fig 2). Fallers and non-fall-
ers present in sharply separated 
clusters. The coordinates (size) 
of the weight vectors reflect the 
importance of the X-variable to 
the LV’s. In this figure, the direc-
tion of the vectors reflects how 
these X-variables relate to fallers 
or non-fallers. The weights show 
that LASA, BTO, BMI and gait pace 
are particularly relevant in the 
identification of fallers, whereas 
handgrip, clock drawing, verbal 
fluency, gait variability, and gait 
coordination are relevant in the 
identification of non-fallers.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LV = Latent Variable; AUC = Area Under the Curve; Sens = sensitivity; Spec = specificity 
 
Model 
 
Factors  
included 
Number of LV’s  X-block (%) Y-block (%) Sens. 
 (%) 
Spec. 
 (%) 
AUC 
1 
 
Patient characteristics 3 LV1 
LV2 
LV3 
Sum 
23.7 
15.0 
15.9 
54.5 
32.5 
6.5 
0.7 
39.7 
92 60 0.86 
2 
 
Patient characteristics + cognition 3 LV1 
LV2 
LV3 
Sum 
15.1 
13.1 
20.5 
48.7 
34.5 
9.5 
2.1 
46.1 
89 72 0.90 
3 
 
Patient characteristics + cognition + gait 5 
 
LV1 
LV2 
LV3 
LV4 
LV5 
Sum 
31.8 
7.8 
18.4 
 7.5 
5.3 
52.4 
33.6 
13.5 
1.3 
1.4 
0.8 
50.7 
92 80 0.93 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LV = Latent Variable; LASA = Longitudinal Aging Study Amsterdam 
 
Independent variable LV1 LV2 LV3 LV4 LV5 Sum 
Gait       
Gait Pace 12.2 0.0 6.0 2.2 1.0 22.2 
Gait Variability 0.3 5.9 5.5 7.2 2.1 21.0 
Gait Coordination 20.4 13.3 1.3 0.4 3.6 39.0 
Cognition       
Mini Mental State Examination 7.7 0.5 58.7 7.5 4.6 86.6 
Benton’s Temporal Orientation test 1.7 0.5 58.7 0.5 1.3 62.7 
Enhanced Cued Recall test 6.3 5.5 53.4 0.1 4.8 70.0 
Clock Drawing test 9.1 12.9 21.7 0.7 8.5 52.0 
Verbal Fluency testa 10.4 15.5 28.1 16.1 0.1 70.3 
Patient characteristics       
Fall Risk Increasing Drugs 2.8 8.2 2.3 18.4 4.5 36.2 
Charlson Comorbidity Index 0.2 6.0 9.0 21.1 0.0 36.4 
Body Mass Index 3.8 8.3 4.1 28.9 26.4 71.5 
LASA  74.4 2.4 0.7 1.4 5.6 84.5 
Handgrip 40.9 15.6 8.9 0.2 0.6 66.2 
Cobb Angle 2.5 0.8 0.0 0.0 10.6 13.9 
Table 4. Explained variance (%) per independent variable of the 
5 extracted Latent Variables in model 3.
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Figure 2. Biplots of Latent Variables 
(LV’s) 1 vs. 2 (left trace) and LV’s 1 
vs. 3 (right trace) provide a graph-
ical representation of the response 
variable (fall-status) and weights of 
the independent variables (patient 
characteristics, cognitive, and gait 
factors) with respect to the included 
LV’s. As clearly shown, fallers and 
non-fallers (green and red respec-
tively) are clustered. Weight vector 
size reflects the importance of the 
variable to the model. The direc-
tion of the vector refers to whether 
variables mainly relate to classi-
fication of fallers (sensitivity) or 
non-fallers (specificity). BMI = Body 
Mass Index; CCI = Charlson Comor-
bidity Index; LASA = Longitudinal 
Aging Study Amsterdam; FRIDs = 
Fall Risk Increasing Drugs; MMSE 
= Mini Mental State Examination; 
BTO = Benton Temporal Orienta-
tion; ECR = Enhanced Cued Recall.
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DISCUSSION
We applied a factor analysis to speed- and dynamic-related measures of gait and we then 
statistically modelled combinations of factors that classified geriatric fallers with the highest 
sensitivity and specificity. The factor analysis identified pace, variability, and coordination 
as key properties of gait. A model that included patient characteristics, cognitive function, 
as well as gait performance produced high classification accuracy (AUC=0.93) and showed 
an increase in specificity from 60% to 80% compared to a model that only included patient 
characteristics. We discuss how a successful fall risk assessment in the future will most 
likely include a large array of variables to optimize the identification of fallers among 
geriatric outpatients.
First, PCA applied to 11 gait variables revealed three unique gait properties: pace, variability, 
and coordination. ‘Pace’ comprised speed-related measures, namely gait speed, stride time, 
and the amplitude of AP and ML accelerations (RMS). ‘Variability’ and ‘coordination’ are 
considered as gait properties that reflect the dynamics of gait and were mainly derived from 
trunk accelerations. The loading structure was consistent, except for the IH in ML direction, 
which loaded on the pace component (absolute loading: 0.791) while it was expected to 
load on the coordination component. This might imply that IH ML is related to gait speed. 
In general, the extracted components were comparable with components identified by 
previous studies [13-16].
Second, three PLS-DA models were generated and compared (Table 2 and Fig 1). The first 
model based on patient characteristics already produced high classification accuracy 
(AUC=0.86). LASA clearly outperformed the other variables, as indicated by the size of the 
weight vectors. LASA provides an extensive screening tool consisting of nine fall-related 
factors such as dizziness, fear of falling, alcohol intake, fall history, and education level [34]. 
Although sensitivity of this first model was quite high (80%), specificity remained relatively 
low (60%). A low specificity (i.e., true negative rate) hampers clinical application because 
non-fallers will be erroneously identified as fallers and such misclassifications may induce 
fear of falling and unnecessary interventions. 
Adding cognitive measures to the model increased specificity by 12%, to 72% (Table 3). 
Age-related decline in gait and cognition co-occurs because brain areas that control gait 
partly overlap with brain areas that control cognitive function [2]. Gait dysfunction can thus 
be expected in the presence of cognitive impairment [27, 41] and an impaired gait control 
in turn increases fall risk. On the other hand, old adults rely on executive functions in daily 
activities that require divided attention (e.g., in traffic and walking while talking). Impairment 
in executive functions may thus cause dangerous situations and increase fall risk. 
Adding gait outcomes to the model further increased the models’ specificity by 8%, to 80% 
(Table 3). Progressive age-related deterioration in neuromuscular and neurophysiological 
function engenders decline in sensory systems, sarcopenia, slower movement time 
and central processing, all linked to deficits in gait and balance [42]. In particular gait 
components ‘variability’ and ‘coordination’ accounted for the increase in specificity, as 
indicated by the size and direction of the corresponding vectors towards non-fallers (high 
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specificity). These results support the idea that speed-related measures such as gait speed 
and (CoV) stride time (captured by the pace domain) may be sufficient for classifying fallers 
only. They do, however, lack specificity that could result in misclassification of non-fallers. 
Gait speed is widely recognized as an important variable associated with many clinical 
conditions later in life [4]. The results of the present study show that combining gait speed 
and speed-related measures with dynamic gait measures will increase specificity and 
thus classification accuracy. Hence, gait dynamics could be added to measures usually 
addressed in clinical practice. Nowadays, extensive gait analysis is more easily accessible 
for clinical practice due to the rapid development of off-the-shelf smartphones, iPods and 
similar smart devices. Equipped with built-in accelerometers and gyroscopes, the devices 
are light, inexpensive, easy to handle, and thus suitable to analyse gait in a clinic [43]. 
However, despite technological advances, we note that future studies should examine the 
clinical applicability of such smart devices.
While one could question whether the 8% gain in specificity is it worth to add gait performance 
to the screening assessments, we signify the importance of a correct fall prediction on a 
clinical level. Misclassification (non-fallers that are classified as fallers) may induce fear 
of falling and unnecessary interventions and therefore hampers clinical application. 
Future studies could compare the sensitivity of gait dynamics with existing fall risk tools 
that examine physical function in the identification of fallers and non-fallers, such as the 
Physiological Profile Assessment (PPA) test [44]. Such tests may complement each other and 
reduce the need for excessive testing. In addition, the integration of test results could help 
to unravel underlying mechanisms of gait dysfunction and neurophysiological changes.
Because of typical challenges associated with clinical research (e.g., recruitment, retention) 
in this patient group, the sample size of the present study was relatively small (n=61). As a 
consequence, because standardization of the follow-up period would induce an in-balance 
of fallers and non-fallers groups, we choose not to exclude the patients who did not complete 
the fall calendar for all 12 months. Although exclusion of those patients did not significantly 
change the results, we recognize this as a potential limitation. Finally, the generalizability 
of the present study can be considered challenging. However, an increasing number of 
hospitals is nowadays equipped with a specialized geriatric outpatient clinic. Therefore, 
assessments used in the present study are often part of regular screening methods, which 
facilitates applicability and generalizability.
In conclusion, geriatric patients represent a vulnerable population with an increased risk for 
falling. Fall risk assessment including modifiable fall risk factors revealed high classification 
accuracy (AUC = 0.93). Although patient characteristics can accurately identify fallers, the 
evaluation of executive function and gait dynamics reduced misclassification with an 
increase in specificity from 60% to 80%. Therefore, we underscore the need for a multifactorial 
approach in fall risk assessment in geriatric patients, including a comprehensive evaluation 
of patient characteristics, cognitive function, and gait performance. These fall risk factors 
should ultimately be targeted by individualized interventions to reduce fall risk.
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Background: A detailed gait analysis (e.g., measures related to 
speed, self-affinity, stability, and variability) can help to unravel 
the underlying causes of gait dysfunction, and identify cognitive 
impairment. However, because geriatric patients present with 
multiple conditions that also affect gait, results from healthy old 
adults cannot easily be extrapolated to geriatric patients. Hence, we 
(1) quantified gait outcomes based on dynamical systems theory, 
and (2) determined their discriminative power in three groups: 
healthy old adults, geriatric patients with- and geriatric patients 
without cognitive impairment. Methods: For the present cross-
sectional study, 25 healthy old adults recruited from community 
(65 ± 5.5 years), and 70 geriatric patients with (n=39) and without 
(n=31) cognitive impairment from the geriatric dayclinic of the MC 
Slotervaart hospital in Amsterdam (80 ± 6.6 years) were included. 
Participants walked for 3 minutes during single- and dual-tasking 
at self-selected speed while 3D trunk accelerations were registered 
with an IPod touch G4. We quantified 23 gait outcomes that reflect 
multiple gait aspects. A multivariate model was built using Partial 
Least Square- Discriminant Analysis (PLS-DA) that best modelled 
participant group from gait outcomes. Results: For single-task 
walking, the PLS-DA model consisted of 4 Latent Variables that 
explained 63% and 41% of the variance in gait outcomes and group, 
respectively. Outcomes related to speed, regularity, predictability, 
and stability of trunk accelerations revealed with the highest 
discriminative power (VIP>1). A high proportion of healthy old 
adults (96% and 93% for single- and dual-task, respectively) was 
correctly classified based on the gait outcomes. The discrimination 
of geriatric patients with and without cognitive impairment was 
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ABSTRACT
GAIT CHARACTERISTICS AND THEIR 
DISCRIMINATIVE POWER IN GERIATRIC 
PATIENTS WITH AND WITHOUT COGNITIVE 
IMPAIRMENT4
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poor, with 57% (single-task) and 64% (dual-task) of the patients 
misclassified. Conclusions: While geriatric patients vs. healthy old 
adults walked slower, and less regular, predictable, and stable, we 
found no differences in gait between geriatric patients with and 
without cognitive impairment. The effects of multiple comorbidities 
on geriatric patients’ gait possibly causes a ‘floor-effect’, with no 
room for further deterioration when patients develop cognitive 
impairment. An accurate identification of cognitive status thus 
necessitates a multifactorial approach.
Keywords: Gait dynamics, Cognitive impairment, Multivariate 
analysis, IPod touch, Trunk accelerations, Discriminant analysis, 
Geriatric patients. 
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INTRODUCTION
Even healthy aging modifies gait. Declines in muscle mass and quality, decreased sensory 
functions, reductions in muscle activation, and a reorganization of the cortical and spinal 
circuits controlling posture and gait underlie the age-related evolution of gait slowing and 
abnormalities [1, 2]. Indeed, habitual gait speed decreases as much as 16% per decade, starting 
at age 60 [3]. Because a slow gait speed predicts numerous clinical conditions later in life 
[4], gait speed is perhaps the most studied feature of physical performance affected by age.
Notwithstanding the attractiveness of gait speed as a simple summary index of mobility, 
numerous other characteristics of gait have been established to quantify and diagnose 
age- and pathology-related gait abnormalities. For example, stride-to-stride variability 
quantified by the Coefficient of Variation (CoV) is 5.3% in elderly fallers compared to 1.1% in 
age-matched non-fallers [5]. Measures derived from trunk acceleration signals can be used 
to characterize postural control during walking and standing by means of quantifying the 
frequency content, amplitude, self-affinity, variability, synchronization, regularity, and local 
stability of the lower trunk [6-9]. In the present study, we use the term ‘gait dynamics’, and 
refer to outcomes that are indicative of the dynamic nature of the gait pattern and reflect 
its stable and adaptive features. Gait dynamics can discriminate young and old adults [10], 
individuals with and without a clinical condition [11, 12], fallers and non-fallers [9, 13-16], 
and older adults with and without cognitive disorders [17, 18].
However, the results of the latter studies cannot easily be extrapolated to geriatric 
patients who typically suffer from many clinical conditions that also interact with gait 
performance. Among many, sarcopenia [19], thoracic kyphosis [11], polypharmacy [20], and 
cognitive impairment [21] can individually and in combination negatively affect gait. We 
therefore suspect that different combinations of gait measures are distinctive for geriatric 
patients vs. healthy old adults. Considering the abundant evidence supporting the effects 
of cognitive impairment on gait and its potential validity to serve as an early marker of 
cognitive impairment [21], we also expect that geriatric patients with additional cognitive 
impairment present with distinct gait characteristics. However, due to a lack of brain and 
neurophysiological correlates of specific gait outcomes, it is not yet possible to specify 
exactly which gait outcome corresponds to a clinical condition. A detailed gait analysis, 
including dynamic gait measures, can therefore help to unravel the underlying causes of 
gait dysfunction, and identify and predict clinical conditions. The identification of cognitive 
impairment could be even more accurate during walking while performing a cognitive 
dual-task [17, 22]. Because gait and cognitive function partly rely on the same cortical 
resources [23], performing a cognitive demanding task while walking stresses the system 
and potentially enlarge the effects of cognitive impairment on gait [17, 22].
Hence, the purpose of the study was to determine gait characteristics in three groups: 
healthy old adults and geriatric patients with and without cognitive impairment. Our 
hypothesis is that a detailed gait analysis (e.g., measures related to speed, self-affinity, 
stability, and variability) will (1) quantify unique gait characteristics of the three groups, and 
(2) accurately discriminate geriatric patients vs. healthy old adults, and geriatric patients 
with and without cognitive impairment. We derived gait outcomes from trunk acceleration 
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signals in 3D during single- and dual-task walking. Because certain gait outcomes 
are inter-related while others are complementary to each other, we performed a Partial 
Least Square – Discriminant Analysis (PLS-DA). PLS combines principal component and 
regression analyses and extracts gait features by modelling the covariance structures [24]. 
By delineating and quantifying the information contained in the dynamics of gait, we can 
identify gait features that are unique to healthy old adults, and geriatric patients with and 
without cognitive impairment.
METHODS
Participants
Seventy patients were recruited from the geriatric outpatient dayclinic of the MC Slotervaart 
hospital in Amsterdam between January 2015 and July 2016 (mean age 80 ± 6.6; 53% 
women). Inclusion criteria were: age 65 or older. Exclusion criteria were: (1) inability to walk 
for at least three minutes without a walking aid, (2) having neurodegenerative disorders 
other than related to dementia (e.g., Parkinson’s), (3) inability to speak fluently Dutch, and 
(4) having mobility disability caused by pain or by neurological or orthopaedic conditions, 
limiting function in one or both legs. The Medical Ethical Committee of the MC Slotervaart 
Hospital approved the study protocol. Data of an additional group of 25 independently living 
healthy old adults (mean age 65 ± 5.5), recruited from the community, were also included 
[10]. The latter group of old adults were carefully questioned about their health, and were 
excluded if they had a history of orthopaedic, cognitive, or neurological problems, or if they 
used medication that would affect gait or postural control. Hence, this group can be considered 
a cognitive and physical healthy control group consisting of relatively young older adults.
Age, height, weight, BMI, The Charlson Comorbidity Index (CCI) [25] and the number of 
medications used (> 4 denoting polypharmacy), were extracted from medical records. Grip 
strength of the dominant hand was quantified with a Jamar hand-held dynamometer. 
Patients were diagnosed for cognitive impairment by a geriatrician and a neuropsychologist 
based on (1) medical records and (2) cognitive performance on the Mini Mental State 
Examination (MMSE) (range 0-30) [26] and the 7-minute screen (7MS) test. The 7MS assessed 
memory and executive function using the Benton’s Temporal Orientation (range 0-113), 
the Enhanced Cued Recall (range 0-16), the animal verbal fluency (range 0-45) and clock-
drawing test (range 0-14) [27]. Based on the evaluation of the two clinical experts, patients 
were categorized as either cognitive impaired or cognitive intact, with the cognitive impaired 
group including patients with a diagnosis for Mild Cognitive Impairment (MCI) or dementia.
Procedures and data analysis
Participants walked for three minutes at a self-selected speed on a 10-m long course 
that was marked with cones, under single- and dual-task conditions. In order to capture 
time dependent (over multiple stride cycles) patterns in the entire accelerations signals, 
participants were instructed to keep walking, and make comfortable turns around the 
cones. Because we were interested in the entire gait pattern over the 3 minutes and 
steps are considered dependent, turns were included in the analysis. When patients did 
not succeed to walk for 3 minutes, the longest continuous part of the signal was used for 
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the analysis. A phonetic fluency task was introduced in the dual-task condition, in which 
participants were asked to name as many words starting with the letters ‘g’, ‘p’, or ‘r’ (one 
minute per letter) while walking. A cognitive single-task with letters ‘d’, ‘a’, and ‘t’ was used 
as control condition [28].
Trunk accelerations were registered with an iPod touch G4 (iOS 6, Apple Inc.; sample 
frequency ± 100Hz) that was fixed with a belt near the level of lumbar segment L3. The validity 
and reliability of gait and standing posture parameters derived from trunk accelerations 
have been reported previously [29]. A custom-made application ‘iMoveDetection’ was used 
to collect and store acceleration data from the built-in tri-axial accelerometer of the iPod 
[29]. Anterior-posterior (AP), medio-lateral (ML), and vertical (V) acceleration signals were 
analysed with custom-made software in MATLAB (version 2014b, The MathWorks Inc.). The 
signals were detrended, corrected for horizontal tilt, and low-pass filtered (Butterworth 
filter, 4th order; cut-off frequency 10 Hz).
Gait outcomes
We computed 23 gait outcomes. Gait speed was calculated by dividing distance walked (m) 
by time (s). The variability of the amplitude of accelerations was indexed by the Root Mean 
Square (RMS). The Index of Harmonicity (IH) was calculated as an indicator of smoothness, 
using the power spectrum of accelerations. The IH was estimated as the cumulative sum of 
the power spectral density of the fundamental frequency (step frequency), divided by that of 
the subsequent 9 harmonics. An IH of 1 represents a perfect smooth gait [8]. 
The Cross-sample Entropy (Cross-SampEn) quantified the degree of synchronization 
between AP and ML, AP and V, and ML and V accelerations. Cross-SampEn is the negative 
natural logarithm of the conditional probability that epochs with length m that match point-
wise in the two related signals, repeat itself for m+1 points, within a tolerance of r (in the 
present study m = 2 and r = 0.2). A Cross-SampEn of 0 reflects perfect synchronization 
between the signals [30]. 
Gait regularity and symmetry was calculated for AP and V accelerations using the unbiased 
auto-correlation function of the acceleration signal. The signal was phase shifted with a 
window approximating average step and stride time. The first peak in de autocorrelation 
coefficient function relates to step- and the second to stride regularity. A value of 1 reflects 
perfect regular steps or strides [31]. The difference between step and stride regularity 
revealed gait symmetry, with 0 representing a perfect symmetric gait [7]. 
Multi-scale sample Entropy (Mscale-En) is an indicator of gait predictability. Multi-scale 
entropy takes the complexity of a system into account by calculating the predictability of 
a signal over time scales with increasing length. A ‘coarse-graining’ process is applied to 
the acceleration signals; non-overlapping windows of data points with an increasing length 
τ are constructed, with τ representing the time scale with a tolerance of r (in the present 
study τ = 7 and r = 0.2). A complete predictable signal will adopt a Mscale-En value of 0 [32].
Local stability of trunk acceleration patterns was expressed as the λ
max
, i.e., maximal 
Lyapunov exponent, calculated with the Wolf algorithm as this algorithm is most appropriate 
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to evaluate local dynamic stability from relatively small data sets [33]. For the present study, 
we used an embedding of n = 5 dimensions, with a time delay τ of 10 samples (0.1s). Larger 
λ
max
 indicate greater sensitivity to local perturbations. 
Finally, stride frequency variability (FreqVar) was computed from AP accelerations. FreqVar 
was estimated as the relative fluctuations in phase progression [6].
Statistical analysis
Differences in participant characteristics were examined with a one-way ANOVA with 
Bonferroni post-hoc test using SPSS version 24. Significance level was set at p<0.05.
A Partial Least Squares Discriminant Analysis (PLS-DA), using the PLS_toolbox for 
MatLab (version 3.7.1; Eigenvector Research Inc.) was applied. PLS is a combination of 
principal component and regression analysis, and can handle data with a large number 
of highly collinear, inter-related variables (gait outcomes) with relatively few observations 
(participants) [24]. In contrast to usual regression analysis, PLS allows to study interrelations 
among multiple, interacting gait outcomes. Such a multivariate analysis thus controls for 
dependencies among gait outcomes and enables to consider the data in an overarching 
way. Note that this dealing with multicollinearity is crucial, in particular with respect to 
gait outcomes (e.g., gait speed and stride time are highly correlated). The PLS-DA model 
identified the internal covariance structure among gait outcomes (X-matrix) that best 
modelled group (Y-matrix) by removing common variance and by finding underlying latent 
variables (LV’s). The optimal number of LV’s was determined with the scree plot [24]. All 
variables were normalized to unit variance. For a more detailed mathematical explanation 
we refer to the study of Wold and colleagues [24]. The amount of variance explained of each 
gait outcome by the LV’s indicated the modelling power of those outcomes in predicting 
the group. Note that a gait outcome without variation may be completely explained by the 
model, while this outcome may be unimportant to predict group. The Variable Importance 
in Projection (VIP) value reflects the importance of each individual gait outcome to the 
particular group. Gait outcomes with a VIP-score >1.0 are considered important to the 
model and have a high discriminative power [24].
Violin plots based on the Kernel density distribution showed the distribution of gait 
outcomes for the three groups, and revealed peaks, bumps, and valleys in the shape of 
distributions [34]. The size of the kernels demonstrates the density between individual 
scores, with a large size reflecting heterogeneity among patients.
RESULTS
Thirty-nine of 70 geriatric patients were diagnosed with cognitive impairment (56%; 10 
patients with dementia and 29 with MCI). Geriatric patients were significantly older (80 ±6.6 
years) than healthy old adults (65 ±5.5 years). Geriatric patients with and without cognitive 
impairment presented with 1.8 serious comorbidities on average and met the criterion for 
polypharmacy (>4). Both geriatric patient groups were comparable for all outcomes (age, 
BMI, handgrip strength, medication use, number of comorbidities), except for cognitive 
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function. Cognitive impaired geriatric patients performed significantly worse on the MMSE 
and on all sub-scales of the 7MS (Table 1). In addition, all groups performed significantly 
different on the cognitive single-task (p<0.00), with a score of 14.2 words/minute for healthy 
old adults, and 10.3 and 7.4 words/minute for cognitive intact and cognitive impaired 
geriatric patients, respectively.
Gait outcomes were computed from 298 ± 50 strides on average (mean walking time 177 s, 
mean stride frequency 1.76 Hz) for single-task walking. For dual-task walking, outcomes 
were derived from 297 ± 45 strides on average (mean walking time 185 s, mean stride 
frequency 1.61 Hz).
Table 1. Characteristics of the 95 participants (mean ± SD)a
Gait characteristics for the 3 groups
For single-task walking, the PLS-DA model contained 4 LV’s that explained 63% and 41% 
of the variance in gait outcomes (X) and group (Y), respectively. Gait outcomes are logically 
grouped and divided over the 4 LV’s, with the first LV explaining most of the variance in X 
and Y. Similarly, the PLS-DA model for dual-task walking consisted of 4 LV’s, explaining 
67% and 38% of the variance in respectively gait outcomes (X) and group (Y). VIP-values per 
group indicated the importance of the gait outcomes to the particular group. Gait outcomes 
related to speed, regularity, predictability and stability of trunk accelerations revealed with 
the highest discriminative power (VIP>1) for both single- and dual-task walking (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significance set at 5%. A = significant difference between healthy old adults and 
geriatric patients; B = significant difference between healthy old adults and cognitive 
impaired geriatric patients; C = significant difference between geriatric and cognitive 
impaired geriatric patients. N.A. = Not applicable; MMSE = Mini Mental State 
Examination; BTO = Benton’s Temporal Orientation; CCI = Charlson Comorbidity 
Index; ST = single task; DT = dual task. 
 
 
Healthy old  
adults  
(n=25) 
Cognitive intact  
geriatric patients  
(n=31) 
Cognitive impaired 
geriatric patients 
(n=39) 
Demographics    
Age (years) 65 ± 5.5 79 ± 5.3 82.0 ± 7.2    A, B 
Height (cm) 168 ± 8.6 167 ± 9.4 166 ± 8.2 
Weight (kg) 71.3 ± 12.2 73.3 ± 14.6 68.0 ± 12.5 
Body Mass Index 25.0 ± 3.6 26.3 ± 5.3 23.5 ± 6.2 
Gait speed ST (m/s) 1.20 ± 0.10 0.88 ± 0.22 0.81 ± 0.22 A, B 
Gait speed DT (m/s) 1.01 ± 0.12 0.69 ± 0.19 0.68 ± 0.22 A, B 
Cognitive function          
MMSE N.A.   27.4 ± 2.3 23.9 ± 3.8   C 
BTO N.A.   4.2 ± 13.8 17.1 ± 29.9 C 
Enhanced Cued Recall N.A.   14.9 ± 1.7 10.5 ± 4.4   C 
Clock drawing N.A.   11.8 ± 1.8 9.8 ± 2.6   C 
Verbal fluency N.A.   18.2 ± 6.6 12.3 ± 4.1   C 
Geriatric syndromes          
CCI N.A.   1.9 ± 1.8 1.7 ± 1.3 
Handgrip strength (kg) N.A.   26.3 ± 6.4 26.0 ± 7.2 
Medications (number) N.A.   6.4 ± 4.1 5.5 ± 3.4 
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The interpretation of the above results necessitates the direction of the relationship 
between gait outcomes and participant group. Violin plots show the distribution of the 
23 normalized gait outcomes for the three groups during single-task walking (Figure 1). 
Both geriatric patient groups walked slower than healthy old adults. In addition, geriatric 
patients presented with smaller amplitude magnitude (RMS), more synchronization of 
trunk accelerations (Cross-Sample Entropy), less regularity and symmetry (step and 
stride regularity and symmetry), less stability (λ
max
), and more stride variability (Frequency 
variability). Gait smoothness (Index of Harmonicity) and gait predictability (Multiscale 
Entropy) were comparable for geriatric patients and healthy old adults, and showed large 
kernel sizes. As visible from the violin plots, differences between cognitive intact and 
cognitive impaired geriatric patients were small for individual gait outcomes.
Table 2. PLSDA model details during single- and dual-task walking for the 
three groupsa
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
aExplained variance (%) per LV for the single-task model, and VIP-values for 
healthy old (HO) adults, Cognitive Intact (CI) geriatric and Cognitive Impaired 
(CIM) geriatric patients during single- and dual task walking. A VIP > 1.0 denotes 
considerable importance of the gait outcome to the particular group (bold). LV = 
latent variable; VIP = Variable Importance in Projection; RMS = Root Mean 
Square; IH = Index of Harmonicity; Cross-SEn = Cross Sample Entropy; Mscale-
En = Multi-scale Entropy; max-Lyap = maximal Lyapunov Exponent; FreqVar = 
Frequency Variability; AP = Anterior-Posterior; ML = Medio-Lateral; V = Vertical.  
	
Gait outcome Variance captured per LV (%) VIP-values 
  Single-task Dual-task 
 LV1 LV2 LV3 LV4 Total HO CI CIM  HO CI CIM  
Gait speed  78 5 1 3 86 1.4 0.5 1.3 1.7 1.2 1.5 
RMS AP 58 4 0 0 62 1.0 0.7 0.8 1.1 1.2 0.9 
RMS ML 47 1 12 3 62 1.3 0.5 1.2 1.3 0.9 1.1 
RMS V 76 0 3 2 81 2.0 1.2 1.9 2.2 1.6 1.8 
IH AP  53 1 3 1 58 1.3 0.9 1.5 1.1 0.8 0.9 
IH ML  0 0 24 8 33 0.2 0.4 0.5 0.1 0.0 0.2 
IH V 3 11 11 13 37 0.3 1.7 0.2 0.2 0.1 0.1 
Cross-SEn AP-ML  42 19 0 6 68 0.8 1.2 0.7 1.0 1.4 0.8 
Cross-SEn AP-V  34 3 15 20 72 0.8 0.3 0.7 1.1 0.7 1.0 
Cross-SEn ML-V  30 4 8 19 61 0.7 0.9 0.9 1.2 0.8 1.1 
Step Reg AP  57 2 8 5 72 1.0 0.5 0.9 1.1 0.7 0.9 
Step Reg V  77 0 4 0 82 1.4 0.3 1. 3 1.3 1.0 1.0 
Stride Reg AP  73 0 9 3 85 1.4 0.5 1.3 1.3 0.9 1.0 
Stride Reg V  82 0 10 1 93 1.5 0.3 1.3 1.5 1.1 1.1 
Symmetry AP  30 2 11 4 47 0.5 0.8 0.7 0.5 0.3 0.6 
Symmetry V  44 3 24 0 71 0.9 0.9 1.4 0.9 0.6 0.8 
Mscale-En AP  19 1 26 5 51 0.3 0.2 0.7 1.8 0.6 3.6 
Mscale-En ML  0 47 0 5 51 0.7 3.2 0.3 0.4 0.6 0.5 
Mscale-En V  18 20 16 0 53 1.2 3.5 1.0 1.0 2.4 1.4 
max-Lyap AP  23 0 8 14 45 0.7 0.4 0.8 1.4 1.0 1.1 
max-Lyap ML  20 20 24 2 66 1.5 2.3 1.4 0.5 0.3 0.6 
max-Lyap V  53 4 5 2 64 1.3 1.1 1.4 0.3 3.5 0.8 
FreqVar AP  35 3 0 3 41 1.0 0.7 0.8 0.3 1.2 0.4 
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Figure 1. Violin plots based on the kernel density distribution show the distribution of gait outcomes. The 
violins show gait outcomes for healthy old adults (n=25), cognitive intact (n=31), and cognitive impaired 
geriatric patients (n=36) during single-task walking. A more compact and less elongated kernel denotes 
greater density and homogeneity across gait outcomes. Black and dashed red lines indicate mean and 
median values, respectively. Outcomes are standardized to unit variance for plotting purposes only. RMS = 
Root Mean Square; IH = Index of Harmonicity; Cross-SampEn = Cross Sample Entropy; Mscale-En = Multi-
scale Entropy; max-Lyap = maximal Lyapunov Exponent; FreqVar = Frequency Variability; AP = Anterior-
Posterior; ML = Medio-Lateral; V = Vertical.
Discrimination of groups
For single- and dual-task walking, 24 (96%) and 23 (92%) of the 25 healthy old controls 
were correctly classified based on the gait outcomes, respectively. Fifteen (48%) and 11 
(35%) of 31 cognitive intact geriatric patients were correctly classified during single- and 
dual-task walking. Fifteen (38%) and 14 (36%) of 39 cognitive impaired geriatric patients 
were correctly classified based on respectively single- and dual-task walking (Figure 2). 
The multivariate models for single- and dual-task conditions were comparable in terms of 
discriminative ability (VIP-scores), and classification accuracy.
DISCUSSION
We examined gait characteristics and their discriminative power in healthy old adults and 
geriatric patients with- and without cognitive impairment. Twenty-three accelerometry-
based gait outcomes were calculated while subjects walked for 3 minutes at habitual 
speed with and without a cognitive dual-task. Gait outcomes related to speed, regularity, 
predictability, and stability of trunk accelerations revealed with the highest discriminative 
power (VIP>1), and were thus most important in the identification of the three groups of 
old adults in terms of their gait. Despite the correct classification of a high proportion of 
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Figure 2. Score plots and classification accuracy. Score plots (left panel) visualize the individual participant 
scores and shows the relationship between gait outcomes and participants of each group with respect to 
the first two Latent Variables for single-task (upper panel) and dual-task walking (lower panel). Healthy old 
adults present in a sharply separated cluster, while 57% and 64% of geriatric patients with cognitive intact 
(CI) and cognitive impaired (CIM) geriatric patients are misclassified for single- and dual-task, respectively 
(right panel).
healthy old adults (96% and 93% for single- and dual-task, respectively), the classification 
of geriatric patients with and without cognitive impairments was poor: 57% (single-task) 
and 64% (dual-task) of the patients were misclassified. We discuss gait characteristics for 
the three groups, and the lack of discrimination between geriatric patients with and without 
cognitive impairments.
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Gait speed and speed-related outcomes (e.g., RMS, AP Index of Harmonicity) were important 
in the characterization of groups. Geriatric patients walked substantially slower (0.81 m/s) 
than healthy old adults (1.20 m/s) but gait speed was similar in patients with (0.88 m/s) and 
without (0.81 m/s) cognitive impairment. These values compare well with normative gait 
speed data for healthy old adults [35] and patients with cognitive impairment [21]. In general, 
age-related gait slowing results from a decline in neuromuscular and neurophysiological 
functioning that for example engenders sarcopenia and a slower reaction time [1]. 
Considering geriatric patients’ higher age compared with healthy old adults, the slower 
gait speed was expected. Because cross-sectional and longitudinal studies reported that 
cognitive impairments are strongly associated with gait slowing [21], we also expected but 
found only 0.07 m/s additional gait slowing in our patients. This result is in agreement with 
a recent population study that concluded that a slow baseline gait speed was only modestly 
related to future cognitive decline, and provided no early marker of clinical progression 
from MCI to dementia [36].
With regards to gait regularity, predictability, and stability, gait outcomes in ML and V 
direction were particularly important, as indicated by the large VIP-scores. Geriatric 
patients vs. healthy old controls walked less regular, less predictable, and less stable. 
Especially, gait control in ML direction is crucial in maintaining balance and gait alterations 
in this direction have been associated with dynamic instability, numerous pathologies, 
as well as with adverse life-events such as falling [9]. The decline in gait regularity and 
stability in geriatric patients may be related to a decline in executive functioning. Because 
imaging studies reported associations between the activation of wide brain networks and 
gait speed, especially in cognitively impaired old adults, gait is far from and automatically 
controlled motor task and involves cognitive functioning [37]. In particular, reductions in 
executive function may result in inaccurate control of limb movements and diminished 
feed-back that caused gait irregularity and instability [38]. For instance, differences in 
step and stride regularity have been suggested to reflect differences in the motor control 
of propulsion and braking phases of gait [7], a process highly depending on lower limb 
control and accurate feedback mechanisms. In support of this explanation, structural and 
functional neuroimaging data suggest that prefrontal brain areas (the areas executive 
functions are predominantly located) are most susceptible to age-related decline [39]. Even 
though geriatric patients with vs. without cognitive impairments did score worse on the 
executive function tests, there was no corresponding decline in gait regularity and stability. 
Those results compare to a recent study [40], but are in contrast to studies that reported a 
lower gait regularity in patients with MCI or dementia during single- tasking [41] and dual-
tasking [42]. Subject characteristics may account for these discrepancies between studies, 
as our patient group was relatively old and presented with multiple geriatric conditions that 
are known to affect gait.   
With respect to the classification accuracy, the gait outcomes revealed close to perfect 
classification of the healthy old group (96% and 92% for single- and dual-task, respectively). 
However, the discrimination between geriatric patients with and without cognitive 
impairments was poor, with 57% (single-task) and 64% (dual-task) of the patients 
misclassified. This finding was unexpected, as the cognitively impaired vs. cognitive intact 
geriatric patients scored significantly lower on global cognition (3.5 points lower MMSE 
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score), and on executive and memory functioning. Furthermore, an additional cognitive 
stressor in the dual-task condition did not improve the discrimination between the geriatric 
patient groups. The number of clinical conditions per se can substantially affect geriatric 
patients’ gait [20]. The effects of comorbidities in our patients presumably sum to a level 
that causes a floor-effect so that when cognitive impairment adds to the symptoms, gait 
does not deteriorate any further, even if tested under dual-task walking. 
Our data are in line with a lack of gait differences between frail and cognitively impaired old 
adults during single- or dual-task walking [40]. The latter study quantified gait kinematics 
derived from lower trunk accelerations in old adults aged >75 who meet Frieds’ criteria 
for frailty. Despite the relatively short walking distance (5m), they found that the gait 
kinematics were highly sensitive to distinguish frail groups and healthy old controls, but not 
between frail patients with and without cognitive impairment during either single- or dual-
task walking. Our and previous data [40] thus raise the possibility of a clinical threshold 
beyond which the use of only gait outcomes to identify cognitive impairment is insufficient. 
We interpret these findings to mean that: (1) the prediction of cognitive impairment from 
gait abnormalities may be most effective in early phases of cognitive decline, where the 
influences of comorbidities on gait are limited. Hence, in frail geriatric patients, (2) the 
identification of cognitive decline requires a multi-variate approach, including physical, 
cognitive, pharmacological, and behavioural measures. 
Although most aspects of gait performance (e.g., related to speed, regularity, predictability, 
and stability) appeared important in the characterization of the groups, some outcomes 
produced low discriminative power. A possible explanation could be that our geriatric 
patients were very heterogeneous, as indicated by the large kernel sizes of for example 
gait synchronization (Cross-sample Entropy), and gait smoothness (Index of Harmonicity) 
(Figure 1). Given this variety in gait patterns, and because geriatric patients often present 
with a shuffling gait, we calculated gait outcomes that are independent of step detection 
and recommend the use of such an approach in geriatric patients. An accurate, automatic, 
detection of foot-contact indices from acceleration signals is difficult, and already achieves 
an error rate of 7.4% in healthy old adults [43]. This error rate is expected to increase with 
gait slowing and/or shuffling; conditions very common among geriatric patients. 
Despite the relatively low sample size, which can be considered a potential limitation of 
the study, we speculate that the outcomes can be generalized to similar population groups 
(i.e., age-matched healthy old adults and geriatric patients admitted to outpatient clinics). 
Although both geriatric patient groups were comparable in terms of age, sex, weight, height, 
BMI, number of comorbidities, gript strength, and medication use (Table 1), we cannot 
exclude the effects of potential other factors on gait function (e., thoracic kyphosis). Finally, 
the present analysis only focused on gait aspects derived from 3D-trunk accelerations. 
Future studies are encouraged to study the discriminative ability of for example gait kinetics 
to identify cognitive impairment. 
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Conclusions
In conclusion, gait outcomes related to speed, regularity, predictability, and stability of trunk 
accelerations were most important in the characterization of patient groups and revealed 
with a large discriminative power. Such measures were highly sensitivity to discriminate 
healthy old adults from geriatric patients but could not discriminate geriatric patients 
with and without cognitive impairment during single- or dual-task walking. Thus, our 
data suggest that caution is needed to predict geriatric patients’ cognitive status from gait 
performance alone. We propose that an accurate identification of cognitive impairment 
requires a multivariate approach that comprises not only a comprehensive gait analysis, 
but also other physical, cognitive, and behavioural measures.
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3D = three dimensional; PLS-DA= Partial Least Squares - Discriminant Analysis; VIP = 
Variable Importance in Projection; BMI = Body Mass Index; CCI = Charlson Comorbidity 
Index; MMSE = Mini Mental State Examination; 7MS = 7-Minute Screen; BTO = Benton’s 
Temporal Orientation; ECR = Enhanced Cued Recall; AP = Anterior-Posterior; ML = Medio-
Lateral; V = vertical; RMS = Root Mean Square; IH = Index of Harmonicity; Cross-SampEn = 
Cross-sample Entropy; Mscale-En = Multi-scale sample Entropy; λ
max
 = maximal Lyapunov 
exponent; FreqVar = stride frequency variability; LV = Latent Variable.
ETHICS APPROVAL AND CONSENT TO 
PARTICIPATE
The Medical Ethical Committee of the MC 
Slotervaart Hospital approved the study protocol. 
CONSENT FOR PUBLICATION
Not applicable.
AVAILABILITY OF DATA AND MATERIAL
The datasets used and/or analyzed during the 
current study are available from the corresponding 
author on reasonable request. PLS_toolbox for 
MatLab (version 3.7.1; Eigenvector Research 
Inc.) was used to analyse the data. This software 
requires a license for non-academics.
82
COMPETING INTERESTS
The authors declare that they have no compet-
ing interests.
FUNDING
This work was supported in part by the French 
national program “programme d’Investisse-
ments d’Avenir IRT Nanoelec” ANR-10-AIRT-05, 
Institut Universitaire de France
AUTHORS’ CONTRIBUTIONS
CL, TH, and JvC designed the study protocol. 
LK collected and analyzed the data, with close 
supervision of CL. Results were interpreted 
by CL, TH, NV, JvC, and LK. LK wrote the first 
draft, and NV, BA, JvC, TH, and CL contributed 
significantly in revising the manuscript. All 
authors read and approved the final manuscript.
ACKNOWLEDGEMENTS
All the participants are gratefully acknow-
ledged. 
AUTHORS’ INFORMATION
1 University of Groningen, University Medical 
Centre Groningen, Center for Human Movement 
Sciences, A. Deusinglaan 1, 9700 AD Groningen, 
The Netherlands 
2 Université Grenoble Alpes, EA AGEIS, La 
Tronche, France
3 Institut Universitaire de France, Paris, France
4 MC Slotervaart Hospital, Department of Neu-
ropsychology, Amsterdam, The Netherlands
5 MC Slotervaart Hospital, Department of Geriat-
ric Medicine, Amsterdam, The Netherlands
483
1. Papegaaij S, Taube W, Baudry S, Otten E, Hor-
tobagyi T. Aging causes a reorganization of 
cortical and spinal control of posture. Front 
Aging Neurosci. 2014;6:28; doi:10.3389/fna-
gi.2014.00028 [doi].
2. Vandervoort AA. Aging of the human neuromus-
cular system. Muscle Nerve. 2002;25 1:17-25; 
doi:10.1002/mus.1215 [pii].
3. Hortobagyi T, Lesinski M, Gabler M, VanS-
wearingen JM, Malatesta D, Granacher U. Ef-
fects of Three Types of Exercise Interventions 
on Healthy Old Adults' Gait Speed: A Systematic 
Review and Meta-Analysis. Sports Med. 2015; 
doi:10.1007/s40279-015-0371-2 [doi].
4. Abellan van Kan G, Rolland Y, Andrieu S, Bau-
er J, Beauchet O, Bonnefoy M et al. Gait speed 
at usual pace as a predictor of adverse out-
comes in community-dwelling older people an 
International Academy on Nutrition and Aging 
(IANA) Task Force. J Nutr Health Aging. 2009;13 
10:881-889.
5. Hausdorff JM, Edelberg HK, Mitchell SL, Gold-
berger AL, Wei JY. Increased gait unsteadi-
ness in community-dwelling elderly fallers. 
Arch Phys Med Rehabil. 1997;78 3:278-283; 
doi:S0003-9993(97)90034-4 [pii].
6. Rispens SM, Pijnappels M, van Schooten KS, 
Beek PJ, Daffertshofer A, van Dieen JH. Consist-
ency of gait characteristics as determined from 
acceleration data collected at different trunk 
locations. Gait Posture. 2014;40 1:187-192; 
doi:10.1016/j.gaitpost.2014.03.182 [doi].
7. Kobsar D, Olson C, Paranjape R, Hadjistav-
ropoulos T, Barden JM. Evaluation of age-re-
lated differences in the stride-to-stride fluctu-
ations, regularity and symmetry of gait using 
a waist-mounted tri-axial accelerometer. Gait 
Posture. 2014;39 1:553-557; doi:10.1016/j.
gaitpost.2013.09.008 [doi].
8. Lamoth CJ, Beek PJ, Meijer OG. Pelvis-tho-
rax coordination in the transverse plane dur-
ing gait. Gait Posture. 2002;16 2:101-114; 
doi:S0966636201001461 [pii].
9. Riva F, Toebes MJ, Pijnappels M, Stagni R, van 
Dieen JH. Estimating fall risk with inertial sen-
sors using gait stability measures that do not re-
quire step detection. Gait Posture. 2013;38 2:170-
174; doi:10.1016/j.gaitpost.2013.05.002 [doi].
10. Kosse NM, Vuillerme N, Hortobagyi T, Lamoth 
CJ. Multiple gait parameters derived from iPod 
accelerometry predict age-related gait changes. 
Gait Posture. 2016;46:112-117; doi:10.1016/j.
gaitpost.2016.02.022 [doi].
11. de Groot MH, van der Jagt-Willems HC, van 
Campen JP, Lems WF, Beijnen JH, Lamoth CJ. 
A flexed posture in elderly patients is associat-
ed with impairments in postural control dur-
ing walking. Gait Posture. 2014;39 2:767-772; 
doi:10.1016/j.gaitpost.2013.10.015 [doi].
12. Kaptein RG, Wezenberg D, IJmker T, Houdijk H, 
Beek PJ, Lamoth CJ et al. Shotgun approach-
es to gait analysis: insights & limitations. J 
Neuroeng Rehabil. 2014;11:120-0003-11-120; 
doi:10.1186/1743-0003-11-120 [doi].
13. van Schooten KS, Pijnappels M, Rispens SM, El-
ders PJ, Lips P, Daffertshofer A et al. Daily-Life 
Gait Quality as Predictor of Falls in Older Peo-
ple: A 1-Year Prospective Cohort Study. PLoS 
One. 2016;11 7:e0158623; doi:10.1371/journal.
pone.0158623 [doi].
14. Doi T, Hirata S, Ono R, Tsutsumimoto K, Misu S, 
Ando H. The harmonic ratio of trunk accelera-
tion predicts falling among older people: results 
of a 1-year prospective study. J Neuroeng Re-
habil. 2013;10:7-0003-10-7; doi:10.1186/1743-
0003-10-7 [doi].
15. Ihlen EA, Weiss A, Bourke A, Helbostad JL, 
Hausdorff JM. The complexity of daily life 
walking in older adult community-dwell-
ing fallers and non-fallers. J Biomech. 2016; 
doi:S0021-9290(16)30254-8 [pii].
16. Toebes MJ, Hoozemans MJ, Furrer R, Dekker J, 
van Dieen JH. Local dynamic stability and vari-
ability of gait are associated with fall history in 
elderly subjects. Gait Posture. 2012;36 3:527-
531; doi:10.1016/j.gaitpost.2012.05.016 [doi].
17. Lamoth CJ, van Deudekom FJ, van Campen JP, 
Appels BA, de Vries OJ, Pijnappels M. Gait sta-
bility and variability measures show effects of 
impaired cognition and dual tasking in frail 
people. J Neuroeng Rehabil. 2011;8:2-0003-8-2; 
doi:10.1186/1743-0003-8-2 [doi].
18. Ijmker T, Lamoth CJ. Gait and cognition: the re-
lationship between gait stability and variabili-
ty with executive function in persons with and 
without dementia. Gait Posture. 2012;35 1:126-
130; doi:10.1016/j.gaitpost.2011.08.022 [doi].
REFERENCES
84
19. Landi F, Liperoti R, Russo A, Giovannini S, To-
sato M, Capoluongo E et al. Sarcopenia as a risk 
factor for falls in elderly individuals: results 
from the ilSIRENTE study. Clin Nutr. 2012;31 
5:652-658; doi:10.1016/j.clnu.2012.02.007 [doi].
20. de Groot MH, van Campen JP, Moek MA, Tul-
ner LR, Beijnen JH, Lamoth CJ. The effects of 
fall-risk-increasing drugs on postural control: a 
literature review. Drugs Aging. 2013;30 11:901-
920; doi:10.1007/s40266-013-0113-9 [doi].
21. Kikkert LH, Vuillerme N, van Campen JP, Hor-
tobagyi T, Lamoth CJ. Walking ability to pre-
dict future cognitive decline in old adults: A 
scoping review. Ageing Res Rev. 2016;27:1-14; 
doi:S1568-1637(16)30009-5 [pii].
22. Montero-Odasso M, Muir SW, Speechley M. Du-
al-task complexity affects gait in people with 
mild cognitive impairment: the interplay be-
tween gait variability, dual tasking, and risk of 
falls. Arch Phys Med Rehabil. 2012;93 2:293-
299; doi:10.1016/j.apmr.2011.08.026 [doi].
23. Holtzer R, Epstein N, Mahoney JR, Izzetoglu M, 
Blumen HM. Neuroimaging of mobility in ag-
ing: a targeted review. J Gerontol A Biol Sci Med 
Sci. 2014;69 11:1375-1388; doi:10.1093/gerona/
glu052 [doi].
24. Wold S, Sjöström M, Eriksson L. PLS-regression: 
a basic tool of chemometrics. Chemometrics In-
tellig Lab Syst. 2001;58 2:109-130; doi:http://dx.
doi.org/10.1016/S0169-7439(01)00155-1.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 
A new method of classifying prognostic comor-
bidity in longitudinal studies: development and 
validation. J Chronic Dis. 1987;40 5:373-383.
26. Tombaugh TN, McIntyre NJ. The mini-mental 
state examination: a comprehensive review. J 
Am Geriatr Soc. 1992;40 9:922-935.
27. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush 
M, DeVeaux RD et al. A 7 minute neurocognitive 
screening battery highly sensitive to Alzheim-
er's disease. Arch Neurol. 1998;55 3:349-355.
28. Schmand,B., Groenink S,C., van den Dungen,M. 
Letterfluency: psychometrische eigenschappen 
en Nederlandse normen.
29. Kosse NM, Caljouw S, Vervoort D, Vuillerme N, 
Lamoth CJ. Validity and Reliability of Gait and 
Postural Control Analysis Using the Tri-axial 
Accelerometer of the iPod Touch. Ann Biomed 
Eng. 2015;43 8:1935-1946; doi:10.1007/s10439-
014-1232-0 [doi].
30. Kavanagh JJ. Lower trunk motion and 
speed-dependence during walking. J Neuroeng 
Rehabil. 2009;6:9-0003-6-9; doi:10.1186/1743-
0003-6-9 [doi].
31. Moe-Nilssen R, Helbostad JL. Estimation 
of gait cycle characteristics by trunk accel-
erometry. J Biomech. 2004;37 1:121-126; 
doi:S0021929003002331 [pii].
32. Costa M, Peng C-, L. Goldberger A, Hausdorff JM. 
Multiscale entropy analysis of human gait dy-
namics. 2003;330 1–2:53-60; doi:http://dx.doi.
org/10.1016/j.physa.2003.08.022.
33. Cignetti F, Decker LM, Stergiou N. Sensitivity of 
the Wolf's and Rosenstein's algorithms to eval-
uate local dynamic stability from small gait data 
sets. Ann Biomed Eng. 2012;40 5:1122-1130; 
doi:10.1007/s10439-011-0474-3 [doi].
34. Hintze JL, Nelson RD. Violin Plots: A Box 
Plot-Density Trace Synergism. 1998;52 2:181-
184; doi:10.1080/00031305.1998.10480559.
35. Bohannon RW, Williams Andrews A. Nor-
mal walking speed: a descriptive meta-anal-
ysis. Physiotherapy. 2011;97 3:182-189; 
doi:10.1016/j.physio.2010.12.004 [doi].
36. Hooghiemstra AM, Ramakers IHGB, Sistermans 
N, Pijnenburg YAL, Aalten P, Hamel REG et al. 
Gait Speed and Grip Strength Reflect Cogni-
tive Impairment and Are Modestly Related to 
Incident Cognitive Decline in Memory Clinic 
Patients With Subjective Cognitive Decline and 
Mild Cognitive Impairment: Findings From the 
4C Study. J Gerontol A Biol Sci Med Sci. 2017;72 
6:846-854; doi:10.1093/gerona/glx003 [doi].
37. Verlinden VJ, de Groot M, Cremers LG, van der 
Geest JN, Hofman A, Niessen WJ et al. Tract-spe-
cific white matter microstructure and gait in 
humans. Neurobiol Aging. 2016;43:164-173; 
doi:10.1016/j.neurobiolaging.2016.04.005 [doi].
38. Yogev-Seligmann G, Hausdorff JM, Giladi N. 
The role of executive function and attention in 
gait. Mov Disord. 2008;23 3:329-42; quiz 472; 
doi:10.1002/mds.21720 [doi].
39. Lemaitre H, Goldman AL, Sambataro F, Verchin-
ski BA, Meyer-Lindenberg A, Weinberger DR 
et al. Normal age-related brain morphometric 
changes: nonuniformity across cortical thick-
ness, surface area and gray matter volume?. 
Neurobiol Aging. 2012;33 3:617.e1-617.e9; 
doi:10.1016/j.neurobiolaging.2010.07.013 [doi].
485
40. Martinez-Ramirez A, Martinikorena I, Lecum-
berri P, Gomez M, Millor N, Casas-Herrero A et al. 
Dual Task Gait Performance in Frail Individuals 
with and without Mild Cognitive Impairment. 
Dement Geriatr Cogn Disord. 2016;42 1-2:7-16; 
doi:10.1159/000447451 [doi].
41. Maquet D, Lekeu F, FAU - Warzee E, Warzee E, 
FAU - Gillain S, Gillain S et al. Gait analysis in 
elderly adult patients with mild cognitive im-
pairment and patients with mild Alzheimer's 
disease: simple versus dual task: a prelimi-
nary report. 1475-097X (Electronic); 1475-0961 
(Linking).
42. Gillain S, Drame M, Lekeu F, Wojtasik V, Ricour 
C, Croisier JL et al. Gait speed or gait variability, 
which one to use as a marker of risk to develop 
Alzheimer disease? A pilot study. Aging Clin Exp 
Res. 2016;28 2:249-255; doi:10.1007/s40520-
015-0392-6 [doi].
43. Dijkstra B, Zijlstra W, Scherder E, Kamsma Y. De-
tection of walking periods and number of steps 
in older adults and patients with Parkinson's 
disease: accuracy of a pedometer and an accel-
erometry-based method. Age Ageing. 2008;37 
4:436-441; doi:10.1093/ageing/afn097 [doi].

Background: Walking ability recently emerged as a sub-clinical marker 
of cognitive decline. Hence, the relationship between baseline gait and 
future cognitive decline was examined in geriatric patients. Because 
a ‘loss of complexity’ (LOC) is a key-phenomenon of the aging process 
that exhibits in multiple systems, we propose the idea that age- and 
cognition-related LOC may also become manifested in gait function. 
We hypothesized that a LOC is reflected in dynamic gait outcomes 
and that such outcomes could increase the specificity of the gait-
cognition link. Methods: 19 geriatric patients (age 80.0±5.8) were 
followed for 14.4±6.6 months. An iPod collected 3D-trunk accelerations 
for 3 minutes. Cognition was evaluated with the Mini Mental State 
Examination (MMSE) and the Seven-Minute screen (7MS) test. The 
Reliable Change Index (RCI) quantified the magnitude of cognitive 
change. Spearman’s Rho coefficients (ρ) indexed correlations between 
baseline gait and future cognitive change. Results: Seven patients 
showed reliable cognitive decline (‘Cognitive Decline’ group), and 12 
patients remained cognitively stable (‘Cognitive Stable’ group) over time. 
Future cognitive decline was correlated with a more regular (ρ=0.579*) 
and predictable (ρ=0.486*) gait pattern, but not with gait speed. 
Conclusions: The increase in gait regularity and predictability possibly 
reflects a LOC due to age- and cognition-related (neuro)physiological 
decline. Because dynamic vs. traditional gait outcomes were more 
strongly correlated with future cognitive decline, the use of wearable 
sensors in predicting and monitoring cognitive and physical health in 
vulnerable geriatric patients can be considered promising. However, 
our results are preliminary and do require replication in larger cohorts. 
Key words: Geriatric patients, Frailty, Cognitive impairment, Gait 
analysis, Non-linear dynamics, Prediction, Loss of complexity. 
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ABSTRACT
THE RELATIONSHIP BETWEEN GAIT 
DYNAMICS AND FUTURE COGNITIVE 
DECLINE: A PROSPECTIVE PILOT 
STUDY IN GERIATRIC PATIENTS5
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INTRODUCTION
Medical developments have substantially extended human lifespan. An increase in age, 
however, comes hand in hand with co-morbidities such as cognitive decline, muscle 
weakness, frailty, polypharmacy, and falling [1]. Hence, we can anticipate an increase 
in the number of ‘older old adults’ who will need specialised geriatric care (i.e., geriatric 
patients) to slow functional decline. Cognitive impairment is a frequent geriatric condition 
substantially affecting independence, mobility, and quality of life (WHO, 2017). If applied in 
time, tailored interventions could delay disease onset and perhaps extend the asymptomatic 
phase. Predicting future cognitive loss is therefore important in this vulnerable population, 
in which walking ability has recently emerged as a non-invasive sub-clinical marker that 
predicts cognitive decline [2].
The view that walking is no longer considered an automatic task supports its potential to 
serve as an early marker of cognitive decline. Because brain areas affected by cognitive 
impairment partly overlap with brain areas activated during walking [3], subtle, pre-clinical 
changes in gait could be precursors of evolving cognitive impairment. Such an overlap 
gave rise to the concepts of the ‘Motoric Cognitive Risk’ syndrome [4], a ‘Gait Phenotype’ 
of cognitive decline [5], and the ‘Motor Signature’ of cognitive decline [6]. Longitudinal 
studies confirmed the close relation between gait and cognition [2, 7], with the majority 
of prediction studies focussing on gait speed as main predictor of cognitive decline [2]. 
Individuals who developed Mild Cognitive Impairment (MCI) or dementia presented with 
a slower baseline gait speed (0.91 and 0.80 m/s, respectively) as compared to individuals 
who remained cognitively intact (1.11 m/s) [2]. While a slow walking speed provides an 
important marker of multiple adverse outcomes (e.g., falling, hospitalization, and even 
survival) [8], more delicate gait measures could unravel why geriatric patients walk slow, 
with final gait speed being the cumulative result of interactions between multiple, subtle 
gait functions. Hence, we hypothesize that those gait details could increase the specificity of 
the gait-cognition link. Key-principles of the aging neuro-musculo-skeletal system (NMSS) 
provide a theoretical framework for the latter hypothesis.
Although age- and pathology related declines in neural, sensory-motor, cognitive, and 
muscular function, i.e., declines in NMSS, are generally examined separately, such a view 
limits our understanding of the aging NMSS as a whole [9]. Because vulnerable geriatric 
patients show degradation in multiple interacting systems, we propose the idea to place the 
gait-cognition link into a more encompassing perspective to better understand the coupling 
and coordination between elements of the NMSS (i.e., gait and cognition). To this idea, we 
consider a key-phenomenon of the aging NMSS, namely the ‘loss of complexity’ (LOC). The 
LOC theory is derived from the field of non-linear dynamics, and suggests that even healthy 
aging is associated with a (neuro)physiological breakdown of system elements that causes 
a loss of overall complexity [10]. This loss of complexity in turn leads to a reduced adaptive 
capacity and most likely to poor functional outcomes such as frailty and an increased fall 
risk [11]. Indeed, frail vs. healthy old adults and fallers vs. non-fallers are characterized by a 
global loss of complexity [11], and a loss of complexity indicates transitions from healthy to 
frail aging [12]. (Neuro)physiological decline and cognitive impairment may add to this loss 
of complexity, and possibly becomes manifested in gait function. A loss of gait complexity 
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is characterized by an increased gait regularity/predictability, in which perfect regular 
signals would resemble a sine function. Coordination dynamics constitutes a conceptual 
framework to quantify complexity caused by physiological breakdown because it can 
capture changes of functional status over time by means of for example indexing coupling 
and self-organisation properties [9]. 
Trunk accelerations have demonstrated their ability to quantify non-linear coordination 
dynamics of gait function including self-affinity, regularity, complexity, variability, and 
stability [13-16]. Such gait dynamics describe overall gait coordination and the ability 
to overcome or adequately respond to perturbations. Cross-sectionally, gait dynamics 
distinguished old adults with- and without cognitive impairment, with cognitively impaired 
old adults presenting with a less variable and less stable gait pattern [17]. Longitudinally, 
adding gait dynamics to clinical tests increased the accuracy of a fall prediction model by 
14% [18], and the specificity of a fall classification model from 60% to 80% [19]. However, 
less is known about the longitudinal link between gait dynamics and cognitive decline. In 
addition to more traditional outcomes such as gait speed, it is quite possible that an age- 
and pathology-related loss of complexity is expressed in detailed dynamic gait outcomes 
derived from non-linear analyses. Gait dynamics could therefore assist to index and predict 
long-term cognitive change and provide insights into (unconscious) strategies old adults use 
to compensate for this anticipated cognitive loss. Hence, the aim of the present prospective 
pilot study was to examine the relationship between baseline gait function and future 
cognitive decline, and to identify indicators of future cognitive decline in terms of a geriatric 
patient’s gait. We hypothesize that a loss of complexity of the aging NMSS translates to gait 
function, and is reflected in measures that quantify dynamic aspects of gait.
METHODS
Patients
Seventy geriatric patients were recruited from the geriatric diagnostic day clinic of the MC 
Slotervaart hospital in Amsterdam between January 2015 and July 2016 (mean age 80 ±6.6; 
53% women). Patients were referred by a general practitioner based on general or specific 
decline, and underwent extensive screening for physical and cognitive functioning during 
their seven-hour visit. Inclusion criteria were: age 65 or older. Exclusion criteria were: (1) 
Inability to walk for three minutes without a walking aid, (2) the presence of neurological 
disorders other than dementia-related (e.g., Parkinson’s disease), (3) having neurological or 
orthopaedic disabilities that limit mobility function (e.g., recent surgery), and (4) inability 
to speak and understand Dutch. Only patients at risk for (further) cognitive deterioration 
were invited for a re-evaluation in approximately one year. However, this referral depended 
on subjective and objective evaluations of the clinical geriatrician who treated the patient. 
Hence, 19 patients were included in the present pilot study. While all patients were at risk 
for cognitive impairment, 10 out of 19 patients actually had a diagnosis of MCI at baseline. 
The protocol was approved by the Medical Ethical Committee of the MC Slotervaart hospital. 
Because some of the test results could directly be used by the involved clinical geriatrician 
(e.g., gait speed, hand grip strength, and frailty), the tests were part of a standard clinical 
evaluation when a researcher was present who could administer the measurements. It was 
therefore not necessary to obtain informed consent from patients. 
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Demographic information including age, height, weight, and Body Mass Index (BMI) were 
extracted from medical records. The Charlson Comorbidity Index (CCI) quantified the number 
and severity of comorbidities, and polypharmacy was denoted when patients used >4 
medications. Cognitive performance was evaluated with the Mini Mental State Examination 
(MMSE) and with the 7-minute screen (7MS) test. The 7MS assessed memory function using 
the Benton’s Temporal Orientation (BTO) (range 0-113) and the Enhanced Cued Recall (ECR) 
test (range 0-16), and executive and visuospatial function using the animal verbal fluency 
(range 0-45) and clock-drawing test (range 0-14). A logistic regression formula based 
on the four sub-tests resulted in a total 7MS-score, with a score of 0 corresponding to a 
50% chance that a patient has dementia, and negative and positive scores corresponding 
to a lower and higher than 50% chance to have dementia, respectively. We refer to our 
previous study for references of the cognitive screening batteries [19]. The Reliable Change 
Index (RCI) quantified the magnitude of cognitive change and to determine whether the 
changes in cognition were clinically meaningful and statistically reliable, with a RCI of 
>1.96 indicating a significant change between baseline and follow-up outcomes (p<0.05) 
[20]. Patients who showed a reliable decline in both, MMSE and 7MS-score (average RCI-
score >1.96) were coded as the ‘Cognitive Decline’ group. Patients who remained cognitively 
stable or showed non-significant changes in cognition formed the ‘Cognitive Stable’ group. 
Figure 1 illustrates the study protocol. 
Procedures and pre-processing
At baseline, patients walked for three minutes at habitual gait speed on a 10-m long course 
marked with cones. Accelerations of the lower trunk (near the level of the 3rd lumbar 
vertebra) were registered using a built-in accelerometer of an iPod touch G4 (iOS 6, Apple 
Inc.; sample frequency ±100Hz). The validity of gait and standing posture parameters from 
trunk accelerations as indicated by intra- class correlation (ICC) was high (ICC = 0.85–0.99), 
and test–retest reliability was good (ICC = 0.81–0.97) in old adults, under varying conditions 
[21]. A custom-made application ‘iMoveDetection’ stored the acceleration signals in anterior-
posterior (AP), medio-lateral (ML), and vertical (V) directions [21]. The signals were then 
transferred via blue tooth to an online platform and analysed with custom MATLAB software 
(version 2014b, The MathWorks Inc.). All times series were de-trended, corrected for horizontal 
tilt, and low-pass filtered using a 4th order Butterworth filter (cut-off frequency 10 Hz).
Gait outcomes 
We previously identified gait outcomes that characterized the same population of geriatric 
patients with and without cognitive impairment in a cross-sectional study (submitted), and 
therefore included those outcomes in the present longitudinal analysis. In addition, average 
stride time and the Coefficient of Variation (CoV) of stride time were computed. Time indices 
of foot contacts were manually identified from peaks in the AP acceleration signals to 
calculate stride-related gait outcomes. The magnitude of the resultant vector of the AP, ML, 
and V signals was calculated according to the following equation: . The 
dynamic gait outcomes were quantified over this ‘summary’ signal. Table 1 describes 
stride-related (outcomes 1-3) and dynamic (outcomes 4-7) gait outcomes. 
𝑅𝑅 = 	 𝐴𝐴𝐴𝐴& + 𝑀𝑀𝑀𝑀& + 𝑉𝑉&. 
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Figure 1. Syntax of the study protocol. 
Abbreviations used in Figure 1: BMI= Body Mass Index; CCI= Charlson Comorbidity 
Index; MMSE= Mini Mental State Examination; 7MS= Seven Minute Screen. 
Between January 2015
and June 2016 
11.3 ± 2.0 months 
Cognitive Decline
(n=7  patients)
Cognitive Stable
(n=12  patients)
Compare baseline gait outcomes
16.2 ± 1.7 months 
Screening for eligibility at 
the geriatric diagnostic 
day clinic of the MC 
Slotervaart
In -  and exclusion criteria 
Patients eligible 
for inclusion
(n=70 patients) 
Patients with a clinical 
indication for a follow - up 
assessment
(n=19  patients) 
   Baseline assessment:
- Demographics (Age, height,
    weight, BMI, CCI, medication) 
- Cognition (MMSE, 7MS) 
- Gait (Speed- and trunk outcomes)
   Follow-up assessment:
- Demographics (Age, height, 
   weight, BMI, CCI, medication) 
- Cognition (MMSE, 7MS)
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Statistical analysis
Statistical analyses were performed using SPSS version 24. Group differences (‘Cognitive 
Decline’ vs. ‘Cognitive Stable’) were examined with the Mann-Whitney’s U test, and within-
group differences (baseline vs. follow-up) with a repeated measure analysis of variance 
(ANOVA). Correlations between baseline gait and longitudinal cognitive change in MMSE and 
7MS scores were computed using Spearman’s Rho correlation coefficients (ρ) for non-linear 
data. Perfect monotonic relations would reveal a ρ of 1 or -1. Significance was set at 0.05.
Table 1. Descriptions and formula of the quantified gait outcomes.
RESULTS
Nineteen patients were followed for 14.4±6.6 months (age 80.0±5.8; 63% women). Based on 
average RCI-scores of MMSE and 7MS, 7 of 19 patients (37%) showed significant cognitive 
decline over time and were retrospectively classified as the ‘Cognitive Decline’ group 
(average follow-up time was 11.3±2.0 months). The other 12 patients remained cognitively 
stable or slightly increased in cognitive function and formed the ‘Cognitive Stable’ group 
(average follow-up time was 16.2±1.7 months). At baseline, the groups were comparable 
in terms of age, height, weight, BMI, CCI, the number of medication used, MMSE-score, 
and 7MS-score (all p>0.05). At follow-up, the groups only differed in MMSE (p=0.05) and 
7MS (p=0.01). The MMSE (p=0.05) and the 7MSE scores (p=0.01) decreased in the ‘Cognitive 
Decline’ group but not in the ‘Cognitive Stable’ group (MMSE: p=1.0; 7MS: p=0.83). Other 
outcomes did not significantly change (p>0.05) in either group (Table 2).
 
 Gait 
outcome 
Formula Description 
(1) Gait speed  
(m/s) 
Speed = 
!"#$%&'(	(+)
-"+(	.%/0(1	(#)
 
Average walking speed. 
(2) Stride time  
(s) 
 
Stride time = 
-"+(	.%/0(1	(#)
23+4(5	67	#$5"1(#	
 
Stride time reflects the average time from heelstrike-to-heelstrike of the 
ipsilateral foot.  
 
(3) CoV Stride 
time  
(%) 
CoV = 
8$%&1%51	1(9"%$"6&
+(%&
∗
100% 
The Coefficient of Variation of stride time is the standardized measure of 
dispersion of the average stride time. 
(4) Root Mean 
Square  
 
RMS = 
>?@>A…@>C	
&
 The RMS quantifies the magnitude of amplitude variability. 
 
(5) Step- and 
stride 
regularity  
AC(t) = 
D
2E $
	 𝑥𝑥"𝑥𝑥"@$
2E $
"GD  
Step and stride regularity indicate the regularity of steps and strides, 
respectively. Autocorrelation refers to the correlation of a time series with its 
own past and future values. Perfect regular steps or strides will adopt a value 
of 1 [15]. 
(6) Multi-scale 
Sample 
Entropy  
𝑀𝑀𝑀𝑀𝑀𝑀 𝑁𝑁,𝑚𝑚, t, g  = 
− ln	[
RST?(U)
RS(U)
	] 
Mscale-En reflects the degree of predictability of a gait pattern. A complete 
predictable signal has a Mscale-En value of 0 [26]. 
 
(7) Maximal 
Lyapunov 
Exponent 
 
𝜆𝜆" = lim
&→\
	
D
$
𝑙𝑙𝑙𝑙𝑙𝑙` 	
ab($)
ab(c)
 Maximal Lyapunov Exponent indicates local dynamic stability, i.e., the ability 
to resist perturbations. A larger λmax reflects a less local dynamic stability [31]. 
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Table 2. Patient demographics (mean±SD) by final cognitive state. Differences were evaluated with the 
Mann-Whitney’s U test, with significant differences between groups indicated in bold.
Relationship between baseline gait and future cognitive change
Table 3 presents correlations between baseline gait outcomes and changes in cognitive 
function 14 months later. Stride-related outcomes (gait speed, stride time, CoV of stride 
time) did not correlate with changes in cognition (ρ<0.3). Trunk outcomes showed modest 
correlations with changes in cognition, with a decline in cognition corresponding to more 
regular steps (ρ=0.579*) and strides (ρ=0.347), and a more predictable gait (ρ=-0.484*). Figure 
2 shows the correlations between gait outcomes (Step regularity, Stride regularity, and 
Multi-scale sample entropy) and changes in cognition in each group. Correlations between 
baseline gait and cognition in MMSE and 7MS separately were in the same direction, in 
which some gait outcomes related more to change in MMSE, while others were more closely 
linked to change in 7MS. For example, stride regularity correlated more strongly with 
ΔMMSE (ρ=0.339) than with Δ7MS (ρ=0.230), while Multi-Scale Sample Entropy correlated 
more strongly with 7MS (ρ=-0.509*) as compared to MMSE (ρ=-0.321). 
Table 3. Spearmans’ Rho (ρ) correlations between baseline gait 
and future change in cognition in 19 geriatric patients. The 
degree of decline in cognition is expressed using the Reliable 
Change Index (RCI), combining MMSE and 7MS-scores. 
 
  Change in cognition  
(Average of MMSE and 7MS) 
Stride-related outcomes  
Gait Speed 0.073 
Stride Time 0.051 
Coefficient of Variation of Stride Time -0.260 
  
Trunk outcomes   
Root Mean Square -0.065 
Step Regularity 0.579* 
Stride Regularity 0.347 
Multi-Scale Sample Entropy -0.484* 
Maximal Lyapunov Exponent 0.196 
* p<0.05.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* p<0.05. 
BMI = Body Mass Index; CCI = Charlson Comorbidity Index; MMSE = Mini Mental State Examination; 7MS = Seven  
Minute Screen; NA = Not Applicable. 
 
 
 Baseline Follow-up 
 ‘Cognitive  
Decline’ (n=7) 
‘Cognitive  
Stable’ (n=12) 
p ‘Cognitive  
Decline’ (n=7) 
‘Cognitive  
Stable’ (n=12) 
p 
Age 80.9 ± 6.4 79.5 ± 5.6 0.37 NA   NA    
Height (cm) 166 ± 7.3 165 ± 9.2 0.53 NA   NA    
Weight (kg) 65.3 ± 10.7 69.7 ± 14.4 0.55 NA   NA    
BMI  23.6 ± 2.3 25.9 ± 5.6 0.40 23.8 ± 2.3 25.9 ± 5.9 0.35 
CCI 3.3 ± 1.5 2.2 ± 1.3 0.13 3.3 ± 1.5 2.5 ± 1.7 0.24 
Medication 6.1 ± 3.4 6.2 ± 3.3 0.93 5.0 ± 4.2 6.1 ± 4.1 0.40 
MMSE 25.7 ± 3.7 26.3 ± 2.8 0.83 22.3 ± 6.2 26.4 ± 3.4 0.05* 
7MS 8.3 ± 16.7 0.0 ± 4.6 1.00 16.1 ± 23.9 0.3 ± 4.3 0.01* 
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Figure 2. Correlations between baseline gait outcomes and future decline in cognition (MMSE+7MS). 
The degree of cognitive change was quantified with the Reliable Change Index (RCI), with an RCI>1.96I 
indicating significant cognitive change over time (p<0.05). Each symbol denotes an individual patient. 
Patients whose MMSE and 7MS decreased are coloured in orange (n=7) and those patients who remained 
cognitively stable are coloured in blue (n=12).
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DISCUSSION
The present prospective pilot study examined whether baseline gait characteristics 
predicted changes in cognition 14.4±6.6 months later in 19 geriatric patients (mean age 
80.0±5.8). The results revealed that a more regular and predictable gait pattern correlated 
with future cognitive decline in geriatric patients admitted to an outpatient diagnostic clinic. 
We discuss these results from a theoretical perspective in terms of the ‘loss of complexity’ 
hypothesis’, and from a clinical perspective in terms of how smart devices that extract gait 
details could possibly facilitate the prediction of cognitive decline and the development of 
early tailored interventions.
While population-based studies reported that gait speed predicts cognitive decline [2, 22], 
the present analyses did not confirm these results. Patient characteristics may account for 
the discrepant data. While previous studies focused on relatively young and healthy old 
adults with a mean age around 65, our geriatric patients had a mean age of 80. Geriatric 
syndromes that are also linked to gait slowing (e.g., muscle weakness, polypharmacy, falling, 
osteoporosis-related factors) [23, 24], may have caused a slower gait, also in the group that 
remained cognitively stable. Gait speed alone might thus not be specific enough to predict 
future cognitive decline in geriatric patients that suffer from multi-system degeneration 
[24]. These results are in agreement with a recent population study that concluded that a 
slow baseline gait speed was only modestly related to future cognitive decline, and provided 
no early marker of clinical progression to dementia [25]. The short follow-up period in the 
present study could also account for the discrepancies relative to previous studies, as our 
average follow-up time vs. the average follow-up time of a systematic review were 1.2 and 
4.5 years, respectively.
Cognitive decline over time correlated with a more regular (higher autocorrelation 
coefficients) and more predictable (lower multi-scale sample entropy) baseline gait pattern. 
Because increases in stride regularity and predictability during gait reflect a decline in 
gait complexity [26], we confirm our hypothesis that the ‘loss of complexity hypothesis’ 
[10] could provide a theoretical framework to relate those findings to health status. The 
LOC theory suggests that a deterioration in age-related and pathological physiological 
functioning leads to a breakdown of system elements, causing a decline in variability and 
overall complexity [10]. This loss of complexity in turn relates to a reduced adaptive capacity 
and most likely relate to poor functional outcomes such as an increased fall risk [11]. Our 
results are in agreement with postural control studies that reported a reduced complexity 
of postural fluctuations (as quantified by the multi-scale sample entropy) in older adults 
with sensory impairments as compared to age-matched controls [27]. A sample of frail 
and pre-frail older adults (who closely compare to the present sample of geriatric patients) 
exhibited less postural complexity as compared to non-frail controls [28]. Physiological 
decline related to cognitive loss possibly adds to this loss of complexity and the association 
between cognitive decline and higher gait regularity and predictability might thus reflect a 
loss of complexity of the aging system. Although increased regularity and predictability may 
seem beneficial, such a strategy reduces the ability to resist and recover from perturbations 
and may actually promote gait instability and increase the risk of falling [9]. The latter is in 
agreement with studies that reported a decline in gait stability in old adults with dementia 
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as compared to age-matched controls [17]. However, given the limited sample size and 
explorative nature of the present study, the results should be taken with caution and need 
replication in larger cohorts. 
The finding that trunk outcomes vs. more traditional gait outcomes (i.e., gait speed) were 
more closely correlated to future cognitive decline provides support for the use of wearable 
sensors in clinics. Indeed, the compact size, relatively low-cost, and ease of operation 
facilitate the incorporation of sensor technologies in gait analysis. Based on the present 
preliminary results, it seems that the use of dynamical systems in gait analyses could 
make prediction of cognitive decline more accurate as compared to the use of traditional 
gait outcomes such as gait speed. Except for its use in the prediction of cognitive decline, 
monitoring gait dynamics is encouraged because such details also relate to one’s ability to 
act independently and autonomously. Intervention strategies could in turn specifically tailor 
gait functions in an aim to remain activities of daily living and to reduce fall risk. Although 
studies that examined the effects of exercise on gait and cognition showed contradictory 
results, a recent population-based study highlighted that transitions in gait as well as in 
cognitive function were mutable and reversible over a 9-year period, even in the oldest-old 
[29]. However, despite technological and clinical advantages of incorporating gait analysis 
derived from wearable sensors, future studies should confirm the clinical utility and the 
predictive ability of such technologies, and applications should be built to translate gait 
details to clinical outcomes.
Procedures at the MC Slotervaart hospital are highly patient-oriented. While this provided 
us with an extensive characterization of this vulnerable population in terms of demographic, 
physical, and social information, standard procedures at the hospital also placed some 
difficulties. For example, even though the protocol for a follow-up appointment is set to 
be at 1 year, the actual follow-up period always depends on organizational and patient 
factors. This resulted in a large variation in follow-up time between patients (follow-up 
period is 14.4±6.6 months), which can be considered a limitation of the present study. For 
the same reasons, we were unable to measure gait function at follow-up. Because there is 
a clear theoretical and experimental basis for the relationship between gait and cognitive 
impairment [2, 7], we expected that gait would have been changed in the patient group who 
presented with significant cognitive decline over time, and that correlations between gait 
and cognition would have become stronger. A recent study highlighted the sensitivity of 
changes in gait speed over a follow-up period of 1 year in healthy old adults aged 75. This 
study showed that 25% of healthy old adults showed a gait speed decline of more than 
0.1 m/s per year [30]. We therefore expected that those changes in mobility may also be 
reflected in elements of mobility that underlie gait speed, i.e., gait dynamics. Finally, the 
small sample size places a limitation of the present study.
In conclusion, the present pilot study revealed that a more regular and predictable gait 
pattern was correlated with future cognitive decline in geriatric patients admitted to an 
outpatient diagnostic clinic. Those results could reflect a loss of complexity of the aging 
NMSS. In addition to traditional outcomes such as gait speed, trunk outcomes derived from 
wearable sensors are promising indicators of cognitive as well as physical decline. Hence, 
we recommend the incorporation of a non-invasive detailed gait analysis in predicting, 
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diagnosing, and monitoring health status in vulnerable geriatric patients. However, our 
results and interpretations are preliminary and need replication in larger cohorts, as for now 
our conclusions are based on a small sample size and a relatively short follow-up period. 
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An 80-year old woman walks down the hallway of the hospital. She has recently noticed that 
she regularly experiences confusion, struggles with finding the right words, and sometimes 
does not remember why she entered a particular room. A fall last week was ‘the straw that 
broke the camels’ back’, and her family encouraged her to make an appointment with her 
general practitioner. The general practitioner referred her to the geriatric diagnostic day 
clinic for a comprehensive screening of physical, cognitive, and mental health. Now she 
walks back and forth for 3 minutes, while an iPod attached to her lower back registers 
accelerations of her trunk. She voluntarily participates in a study that investigates the 
relationship between gait and cognition in geriatric patients. Acceleration signals derived 
from a simple, non-invasive walking test contain a wealth of specific information about 
her gait, reflecting not only mobility-, but also cognitive functioning. The presence of (pre-
clinical stages of) cognitive impairment may thus be reflected in the way she walks. How is 
her gait pattern characterized? (How) can gait characteristics add to usual screening tests 
to identify cognitive impairment and/or an increased fall risk? The present thesis aimed to 
answer those research questions, shed light on methodological challenges with regards to 
an accurate gait analysis in geriatric patients, and discussed clinical perspectives of a gait 
analyses as part of comprehensive geriatric assessments.
Main findings
In 2015, a systematic literature search identified 20 longitudinal studies (including data 
from 24.368 old adults aged over 65) that examined associations between baseline gait 
function and future cognitive decline. The review discussed the current knowledge 
and gaps in the literature on this topic, and therefore provided the basis of this thesis. 
Eighteen out of 20 studies documented gait speed as main outcome, and a slow gait 
speed was associated with future decline in MMSE score and specific cognitive functions 
such as executive functioning. Moreover, a slow gait speed increased the risk for MCI and 
dementia (maximal odds and hazard ratios of 10.4 and 11.1, respectively). The results also 
emphasized methodological inequalities and inaccuracies in the 20 studies, and projected 
that future research could increase the specificity of the gait-cognition link by indexing gait 
and cognition in more detail (Chapter 2). From this perspective, a more extensive cognitive 
evaluation (MMSE, memory, and executive functioning) and fine-grained, dynamic gait 
outcomes were complemented to a usual fall-risk screening. The overall classification 
accuracy of fallers and non-fallers increased from AUC=0.86 to AUC=0.93. The specificity 
of the fall-classification model increased from 60% to 72% when cognitive outcomes were 
added, and from 72% up to 80% when gait dynamics were added to the model. The results 
underscored the need for a multifactorial approach in fall risk assessment in geriatric 
patients, including a detailed evaluation of cognitive- and gait functions (Chapter 3). To 
explore what gait characteristics are most susceptible to cognitive decline, the next study 
scrutinized the relationship between multiple gait outcomes and cognitive impairment in 
geriatric patients. Outcomes related to gait speed, regularity, predictability, and stability 
revealed with the highest discriminative power for single- and dual-tasking (average 
VIP-score of 1.12, with a VIP-score>1 indicating a high discriminative power). Geriatric 
patients walked slower, less regular, and less stable than healthy old controls. However, 
the discrimination of geriatric patients with- and without cognitive impairment based on 
gait outcomes alone was poor, with 57% (single-task) and 64% (dual-task) of the patients 
being misclassified (Chapter 4). Gait outcomes with the highest discriminative power in 
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chapter 4 were then studied in a prospective pilot study. Significant cognitive decline over 
14.4 months on average correlated with a more regular (ρ=0.579*) and a more predictable 
(ρ=0.486*) gait at baseline, but not with baseline gait speed (ρ=0.073). The increased gait 
regularity and predictability most likely reflected a loss of gait complexity and this may thus 
signify future cognitive decline in geriatric patients. Yet, the quantification of gait dynamics 
(including complexity outcomes) in geriatric patients provided a non-invasive mobility 
measure that could be added to routine geriatric assessments and potentially facilitates the 
identification of cognitive impairment in this vulnerable population (Chapter 5).
A broader perspective on gait and cognition via the ‘Loss of Complexity’ theory
Researchers have been using gait speed extensively as a comprehensive index of old 
adults' locomotor performance [1]. Even natural aging entails a pyramid of alterations 
in neuromuscular and neurophysiological functions that engender declines in muscle 
structure and function, resulting in a slower gait [2]. Considering the sizable body of 
literature that suggests that gait speed further slows with cognitive impairment [3-10], 
we expected but did not find associations between gait speed and cognitive impairment. 
Differences in patient characteristics may account for the discrepant results between 
our and previous findings, as most studies recruited old adults from the community, who 
were healthier and younger than our geriatric patients who are 80 years on average. In 
addition to age-related declines, geriatric patients presented with 1.8 co-existing chronic 
conditions (e.g., pulmonary disease, tumours, diabetes) on the Charlson Comorbidity Index 
[11]. Furthermore, they on average met the criteria for polypharmacy (>4 medication), 
and 63% of the patients were frail or pre-frail according to Frieds´ definition [12]. Finally, 
conditions typically present in geriatric patients (e.g., vision impairment, pain, thoracic 
kyphosis, polypharmacy, sarcopenia) have been associated with a gait slowing [13-16]. Such 
conditions may already have substantially slowed a patients’ gait, causing a 'floor-effect' so 
that gait speed did not slow further when cognitive impairment added to the symptoms [16].
 
Fine-grained, dynamic gait outcomes described features of gait not apparent in gait speed. 
Because geriatric patients show multi-system degeneration, the gait-cognition link was 
placed in a theoretical framework to better understand the coupling and coordination 
between elements of the aging neuro-musculo-skeletal system (NMSS), for which the ‘loss 
of complexity’ (LOC) theory was considered [17]. As derived from the field of cardiology, 
complexity could be defined as ‘irregular (variable) fluctuations that appear in healthy 
physiological rhythms which take the form of chaos’ [18]. Similar to sinus rhythm in 
heartbeats, human gait is a highly rhythmic movement, which is why several studies 
speculated that the gait pattern would also be characterized by a complex type of variability, 
and if it is, that alterations in complexity reflect disease-related aging. Because pathological 
conditions such as sensory impairment [19], frailty [20], recurrent falling [21], and 
Huntington’s disease [22] have been associated with a loss of gait complexity, in this thesis 
the hypothesis was that cognitive impairment may also induce a loss of gait complexity. A 
loss of gait complexity could become manifested through an increased gait regularity and 
an increased gait predictability. Although preliminary, the results of Chapter 5 underscored 
this hypothesis by revealing correlations between a more regular and more predictable 
baseline gait and reliable cognitive decline over time, reflecting a loss of gait complexity [23].
104
Gait complexity is often interpreted and discussed in terms of gait variability. Several 
studies examined the ability of gait variability, quantified by the coefficient of variation, 
to identify and predict cognitive impairment or dementia syndromes [10, 24, 25]. A quite 
robust finding from this literature is that a higher gait variability signifies cognitive 
pathology. Those findings, however, cannot explain the observation that highly complex 
activities (e.g., Epke Zonderland doing his exercise on the rings) are usually performed in 
a variable, infinite number of ways, while performance remains stable or even improves. 
According to this view, and in line with findings of the present thesis, variability increases 
rather than decreases in a ‘healthy system’, and decreases with aging and pathology [18, 
26-28]. The contrasting results reported in the literature could be explained by the way gait 
variability is quantified in most studies. Traditional variability measures typically quantify 
the magnitude of variability by delineating outcomes such as the standard deviation or the 
coefficient of variation. Such linear statistical tools treat every step as being independent, 
averaging data over multiple strides. However, variability of how gait evolves over time, i.e., 
the structure of gait variability, is best described by non-linear statistical tools that presume 
steps being not independent but instead temporally interdependent: previous steps affect 
subsequent steps [23, 28-32]. The increased magnitude of variability and the decreased 
structure variability thus represent different characteristics of gait functioning and are 
mutually not exclusive. While a relatively large number of studies were designed to clarify 
changes in magnitude variability, the functional meaning and implications of changes 
in structure variability, i.e., a loss of gait complexity, are poorly studied and understood.
A consistent finding from previous studies is that a loss of complexity in physiological 
systems results in more rigid, more regular, and less flexible systems, reducing the ability 
to adapt to stimuli arising from the ever-changing environment [17, 33-36]. From this 
perspective, Stergiou and colleagues developed a model that explained how gait complexity 
could relate to health [18]. This model proposed that there is an optimal amount of complexity 
so that too little complexity results in a more rigid system and too much complexity results 
in a noisy and unstable system. Both situations significantly affect the capacity to adapt 
to perturbations. The authors directly associated this reduced adaptive capacity with a 
lack of health [18]. With respect to gait function, it remains however unknown whether 
a loss of gait complexity actually translates to a reduced adaptive capacity to overcome 
potential perturbations during walking. A possible way to study this is to examine geriatric 
patients with and without a loss of gait complexity and to compare the effects of unexpected 
perturbations to their adaptive responses. A more challenging walking environment or task 
would be required for such a study design. Because a loss of gait complexity has been 
linked to an increased fall risk [27, 28], it seems likely that this relationship is mediated 
through reductions in ones’ adaptive capacity to perturbations during walking.
A conceptual model of gait characteristics in geriatric patients with- and without 
cognitive impairment, as compared to healthy old controls
Based on the findings and corresponding interpretations of the experimental studies 
presented in Chapters 4 and 5, figure 1 illustrates a conceptual model that shows how gait 
is possibly characterized in cognitive intact geriatric patients and in cognitive impaired 
geriatric patients, as compared to relatively young and healthy old controls. Lines visualize 
the trajectory of how gait may change with ‘geriatric aging’ and with the development of 
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cognitive impairment. Gait speed declined from healthy old controls to cognitive intact 
geriatric patients, but did not further decline with diagnosed cognitive impairment (solid 
line). Gait regularity and predictability decreased from healthy old controls to cognitive intact 
geriatric patients, but increased when cognitive impairment added to geriatric conditions. 
The increase in gait regularity and predictability most likely come with a gradual loss of 
gait complexity and a decline in gait stability (dashed lines).
The combination of gait characteristics per population is caused by many underlying 
factors such as age and other patient demographics, and should therefore not be viewed as 
a functional capacity, but rather as an emerging, dynamic system. The high gait regularity 
observed in healthy old adults and geriatric patients with cognitive impairment, for 
example, results from different underlying factors and are therefore not comparable. While 
the higher gait regularity in healthy old adults may be beneficial in terms of for example 
metabolic cost, the high gait regularity in geriatric patients with cognitive impairment may 
come with a loss of gait complexity and a decline in gait stability.
Figure 1. A conceptual model that shows how gait is possibly characterized in cognitive intact geriatric 
patients and in cognitive impaired geriatric patients, as compared to relatively young and healthy 
old controls. Lines visualize the trajectory of how gait may change with ‘geriatric aging’ and with the 
development of cognitive impairment.
How can the assessment of gait function contribute to the identification of 
cognitive impairment and falls in geriatric patients?
A consistent finding in this thesis was that gait dynamics added to widely used gait outcomes 
such as gait speed. Adding gait dynamics to usual diagnostics increased the specificity of 
a fall-classification model (Chapter 3). Similarly, gait regularity, predictability, and stability 
presented with the highest power to discriminate patient groups (Chapter 4). Additionally, 
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cognitive decline over time correlated with baseline gait regularity and predictability, 
but not with baseline gait speed (Chapter 5). Notwithstanding the attractiveness of gait 
speed as a simple summary index of mobility, the assessment of gait speed alone may 
lack specificity because many clinical and non-clinical conditions induce a gait slowing. 
In geriatric patients, typical conditions such as vision impairment, pain, thoracic kyphosis, 
the use of multiple medications, and sarcopenia all have been associated with a decline 
in gait speed [13-16]. Therefore, gait speed can be viewed as a marker for global health, 
but perhaps not as a cognition-specific marker. Dynamic gait outcomes enable to extract 
additional information about someone’s gait in terms of for example gait coordination, 
complexity, and stability. However, even though gait dynamics could complement gait 
speed, a detailed gait analysis on its own was not sufficient to identify cognitive impairment. 
Geriatric patient groups with- and without cognitive impairment could not be discriminated, 
with 57% (single-task) and 64% (dual-task) of the patients misclassified. Those findings 
are interpreted to mean that an accurate identification of falls and cognitive impairment 
necessitates a multifactorial approach, including patient characteristics (e.g., geriatric co-
conditions), and a comprehensive evaluation of cognitive- and gait function.
Challenges posed by analysing a geriatric patients’ gait
As highlighted by the scoping review in Chapter 2, several methodological weaknesses 
complicate an accurate gait analysis in old adults. For example, some studies used very 
short distances such as 8 feet (~2.4 meters) to compute average gait speed, while it is 
recommended to exclude the first 2.5 meters of the gait pattern in frail old adults because of 
acceleration and deceleration phases [37]. Another study recommended extracting at least 
30 steps and preferably 50 steps to accurately determine temporal-spatial gait outcomes 
(e.g., gait speed, step length, step width, swing time, stance time) in patients with Parkinson’s 
disease [38]. One requirement for reliable estimates of gait outcomes derived from non-
linear dynamics is that the length of the acceleration signal should be long. Despite the fact 
that the exact length depends on the gait outcome to be calculated, the signal should contain 
enough input to be able to quantify time-dependent fluctuations. For example, extracting 
gait regularity and symmetry outcomes using autocorrelation procedures has found to be 
reliable when at least 40 steps [39] or 40 meters [40] are included in the analysis.  
Another challenge to accurately examine gait in geriatric patients comes from outcomes 
that rely on step detection methods. In a healthy gait pattern, steps are reflected in clear 
and smooth peaks in the anterior-posterior acceleration signals of the lower trunk [41]. 
Nevertheless, peak detection in healthy old adults already achieved an error rate of 7.4%, 
and this rate is expected to increase with gait slowing and gait shuffling [42]. In contrast to 
healthy old adults, geriatric patients not only walk (much) slower, but also typically present 
with a shuffling gait and/or a stooped posture. Such conditions can result in abnormalities 
in acceleration signals such as the presence of extra peaks, and thus complicate the 
automatic detection of steps from trunk acceleration signals. Unreliable step detection in 
turn substantially affects gait outcomes [43]. The use of gait outcomes that are independent 
of step detection is therefore essential in this vulnerable population.
Finally, an unexpected finding of this thesis was that dual-tasking did not identify cognitive 
impairment better than single-task walking (Chapters 4, and 5). While dual-task paradigms 
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are often used to highlight motor-cognitive interactions [9, 44-47], recent dual-task studies 
reported no increased sensitivity of dual-tasking vs. single-tasking to detect cognitive 
impairment, and shed light on concerns and difficulties of dual-task paradigms [48, 49]. 
For example, the majority of studies do not report the dual-task effect on the cognitive 
task, nor do these studies report the performance for the cognitive single-task. Therefore, 
it is possible that patients ignored the secondary task and only performed the gait task, or 
vice versa. Furthermore, the taxing effect of the cognitive task on gait functioning strongly 
depends on the nature and complexity of the cognitive task, instructions about task 
prioritizing, distractions of the environment, and baseline gait and cognitive function of the 
patient [50]. Those difficulties particularly arise in cognitive impaired geriatric patients, as 
cognitive impairment could affect their ability to follow task instructions. As a consequence, 
there is a lack of clear recommendations on how to use and interpret dual-task paradigms 
in different patient groups, which limits its implementation in clinical practice [50]. Taken 
together, it remains questionable whether and how a motor-cognitive dual-task paradigm 
in a heterogeneous sample of geriatric patients actually improves the detection of cognitive 
impairment, or poses additional uncertainties with regards to an accurate interpretation of the 
data. To increase its validity, recent studies suggested tailoring the cognitive task specifically 
to the cognitive domain that is predominantly affected by cognitive pathologies [48].
Clinical perspectives  
Gait assessment as used throughout the present thesis is an easy and non-invasive measure, 
taking clinicians only minutes to assess. Today’s rapid development in technologies 
facilitates the use of an extensive gait analysis in clinics and research. Wearable sensors 
(phones, iPods, or accelerometers) become more and more incorporated in healthcare 
sectors [51], and are nowadays standardly equipped with Inertial Measurement Units (IMU) 
such as gyroscopes, accelerometers, and magnetometers. Furthermore, those wearable 
sensors are widely-available, easy to operate, low-cost, and of compact size [52]. 
In addition to its potential to identify cognitive impairment and fall-status, dynamic gait 
outcomes identified subtle gait disturbances [27, 28, 53, 54]. Intervention strategies can 
be specifically tailored to reduce fall risk, and to maintain independent living. A promising 
finding from a recent population study was that transitions in gait disorders as well as 
cognitive impairment were mutable and reversible over a 9-year period, even in the oldest-
old [55]. While there is abundant evidence that walking ability has the capacity to pick-up 
changes in physical as well as in mental health-related quality of life, a mobility measure 
is usually not part of standard assessments in geriatric diagnostic clinics. A recent study 
therefore recommended healthcare professionals to focus on screening procedures and 
intervention strategies to maintain mobility in old adults in order to preserve and/or 
increase their health-related quality of life [56]. 
In summary, there are multiple technological and clinical advantages of incorporating a 
3-minute gait assessment into standard clinical routine evaluations. Future studies should 
confirm the clinical utility and the predictive ability of such technologies, and norm-scores 
and cut-off scores need to be determined for different population groups. Ultimately, an 
application that translates the technical gait details to clinical outcomes, integrates gait 
and other diagnostics could be built, and ultimately provides a multifactorial risk profile for 
cognitive decline and falling.
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Future directions
Future studies are urged to study multiple gait outcomes that reflect different aspects of the 
gait pattern in a larger sample of old adults to disentangle the trajectory of how gait changes 
with healthy aging, with geriatric aging, with cognitive impairment, and with falling. 
Because an increase in age is often accompanied by the presence of comorbidities, the 
effect of such conditions should be documented and taken into account in the analysis. In 
addition, future studies are encouraged to improve the sub-typing of cognitive impairment 
(e.g., amnestic MCI, non-amnestic MCI, multiple-domain MCI). For example, patients with 
amnestic MCI presented with less gait rhythm and more gait variability as compared to 
patients with non-amnestic MCI [57]. A recent report from the GOOD (Gait, cOgnitiOn, and 
Decline) initiative, including data from 7 countries, presented distinct gait characteristics 
from the earliest to the latest stages of dementia, depending on the type of dementia [58]. 
In line with this recommendation, concepts and definitions of dementia-related diagnoses 
should be improved, as they are still in evolution [59]. Although much effort has been 
devoted to the field of dementia during the last decade, the uptake of the use of MCI is still 
premature, and clinicians as well as researchers use inconsistent criteria for diagnoses 
[59]. In addition, even though 15% of the patients with MCI yearly convert to dementia 
syndromes [60], MCI is not always a precursor of dementia. Several causes of MCI (e.g., 
depression) are of transient nature, and approximately 40% of the patients with MCI actually 
convert back to normal cognition within 2 to 3 years [61]. Furthermore, there is a need to 
develop guidelines that standardize gait protocols (e.g., procedures, instructions, analyses, 
type of task) for single- as well as for dual-task walking. Examining neural correlates of gait 
dynamics could help to underpin the neural control of gait, and is therefore recommended 
in the neuroscientific field. Finally, while there is a clear theoretical and experimental basis 
for the use of dynamic gait outcomes in the identification of cognitive impairment, multi-
factorial models should examine whether incorporating gait outcomes in prediction models 
actually significantly improves the prediction accuracy of cognitive status.
Conclusions
This thesis contributed to our understanding of the relationship between gait and cognition 
in geriatric patients. In line with the hypothesis, the results revealed that the presence of 
cognitive impairment in the geriatric population possibly becomes manifested through an 
increased gait regularity and predictability, reflecting a loss of gait complexity. Against the 
hypothesis and in contrast to previous research, the results revealed no associations between 
cognitive impairment and gait speed as a summary index of mobility. Hence, gait outcomes 
related to gait complexity could increase the specificity of the gait-cognition link, and gait 
dynamics can therefore be considered promising indicators of cognitive impairment and 
falls. However, clinicians and researchers should be aware of the effects of multiple, co-
existing, conditions in geriatric patients that interact with each other and with gait function. 
An accurate identification of cognitive impairment and falls thus most likely necessitates 
a multifactorial approach in this vulnerable population, including physical, cognitive, 
pharmacological, and behavioural measures. Because smart devices such as smartphones 
are nowadays routinely equipped with IMU’s (e.g., accelerometers), the assessment of gait 
function provides a cheap and non-invasive mobility measure that in the near future could 
be added to routine geriatric assessments. However, future studies are encouraged to 
replicate our findings in larger cohorts, and to reduce methodological weaknesses in gait- 
and cognitive measurements that complicate an accurate gait analysis in geriatric patients.
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Introduction générale
La société vieillissante
Comme la sagesse et l’expérience augmentent avec l’âge, les personnes âgées sont 
précieuses pour leurs familles, les communautés locales et la société en général. À présent, 
on constate une augmentation considérable au niveau de la durée de vie des populations 
dans la plupart des pays. Ce phénomène aboutit à une proportion accrue de personnes 
âgées de plus de 65 ans au niveau mondial [1]. Le bénéfice personnel et social d’une 
vie prolongée dépend apparemment largement de la question suivante: est-ce que les 
personnes concernées peuvent s’attendre à des années en bonne santé où doivent-elles 
s’attendre à des années de souffrance? D’après l’Organisation mondiale de la santé, il y a 
donc un grand défi à relever: il ne faut pas se limiter à ajouter des années à la vie; il faut 
veiller à ajouter des années pleines de santé.
‘Le vieillissement en bonne santé’ par rapport au ‘vieillissement gériatrique’
Personne n’échappe aux changements liés à l’âge à long terme. Même ‘le vieillissement 
en bonne santé’ entraîne toute une série de changements physiologiques, psychologiques 
et sociaux dans le temps [2]. Lorsque le degré du déclin des fonctions physiques et/ou 
psychologiques dépasse le degré de déclin attendu à cause du vieillissement seul, on 
adresse les personnes âgées en général à des gériatres ou à d’autres spécialistes ayant de 
l’expérience avec le traitement d’affections et de maladies gériatrique [3]. Parmi les affections 
gériatriques typiques on trouve la sarcopénie, le délire, la perte de poids, la déficience 
cognitive, l’ostéoporose et les chutes récurrentes. De telles affections se caractérisent 
souvent par des facteurs étiologiques et des mécanismes pathogènes interdépendants [4]. 
La définition suivante s’applique donc aux patients gériatriques: un segment vulnérable de 
personnes âgées chez lesquelles la moindre affection risque d’aboutir à une catastrophe. 
La population étudiée dans la présente thèse
Les études expérimentales incluses dans cette thèse (chapitres 3-5) portent sur des patients 
gériatriques qui ont été recrutés parmi les patients admis à l’hôpital MC Slotervaart à 
Amsterdam pendant la période de 2014 à 2017. Ces patients se sont présentés à la clinique 
de jour spécialisée en diagnostic gériatrique pour une évaluation des fonctions physiques, 
cognitives et psychologiques. Les patients gériatriques qui se présentaient au service de 
gériatrie avaient env. 80 ans en moyenne et une espérance de vie moyenne d’env. 4 ans. 
Déficience cognitive de la population gériatrique
Parmi les causes majeures de l’invalidité des patients gériatriques, il faut citer les déficiences 
cognitives du fait qu’elles affectent la mémoire, la réflexion, le comportement, les émotions 
et/ou les facultés de perception [5]. Les études au niveau de la population montrent des taux 
de prévalence de déficiences cognitives de 5% à 29% chez les personnes âgées de plus de 65 
ans qui vivent dans la collectivité [6]. Les déficiences cognitives émergentes sont souvent 
considérées comme précurseurs de démence. Même s’il n’y a pas de remède permettant 
de guérir voire d’inverser la neurodégénérescence cognitive, des interventions sur mesure 
(médication, psychothérapie, psychoéducation, modifications de l’environnement, activité 
physique) peuvent ralentir la progression de la maladie et réduire les symptômes [5].
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Les caractéristiques de la démarche comme indicateurs d’une déficience cognitive
Les modèles actuels ont recours à des variables démographiques, génomiques, vasculaires, 
comportementales et neuropsychologiques pour prédire la pathologie liée à la démence 
[7]. Du fait que ces modèles ne distinguent pas suffisamment entre les patients à risque 
et les patients sans risque (aire sous la courbe comprise dans une plage de AUC=0.50 à 
AUC=0.87) [8], on a besoin de marqueurs supplémentaires. Outre les prédicteurs courants, 
la présente thèse étudiait les caractéristiques de la démarche comme indicateurs potentiels 
non invasifs de déficiences cognitives chez des patients gériatriques.
Des études de nombreux domaines scientifiques soulignent l’interdépendance entre les 
fonctions motrices et cognitives. Exemple: le cerveau fonctionne mieux et le risque de 
développer des troubles neurodégénératifs baisse lors d’une augmentation de la condition 
physique [9, 10]. En outre, les troubles neurodégénératifs comme la démence et le syndrome 
de Parkinson entraînent souvent une forte perte de poids [11].
L’interdépendance entre les fonctions motrices et cognitives se traduit également dans 
la démarche humaine. La marche exige l’exécution d’actions ciblées. C’est donc un 
processus qui s’appuie fortement sur la mémoire et la fonction exécutive pour anticiper 
et interpréter l’environnement et le comportement d’autrui. La démarche et la cognition 
montrent des structures associatives distinctes dans ce processus [12, 13]. Des études 
impliquant l’imagerie neurologique ont confirmé le lien entre la démarche et la cognition 
du fait d’illustrer que la marche sollicite des régions cérébrales qui assurent des fonctions 
exécutives, des fonctions de mémoire et des fonctions visuo-spatiales ainsi que des régions 
motrices comme le cortex moteur, le cervelet et les noyaux gris centraux [14]. Les régions 
cérébrales impliquées dans la fonction de démarche et la fonction cognitive se recoupent 
donc partiellement. On peut alors s’attendre à des changements au niveau de la démarche 
lors du début d’une déficience cognitive. 
Le lien entre la démarche et la cognition à la lumière de la théorie de la ‘Perte de Complexité’
Comme les patients gériatriques montrent des dégradations dans des systèmes 
interdépendants multiples, le lien entre la démarche et la cognition peut être placé dans 
un contexte théorique pour augmenter la compréhension du couplage et de la coordination 
entre les éléments du système neuro-musculo-squelettique (NMSS) (c.-à-d. la démarche et 
la cognition). Eu égard à cette idée, on considérait un phénomène clé du NMSS vieillissant, à 
savoir la ‘perte de complexité’ (LOC). La théorie de la LOC relève du domaine des dynamiques 
non-linéaires et présume que même le vieillissement en bonne santé est associé à une 
défaillance (neuro)-physiologique d’éléments qui cause une perte de complexité générale 
[15]. Dans la présente thèse, on a établi l’hypothèse que le déclin (neuro)-physiologique causé 
par le déficit cognitif se traduisait également dans la démarche. Une perte de complexité au 
niveau de la démarche devrait donc se caractériser par une augmentation de la régularité 
et de la prévisibilité [16]. Les résultats seront détaillés dans les paragraphes qui suivent.
La nature dynamique de la marche: Qu’est-ce que la démarche traduit?
La vitesse de démarche est le paramètre le plus documenté de la démarche [17]. Une 
observation omniprésente d’études précédentes est la baisse de la vitesse de démarche 
liée à l’âge. Une vitesse de démarche de moins de 1.0 m/s indique la présence d’affections 
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cliniques comme des troubles de mobilité, des chutes récurrentes, une perte d’indépendance 
et très probablement une faible fonction cognitive. L’importance de la mesure de la vitesse 
de démarche chez des personnes âgées est donc soutenue davantage et la vitesse de 
démarche a même été proposée comme ‘sixième signe vital’ [18]. C’est par ailleurs un test 
utilisé dans les cliniques de gériatrie [17, 19].
 
À côté de la vitesse de démarche comme indice global de la mobilité, des paramètres 
de démarche dynamiques finement grainés décrivent des caractéristiques qui ne se 
manifestent pas dans la vitesse de démarche. La quantification d’une telle dynamique de 
démarche peut être obtenue lorsqu’on considère la démarche comme tâche dynamique. La 
marche exige en effet des interactions permanentes entre les différents segments du corps, 
le corps et l’environnement et nécessite des réponses tant préventives que réactives. Nous 
parvenons facilement à marcher sur des surfaces différentes, à prévoir le trafic arrivant, 
à éviter des obstacles qui bloquent la route et à assurer le contrôle et la coordination des 
parties du corps en mouvement comme les jambes, les bras, le torse et la tête [20].
 
L’analyse des fluctuations dépendant du temps, c.-à-d. la manière dont la démarche évolue 
dans le temps peut révéler les causes d’une démarche lente en termes de coordination 
de la marche et des réactions à des perturbations [16, 20-24]. La corrélation des séries 
temporelles entre les évènements constituants de la démarche peut montrer des troubles 
ou des pathologies de démarche sous-jacentes. Le recours aux mesures traditionnelles de 
la démarche comme la vitesse et (le coefficient de la variation de) l’avancée peut masquer 
l’interdépendance temporelle entre les étapes successives du fait que ces mesures ne 
moyennent que les informations relatives aux étapes dans le temps. La quantification des 
fluctuations dépendant du temps qui surviennent pendant la marche pourrait augmenter 
notre compréhension de la relation entre la démarche et le déficit cognitif et aider à étayer 
le contrôle neural de la démarche. 
 
La théorie des systèmes dynamiques propose des outils et des concepts pour la 
quantification des fluctuations dépendant du temps survenant pendant la démarche [16, 
21-23, 25, 26]. Le monitorage continu du type de démarche d’un patient est nécessaire pour 
saisir ces fluctuations dépendant du temps. Il y a toute une série de méthodes permettant la 
surveillance continue de la démarche (exemples: les systèmes optoélectroniques, les essais 
sur une plateforme de force). L’avantage de l’accélérométrie réside pourtant dans le fait que 
la marche est largement sans contrainte et peut être mesurée en dehors du laboratoire sur 
des distances et des durées de marche prolongées [27]. Comme on sait que la régulation 
de l’équilibre pendant la marche se traduit par des signaux d’accélération du bas du torse 
(à cause de sa proximité du centre de gravité du corps) [28], les accélérations du torse 
traduisent exactement le comportement du centre de gravité pendant la démarche [27]. Sur 
la base des signaux d’accélération du torse, des paramètres de démarche dynamiques, qui 
quantifient les fluctuations et schémas dépendant du temps pendant le cycle de démarche 
[16, 21-23, 25, 26], peuvent être saisis. Dans cette thèse, le terme ‘dynamique de démarche’ 
est employé pour désigner les aspects dynamiques de la marche. En général, la dynamique 
de démarche indique la coordination, la capacité d’adaptation et la faculté de réagir à des 
perturbations en général.
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Une approche multivariée 
Le grand nombre de comorbidités exige une approche multivariée pour étudier le lien 
entre la démarche et la cognition chez des patients gériatriques. Comme nous venons 
de mentionner, de telles affections se caractérisent souvent par des facteurs étiologiques 
et des mécanismes pathogènes interdépendants [4]. Ces affections gériatriques sont 
probablement inter-reliées. Exemple: des affections typiquement présentes chez des 
patients gériatriques sont connues pour leur interaction avec la performance de démarche, 
comme la posture voûtée [29], la faiblesse musculaire [30], et la poly-pharmacie [31]. Par 
ailleurs, les caractéristiques de démarche semblent corréler entre elles. Outre le fait que 
les hypothèses statistiques ne sont pas remplies, les analyses à une variable pour chaque 
paramètre individuel risquent de masquer des clusters/dépendances dans les données. 
De ce fait, des analyses à variables multiples basées sur la Régression par les Moindres 
Carrés Partiels (PLS) ont été effectuées [32] dans les chapitres 3 et 4. La PLS combine des 
caractéristiques de l’analyse en Composantes Principales et de l’analyse de la régression 
courante. Des structures de covariance ont été modelées; les clusters latents sous-jacents 
ont été extraits.
Objectifs et schémas scientifiques
La plupart de la littérature existante sur la relation entre la démarche et la déficience 
cognitive se concentre sur des personnes âgées relativement jeunes et en bonne santé, 
tandis que les patients gériatriques de notre échantillon sont plus âgés et présentent 
de nombreuses comorbidités qui sont connues pour leur interaction avec la fonction 
de démarche. Par ailleurs, les études précédentes se concentraient en premier lieu sur 
la vitesse de démarche comme indicateur de déficit cognitif, tandis que des paramètres 
de démarche dynamiques finement grainés sont susceptibles d’augmenter la spécificité 
du lien entre la démarche et la cognition et peuvent aider à étayer le contrôle neural de 
la démarche. De ce fait, l’augmentation de notre compréhension de la relation entre la 
démarche et la cognition dans des patients gériatriques constituait l’objectif principal de 
la thèse. Des analyses à variables multiples ont à cet effet été employées pour étudier des 
paramètres de démarche multiples en relation avec le statut cognitif. En fin de compte, les 
caractéristiques de démarche pourraient servir d’indicateurs non invasifs d’une déficience 
cognitive chez cette population vulnérable. Pour arriver à ce but principal, un double sous-
objectif a été établi: (1) définir le type de démarche de patients gériatriques avec et sans 
déficit cognitif par rapport à des personnes âgées relativement jeunes et en bonne santé, 
et (2) étudier si et dans quelle mesure les caractéristiques de démarche peuvent contribuer 
à l’identification et/ou à la prédiction d’une déficience cognitive et de chutes. On a établi 
l’hypothèse que les patients gériatriques souffrant d’une déficience cognitive présentaient 
un type de démarche plus lent, plus régulier et moins complexe par rapport aux patients 
gériatriques cognitivement intacts. Par ailleurs, on s’attendait à ce que les paramètres 
de démarche dérivés d’une analyse de démarche exhaustive pouvaient contribuer aux 
diagnostics habituels servant à identifier/prévoir une déficience cognitive et des chutes.
L’illustration 1 montre le protocole de démarche et les mesures employées dans les chapitres 
3-5. Outre les procédures de dépistage courantes employées au MC Slotervaart hospital, les 
patients marchaient pour 3 minutes pendant un test à tâche simple ou à double-tâche. Les 
accélérations du torse exprimées en signaux des sens suivants: antérieur-postérieur (AP), 
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médio-latéral (ML) et vertical (V) étaient extraits d’un Ipod touch 4G. L’illustration montre 
l’exemple d’un signal d’accélération brute dans le sens AP qui servait de base pour le calcul 
en 3D des paramètres du torse, c.-à-d. de la dynamique de démarche. Compte tenu de la 
nature exploratoire des études, des paramètres de démarche multiples ont été quantifiés. 
Tandis que tous les paramètres reflètent la nature dynamique de la démarche, ils quantifient 
différents aspects du schéma de démarche en se basant sur différentes propriétés du signal 
d’accélération (ex. l’amplitude, la fréquence, les cadres temporels, l’espace de phases). 
Schéma de la thèse
Pour arriver à une vue d’ensemble de la littérature existante sur la relation entre les 
caractéristiques de démarche et le déficit cognitif chez des personnes âgées, on a 
systématiquement révisé les preuves fournies par des études longitudinales qui révélaient 
des associations entre la fonction de démarche et le déclin cognitif dans le chapitre 2. Dans 
le chapitre 3, on a étudié la contribution d’une évaluation exhaustive de la cognition et de 
la démarche en ce qui concerne l’exactitude de la classification de patients chuteurs et de 
patients non chuteurs. Dans le chapitre 4, on a examiné les caractéristiques de démarche 
et leur pouvoir distinctif chez des individus témoins en bonne santé et chez des patients 
gériatriques avec et sans déficit cognitif. Les paramètres de démarche qui montraient le 
plus grand pouvoir distinctif ont alors été étudiés dans une conception prospective dans 
le chapitre 5. Cette étude pilote servait à examiner la manière dont les paramètres de 
démarche initiaux corrélaient avec le déclin cognitif future.
Résultats principaux et discussion générale
En 2015, une recherche littéraire systématique permettait d’identifier 20 études 
longitudinales (y compris les données de 24.368 personnes âgées de plus 65 ans) qui 
examinaient les associations entre la fonction de démarche initiale et le déclin cognitif 
futur. La révision discutait les connaissances actuelles et les lacunes présentes dans la 
littérature à ce sujet et servait donc de base à la présente thèse. Dix-huit sur 20 études 
citaient la vitesse de démarche comme paramètre principal: une vitesse de démarche lente 
était associée au déclin futur dans le score MMSE et à des fonctions cognitives spécifiques 
comme le fonctionnement exécutif. Par ailleurs, une vitesse de démarche lente augmentait 
le risque pour un MCI et la démence (odds et hazard ratios maximaux de 10.4 et de 11.1 
respectivement). Les paramètres ont également souligné les inégalités et inexactitudes 
méthodologiques dans les 20 études et montraient que la recherche future pourrait 
augmenter la spécificité du lien entre la démarche et la cognition par une indexation plus 
détaillée de la démarche et de la cognition (chapitre 2). Sous cette optique, une évaluation 
cognitive plus exhaustive (MMSE, mémoire, fonctionnement exécutif) et des paramètres 
de démarche finement grainés ont été ajoutés à un dépistage chute-risque courant. 
L’exactitude globale de la classification des patients chuteurs et patients non chuteurs 
passait d’une valeur AUC=0.86 à une valeur AUC=0.93. La spécificité de ce modèle de 
classification des chutes passait de 60% à 72% lorsque les paramètres cognitifs étaient 
ajoutés et de 72% à 80% avec l’ajout des paramètres de démarche dynamiques au modèle 
(illustration 2). Les résultats soulignaient la nécessité d’une approche multifactorielle dans 
l’évaluation du risque de chute chez des patients gériatriques, y compris une évaluation 
détaillée des fonctions cognitives et de démarche (chapitre 3). Afin de déterminer quelles 
caractéristiques de démarche sont les plus sensibles au déclin cognitif, l’étude suivante 
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examinait la relation entre des paramètres de démarche multiples et le déficit cognitif chez 
des patients gériatriques. Les paramètres relatifs à la vitesse de démarche, la régularité, 
la prévisibilité et la stabilité montraient le plus grand pouvoir distinctif au niveau de la 
simple tâche et de la double tâche (score VIP moyen de 1.12 avec un score VIP>1 indiquant 
un important pouvoir distinctif). Les patients gériatriques montraient une démarche plus 
lente, moins régulière et moins stable que les individus témoins en bonne santé (illustration 
3). Quoi qu’il en soit, la distinction entre les patients avec et sans déficit cognitif sur la 
seule base des paramètres de démarche était insuffisante, avec 57% (simple tâche) et 64% 
(double tâche) des patients ayant été incorrectement classés (illustration 4) (chapitre 4). Les 
paramètres de démarche avec le plus grand pouvoir distinctif du chapitre 4 ont été étudiés 
dans le cadre d’une étude pilote prospective. Déclin cognitif significatif pendant une période 
de 14.4 mois en moyenne corrélé avec une démarche initiale plus régulière (ρ=0.579*) et 
plus prévisible (ρ=0.073), mais pas avec la vitesse de démarche initiale (ρ=0.073) (illustration 
5). La régularité et la prévisibilité de démarche reflètent très probablement une perte de 
complexité de démarche et peuvent donc indiquer un déclin cognitif futur chez des patients 
gériatriques. La quantification de la dynamique de démarche (y compris les paramètres de 
complexité) chez des patients gériatriques apportait pourtant une mesure de mobilité non-
invasive qui pourrait être ajoutée aux évaluations gériatriques de routine où elle pourrait 
éventuellement faciliter l’identification d’une déficience cognitive chez cette population 
vulnérable (chapitre 5).
Illustration 1. Le protocole de démarche et les mesures employées dans les chapitres 3-5.
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Illustration 2. Obtention de caractéristiques de fonctionnement - 
courbes pour les trois modèles de classification de chutes Modèle 1 = 
caractéristiques du patient; Modèle 2 = caractéristiques du patient + 
paramètres cognitifs ; modèle 3 = Caractéristiques du patient + paramètres 
cognitifs + paramètres de démarche. AUC = région sous la courbe.
Illustration 3. Des diagrammes en violon basés sur l’estimation par noyau indiquent la répartition des 
paramètres de démarche. Les diagrammes en violon montrent les paramètres de démarche pour des 
personnes âgées en bonne santé (n=25), des patients gériatriques cognitivement intacts (n=31) et des 
patients atteints d’un déficit cognitif (n=36) pendant un test de marche à tâche simple. Un noyau plus 
compact et moins allongé indique une densité et une homogénéité plus élevées à travers les paramètres 
de marche. Les lignes noires et les lignes rouges pointillées indiquent des valeurs moyennes et médianes 
respectivement. Les paramètres sont normalisés en une variance au carré aux fins du traçage uniquement. 
RMS = Moyenne quadratique; IH = Indice d’harmonicité; Cross-SampEn = Entropie croisée Mscale-En = 
Entropie multi-échelle; max-Lyap = Exposant de Liapounov maximal; FreqVar = Variabilité de fréquence; 
AP = Antérieur-Postérieur; ML = Médio-Latéral; V = Vertical.
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Illustration 4. Tracés de scores et exactitude de classement. Les tracés de scores (tableau gauche) illustrent 
les scores des participants individuels et montrent la relation entre les paramètres de marche et les 
participants de chaque groupe compte tenu des deux premières variables latentes pour la simple tâche 
(tableau du haut) et la marche à double tâche (tableau du bas). Les personnes âgées en bonne santé se 
trouvent dans un cluster clairement délimité tandis que 57% et 64% des patients gériatriques cognitivement 
intacts (CI) et des patients atteints d’une déficience cognitive (CIM) sont incorrectement classés pour la 
simple tâche et la double tâche respectivement (tableau droit).
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Illustration 5. Corrélations entre les paramètres de démarche initiaux et le déclin cognitif futur (MMSE+7MS) 
Le degré du changement cognitif a été quantifié par l’Indice de Changement Fidèle (RCI) où un RCI>1.961 
indique un changement cognitif considérable dans le temps (p<0.05). Chaque symbole désigne un patient 
individuel. Les patients chez lesquels les valeurs MMSE et 7MS ont baissé sont marqués en orange (n=7) et 
les patients qui restaient cognitivement stables sont marqués en bleu (n=12).  
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Une perspective plus large sur la démarche et la cognition obtenue par le biais de la 
théorie de la ‘Perte de Complexité’
La vitesse de démarche est le paramètre le plus documenté dans le domaine de la mobilité 
[17]. Même le vieillissement naturel entraîne toute une série d’altérations au niveau des 
fonctions neuro-musculaires et neuro-physiologiques qui aboutissent à un déclin de la 
structure et de la fonction musculaire et donc à une démarche plus lente [33]. Compte tenu 
de la littérature abondante qui dit que la vitesse de démarche baisse davantage avec la 
déficience cognitive [34-41], nous avons espéré trouver des associations avec la vitesse de 
démarche et le déficit cognitif mais en vain. Les différences au niveau des caractéristiques 
des patients pourraient expliquer les résultats divergents entre nos constatations et les 
constations précédentes du fait que la plupart des études recrutaient des personnes âgées de 
la communauté qui étaient en meilleure santé et plus jeunes que nos patients gériatriques 
qui ont 80 ans en moyenne. À côté du déclin lié à l’âge, les patients gériatriques présentaient 
un score de 1.8 sur l’indice de comorbidités de Charlson (affections pulmonaires, tumeurs, 
diabète) [42]. Par ailleurs, ils remplissaient en moyenne les critères d’une poly-pharmacie 
(>4 médicaments) et 63% des patients étaient fragiles ou pré-fragiles selon la définition 
de Fried [43]. En fin de compte, les conditions typiquement présentes chez des patients 
gériatriques (comme la déficience visuelle, les douleurs, la cyphose thoracique, la poly-
pharmacie, la sarcopénie) ont été associées au ralentissement de la démarche [29, 44-46]. 
De telles affections peuvent déjà avoir causé un ralentissement considérable de la démarche 
d’un patient et un ‘effet de plancher’ de manière à ce que la vitesse de démarche ne pouvait 
pas baisser davantage au moment où le déficit cognitif venait s’ajouter aux symptômes [46].
Les paramètres de démarche dynamiques finement grainés décrivaient des caractéristiques 
de démarche qui ne se manifestaient pas dans la vitesse de démarche. Du fait que 
les patients gériatriques montrent des dégénérescences multi-systèmes, le lien entre 
la démarche et la cognition a été placé dans un cadre théorique pour augmenter la 
compréhension du couplage et de la coordination entre les éléments du système neuro-
musculo-squelettique vieillissant (NMSS) pour lesquels la théorie de la ‘Perte de complexité’ 
(LOC) a été prise en considération [15]. Tel qu’il ressort de la cardiologie, la complexité 
pourrait être définie comme fluctuations ‘irrégulières (variables) qui se présentent dans 
des rythmes physiologiques saines qui aboutissement à une forme de chaos’ [47]. Tel le 
rythme sinusal dans les battements du cœur, la démarche humaine est un mouvement 
hautement rythmique. C’est pour cette raison que différentes études prétendaient que le 
schéma de démarche était également caractérisé par un type de variabilité complexe et que, 
dans l’affirmative, les altérations au niveau de la complexité reflétaient le vieillissement 
lié à des maladies. Du fait que les affections pathologiques comme le déficit sensoriel 
[48], la fragilité [49], les chutes récurrentes [50] et le syndrome de Huntington [51] ont été 
associés à une perte de complexité de démarche, cette thèse partait de l’hypothèse que la 
déficience cognitive pouvait également induire une perte de complexité de démarche. Bien 
que préliminaires, les résultats du chapitre 5 étayent cette hypothèse du fait de révéler des 
corrélations entre une démarche initiale plus régulière et prévisible et un déclin cognitif 
fiable dans le temps où la régularité et la prévisibilité accrues de la démarche reflètent une 
perte de complexité de démarche [16].
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Une constatation cohérente des études précédentes est le fait qu’une perte de complexité 
dans les systèmes physiologiques aboutit à des systèmes plus rigides, réguliers et moins 
flexibles. La faculté de s’adapter à des stimulations de l’environnement en évolution constant 
est donc réduite [15, 52-55]. Dans cette perspective, Stergiou et collègues ont développé un 
modèle qui expliquait la manière dont la complexité de démarche pouvait être liée à la santé 
[47]. Selon ce modèle, il y a une quantité optimale de complexité: un manque de complexité 
se traduit donc dans un système plus rigide tandis qu’une complexité excessive aboutit à 
un système bruyant et instable. Les deux situations affectent la capacité de s’adapter à des 
perturbations de manière considérable. Les auteurs ont directement associé cette capacité 
d’adaptation réduite à un manque de santé [47]. En ce qui concerne la fonction de démarche, 
on ignore pourtant toujours si une perte de complexité de démarche aboutit vraiment à une 
capacité d’adaptation réduite qui est nécessaire pour maîtriser les perturbations potentielles 
pendant la marche. L’étude de patients gériatriques avec et sans perte de complexité de 
démarche et la comparaison des effets de perturbations inattendues sur leurs réponses 
adaptatives constitue une possibilité d’examiner ce phénomène. Un environnement de 
marche ou une tâche plus exigeante seraient nécessaires pour un tel scénario d’étude. 
Du fait qu’une perte de complexité de démarche a été mise en relation avec un risque de 
chute accru [21, 56], il paraît probable que cette relation est induite par les réductions de la 
capacité d’adaptation à des perturbations pendant la marche.
Un modèle conceptuel des caractéristiques de démarche de patients gériatriques 
avec et sans déficience cognitive par rapport à des individus témoins en bonne santé.
Sur la base des constatations et des interprétations correspondantes des études 
expérimentales présentées dans les chapitres 4 et 5, l’illustration 6 montre un modèle 
conceptuel qui indique la manière dont la démarche se distingue probablement chez 
des patients gériatriques cognitivement intacts et des patients souffrant d’une déficience 
cognitive par rapport à des individus témoins relativement jeunes et en bonne santé. Les 
lignes illustrent l’évolution du changement probable de la démarche avec le ‘vieillissement 
gériatrique’ et avec le développement d’une déficience cognitive. La vitesse de démarche 
diminuait lors du passage d’individus témoins en bonne santé à des patients gériatriques 
cognitivement intacts. Elle ne diminuait pourtant pas davantage avec les patients souffrant 
d’une déficience cognitive diagnostiquée (ligne pleine). La régularité et la prévisibilité de 
démarche diminuaient lors du passage d’individus témoins en bonne santé à des patients 
gériatriques cognitivement intacts. Les deux augmentaient pourtant au moment où une 
déficience cognitive venait s’ajouter aux conditions gériatriques. Cette augmentation de 
la régularité et de la prévisibilité survient probablement avec la perte progressive de la 
complexité de démarche et un déclin de la stabilité de démarche (lignes pointillées).
 
La combinaison des caractéristiques de démarche par population est due à de nombreux 
facteurs sous-jacents comme l’âge et d’autres données démographiques des patients. 
La combinaison ne devrait donc pas être considérée comme capacité fonctionnelle mais 
plutôt comme système dynamique émergent. La grande régularité de démarche qu’on peut 
observer chez des personnes âgées en bonne santé et des patients gériatriques atteints 
d’une déficience cognitive p. ex. provient de différents facteurs sous-jacents. La comparaison 
est impossible de ce fait. Tandis qu’une régularité de démarche plus importante peut être 
bénéfique chez des personnes âgées en bonne santé en termes du coût métabolique p. ex., 
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la grande régularité de démarche chez des patients gériatriques atteints d’une déficience 
cognitive peut être accompagnée d’une perte de complexité de démarche et d’un déclin au 
niveau de la stabilité de démarche. 
Illustration 6. Un modèle conceptuel qui montre la manière dont la démarche se distingue probablement 
chez des patients gériatriques cognitivement intacts et chez des patients gériatriques atteints d’une 
déficience cognitive par rapport à des individus témoins relativement jeunes et en bonne santé. Les lignes 
illustrent l’évolution du changement probable de la démarche avec le ‘vieillissement gériatrique’ et avec le 
développement d’une déficience cognitive.
Comment est-ce que l’évaluation de la fonction de démarche peut contribuer à 
l’identification de déficits cognitifs et de chutes chez des patients gériatriques?
Une constatation cohérente de cette thèse indique que la dynamique de démarche pouvait 
compléter des paramètres de marche largement utilisés comme la vitesse de démarche. 
L’ajout de la dynamique de démarche aux diagnostics courants augmentait la spécificité 
d’un modèle de classification de chutes (chapitre 3). Par ailleurs, la régularité de démarche, 
la prévisibilité et la stabilité présentaient le plus grand pouvoir distinctif au niveau des 
groupes de patients (chapitre 4). De plus, le déclin cognitif dans le temps corrélait avec la 
régularité de démarche et la prévisibilité initiales mais pas avec la vitesse de démarche 
initiale (chapitre 5) Bien que la vitesse de démarche puisse se prêter comme simple indice 
global de mobilité, l’évaluation de la vitesse de démarche seule ne présente pas forcément 
la spécificité suffisante du fait que de nombreuses affections cliniques et non cliniques 
induisent un ralentissement de démarche. Chez les patients gériatriques, les affections 
typiques comme la déficience visuelle, les douleurs, la cyphose thoracique, l’utilisation de 
nombreux médicamente et la sarcopénie ont toutes été associées à un déclin au niveau de 
la vitesse de démarche [29, 44-46]. De ce fait, la vitesse de démarche peut être considérée 
comme marqueur de la santé globale mais probablement pas comme marqueur spécifique 
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de la cognition. Les paramètres de démarche dynamiques permettent l’extraction 
d’informations supplémentaires sur la démarche d’une personne en termes de coordination, 
de complexité et de stabilité de démarche p. ex. Par contre, même si la dynamique de 
démarche peut compléter la vitesse de démarche, une analyse détaillée de la démarche 
seule est insuffisante à l’identification de déficiences cognitives. La distinction entre les 
groupes de patients gériatriques avec et sans déficit cognitif n’était pas possible, du fait que 
57% (simple tâche) et 64% (double tâche) de patients avaient été incorrectement classés. Ces 
constatations sont interprétées dans le sens qu’une identification exacte des chutes et des 
déficiences cognitives exige une approche multifactorielle y compris les caractéristiques 
des patients (affections concomitantes) et une évaluation globale de la fonction cognitive et 
de la fonction de démarche.
Perspectives cliniques  
L’évaluation de la démarche telle qu’utilisée pour la présente thèse est une mesure facile et 
non-invasive qui prend juste quelques minutes aux médecins. Le progrès rapide au niveau 
des technologies facilite le recours à une analyse exhaustive de la démarche dans les milieux 
cliniques et de recherche. Les capteurs portables (téléphones, iPods ou accéléromètres) 
sont de plus en plus présents dans le secteur de la santé [57]. De nos jours, ces appareils 
sont par défaut équipés d’unités de mesure d’inertie (IMU) comme les gyroscopes, les 
accéléromètres et les magnétomètres. Par ailleurs, ces capteurs portables sont largement 
disponibles, faciles à opérer, peu chers et de taille compacte [58]. 
Outre le potentiel d’identifier des déficiences cognitives et le statut de chutes, les paramètres 
de démarche dynamiques permettent d’identifier des perturbations de démarche subtiles 
[21, 56, 59, 60]. Des stratégies d’intervention sur mesure peuvent être élaborées pour réduire 
le risque de chutes et pour maintenir la vie indépendante. Une constatation prometteuse 
d’une récente étude de population montrait que les transitions concernant des troubles 
de démarche ainsi que la déficience cognitive étaient mutables et réversibles pendant 
une période de 9 ans même chez les personnes les plus âgées [61]. Tandis qu’il y a des 
preuves abondantes disant que la capacité de marche permet de mesurer les changements 
au niveau de la qualité de vie liée à la santé tant physique que mentale, une mesure de 
mobilité ne fait en général pas partie des évaluations standards dans les cliniques de 
diagnostic gériatrique. Une étude récente conseille donc aux professionnels de la santé de 
se concentrer sur des procédures de dépistage et des stratégies d’intervention permettant 
de maintenir la mobilité des personnes âgées afin de préserver et/ou d’augmenter la qualité 
de vie liée à la santé [62]. 
 
En résumé, l’incorporation d’une évaluation de démarche de 3 minutes dans les évaluations 
cliniques de routine présente des avantages techniques et cliniques multiples. D’autres 
études devront confirmer l’utilité clinique et la capacité prédictive de telles techniques; 
des scores de norme et des scores seuil doivent être établis pour différents groupes de 
populations. Finalement, une application qui traduit les détails techniques de la démarche 
en paramètres cliniques, qui incorpore par ailleurs des diagnostics de démarche et d’autres 
pourrait être conçue et finalement fournir un profil de risque multifactoriel pour le déclin 
cognitif et les chutes.
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Conclusions
La présente thèse contribuait à notre compréhension de la relation entre la démarche et la 
cognition chez des patients gériatriques. Les résultats montraient que la présence d’une 
déficience cognitive chez la population gériatrique se manifeste probablement à travers 
une régularité et une prévisibilité de démarche augmentées et reflète une éventuelle perte 
de complexité de démarche. Comme les résultats n’ont pas révélé des associations avec la 
vitesse de démarche en tant qu’indice globale de la mobilité, les paramètres dynamiques 
pourraient augmenter la spécificité du lien entre la démarche et la cognition. La dynamique 
de démarche peut donc être considérée comme indicateur prometteur du déficit cognitif et 
des chutes. Les médecins et les chercheurs devraient toutefois être conscients des effets 
d’affections multiples concomitantes chez des patients gériatriques qui peuvent interagir 
entre elles et avec la fonction de démarche. Une identification exacte du déficit cognitif et 
des chutes exige très probablement une approche multifactorielle chez cette population 
vulnérable et devrait inclure des mesures physiques, cognitives, pharmacologiques et 
comportementales. Du fait que les appareils intelligents comme les smartphones sont de 
nos jours par défaut équipés d’IMU (comme les accéléromètres), l’évaluation de la fonction 
de démarche fournit une mesure de mobilité avantageuse et non-invasive qui pourrait 
bientôt être ajoutée aux évaluations gériatriques de routine. Il convient pourtant que des 
études futures reproduisent nos constatations avec des cohortes plus larges et réduisent 
les faiblesses méthodologiques au niveau des mesures de la démarche et de la cognition 
qui compliquent l’analyse exacte de la démarche chez des patients gériatriques.
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SUMMARY
The rising life expectancy will result in an increased number of ‘older old adults’ who 
will need specialized geriatric care to slow functional decline. Cognitive impairment is a 
major cause of disability in geriatric patients. Even though there is no cure yet to reverse 
neurodegeneration, tailored interventions can slow disease progression and reduce 
symptoms. Because of the abundant evidence from experimental, neuroscientific, and 
behavioral studies that underscored the close link between motor- and cognitive function, 
the present thesis proposed to use gait characteristics as non-invasive indicators of cognitive 
impairment and falls in geriatric patients. The main objective therefore was to increase our 
understanding of the relationship between gait and cognition in this vulnerable population, 
in which gait outcomes were calculated from 3D-acceleration signals of the lower trunk 
that were collected with an iPod Touch 4G. The ‘Loss of Complexity’ hypothesis provided 
a theoretical framework. Multivariate analyses were applied to dynamic gait outcomes in 
relation to cognitive- and fall-status (Chapter 1).
Chapter 2 presents a systematic literature review including 20 longitudinal studies that 
examined associations between baseline gait function and future cognitive decline. A slow 
gait speed was associated with future decline in global cognition and in specific cognitive 
functions, and with an increased risk for Mild Cognitive Impairment (MCI) and dementia 
(maximal odds and hazard ratios of 10.4 and 11.1, respectively) in 4.5 years on average. The 
review projected that future research could increase the specificity of the gait-cognition link 
by indexing gait and cognition in more detail.
From this perspective, Chapter 3 examined whether an extensive cognitive evaluation 
(global cognition, memory, and executive functioning) and fine-grained, dynamic gait 
outcomes could add to a usual fall-risk screening. The overall classification accuracy of 
fallers and non-fallers increased from Area Under the Curve (AUC) =0.86 to AUC=0.93. 
The specificity of the fall-classification model increased from 60% to 72% when cognitive 
outcomes were added, and from 72% up to 80% when gait dynamics were added to the 
model. The results underscored the need for a multifactorial approach in fall risk assessment 
in geriatric patients, including a detailed evaluation of cognitive- and gait function.
Chapter 4 explored what gait outcomes are most susceptible to change with cognitive 
decline, and examined multiple gait outcomes in relation to cognitive impairment. Outcomes 
related to gait speed, regularity, predictability, and stability revealed with the highest 
discriminative power, indicated by the Variable Importance in Projection (VIP)-values for 
single- and dual-tasking (average VIP-score of 1.12, with a VIP-score>1 indicating a high 
discriminative power). Geriatric patients walked slower, less regular, and less stable than 
healthy old controls. However, the discrimination of geriatric patients with- and without 
cognitive impairment based on gait outcomes alone was poor, with 57% (single-task) and 
64% (dual-task) of the patients being misclassified. 
In Chapter 5, the gait outcomes with the highest discriminative power in chapter 4 were 
studied in a prospective pilot study. Significant cognitive decline (in global cognition, 
memory, and executive functioning) over 14.4 months on average correlated with a more 
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regular (ρ=0.579*) and more predictable (ρ=0.486*) gait at baseline, but not with baseline 
gait speed (ρ=0.073). The increased gait regularity and predictability reflected a loss of gait 
complexity and this loss of gait complexity may thus predict future cognitive decline in 
geriatric patients.
The results are summarized and discussed in Chapter 6 of this thesis. Cognitive impairment 
in the geriatric population possibly becomes manifested trough increased gait regularity 
and predictability, reflecting a loss of gait complexity. Therefore, dynamic gait outcomes 
could increase the specificity of the gait-cognition link, and can be considered promising 
indicators of cognitive impairment and falls. Ultimately, the assessment of gait function 
provides a cheap and non-invasive mobility measure that in the future could be added to 
routine geriatric assessments. However, clinicians and researchers should be aware of the 
effects of multiple, co-existing, conditions in geriatric patients that interact with each other 
and with gait function. An accurate identification of cognitive impairment and falls thus 
most likely necessitates a multifactorial approach in this vulnerable population.
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RÉSUMÉ
Le déficit cognitif est une cause majeure de handicap de la personne âgée. Du fait de 
l’augmentation de la durée de vie, le nombre de personnes âgées qui pourraient bénéficier 
d’une prise en charge spécialisée dans le but de ralentir leur perte fonctionnelle va 
croitre. En dépit de traitement validé qui stoppe le processus neurodégénératif, des 
interventions spécifiques peuvent en ralentir les manifestations. De nombreuses études 
expérimentales, neuroscientifiques et comportementales ont démontré la relation étroite 
entre cognition en motricité.
Ce travail doctoral propose d’explorer si certaines caractéristiques de la marche sont des 
biomarqueurs non-invasifs d’un trouble cognitif et des chutes, et de mieux comprendre les 
relations entre la cognition et le contrôle de la marche. Le cadre théorique était l’hypothèse 
de la « Perte de Complexité ». Des analyses multivariées ont été appliquées aux critères de 
jugement dynamiques de marche en relation avec le statut cognitif-et-chute (Le Chapitre 1). 
Le Chapitre 2 est une revue systématique de la littérature. Nous avons recensé 20 études 
longitudinales de prédiction de trouble de la marche et de déficit cognitif. La vitesse de 
marche était associée à la cognition, son ralentissement était un prédicteur de la perte 
cognitive. Cette revue a aussi mis en évidence la nécessité d’améliorer la mesure des 
phénomènes concernés 
L’objectif du Chapitre 3 était de déterminer ce qu’apportait l’évaluation cognitive (MMSE, 
mémoire et fonctions exécutives) et des paramètres dynamiques précis de la marche, au 
bilan habituel du risque de chute. La précision de la classification entre chuteurs et non-
chuteurs a augmenté avec l’ajout de la cognition et des paramètres de marche de AUC=0.86 
à AUC=0.93. La spécificité du modèle de classification a, quant à elle, augmenté de 60% 
à 72% avec l’ajout des mesures cognitives, et de 72% à 80% avec l’ajout des paramètres 
dynamiques de la marche. Dans leur ensemble, ces résultats montrent l’intérêt d’une 
approche multidimensionnelle incluant l’évaluation des fonctions cognitives et de la 
marche, dans la prédiction du risque de chute chez la personne âgée.
Le Chapitre 4 détermine les paramètres de marche les plus associés au déclin cognitif. La 
vitesse de marche, la régularité, la prévisibilité et la stabilité ont montré que les simples et 
doubles-tâches étaient les plus discriminantes (score VIP moyen de 1.12). La marche des 
patients avec troubles cognitifs est plus lente, moins régulière et moins stable que celle de 
personnes âgées saines. Cependant, les résultats montrent également que la discrimination 
des patients âgés avec et sans déficit cognitif, fondée sur l’exploitation des paramètres de 
marche uniquement, est faible, avec 57% (simple tâche) et 64% (double-tâche) des patients 
classés de manière erronée. 
Le Chapitre 5 présente une étude pilote prospective dans laquelle les paramètres de marche 
les plus discriminants du Chapitre 4 ont été étudiés. Les résultats ont montré qu’un déclin 
cognitif significatif observé après 14.4 mois en moyenne était corrélé avec une marche plus 
régulière (ρ=0.579*) et plus prévisible (ρ=0.486*) mesurée pendent les mesures de ligne de 
base, mais pas avec la vitesse de marche de la ligne de base (ρ=0.073). Une augmentation 
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de la régularité et de la prévisibilité de la marche est le reflet d’une perte de la complexité de 
la marche, témoin d’une détérioration future des fonctions cognitives chez les patients âgés. 
Les résultats de ce travail doctoral sont résumés et discutés dans le Chapitre 6. Le déficit 
cognitif chez la population gériatrique se manifeste par une augmentation de la régularité 
et la prévisibilité de la marche, reflétant une perte de la complexité de la marche. Par 
conséquent, des paramètres dynamiques de marche pourraient augmenter la spécificité 
de la relation marche-cognition, et être considérés comme des marqueurs du déficit 
cognitif et des chutes chez les patients gériatriques. L’évaluation de la marche est un test 
de mobilité bon marché et non-invasif qui pourrait avantageusement compléter les bilans 
de routines en gériatrie. Cependant, cliniciens et chercheurs doivent être conscients de 
l’effet des pathologies multiples co-existants qui interagissent entre elles ainsi que sur le 
contrôle de la marche dans cette population. En définitive, l’identification fiable et précise 
du déficit cognitif et des chutes nécessite donc une approche multifactorielle chez cette 
population vulnérable.
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SAMENVATTING
‘Ouder worden komt met gebreken’. Met andere woorden: Met de leeftijd neemt het aantal 
comorbiditeiten en chronische condities toe. Met het stijgen van de levensverwachting 
kunnen we daarom verwachten dat het aantal ouderen dat gespecialiseerde geriatrische 
zorg nodig heeft ook zal stijgen. Geriaters richten zich op deze kwetsbare populatie, en 
hebben als doel om ziektes te behandelen en functies van het dagelijks leven zoveel mogelijk 
te behouden. Cognitieve achteruitgang (zoals vormen van dementie of milde cognitieve 
problematiek (MCI)) heeft een desastreus effect op het dagelijks functioneren van ouderen. 
Ondanks dat medische behandelingen cognitieve achteruitgang nog niet kunnen ‘genezen’, 
blijken doelgerichte interventies het ziekteproces wel te vertragen.
Omdat er een duidelijk verband is aangetoond tussen motorisch- en cognitief functioneren 
in verschillende takken van wetenschappelijk onderzoek (e.g., neurowetenschappen en 
gedragswetenschappen), veronderstelt het huidige proefschrift dat karakteristieken van 
het lopen kunnen dienen als non-invasieve indicatoren van cognitieve achteruitgang in 
geriatrische patiënten. Het overkoepelende doel van dit proefschrift was daarom om meer 
inzicht te verkrijgen in de relatie tussen lopen en cognitie in geriatrische patiënten, waarbij 
een breed scala aan loopvariabelen is berekend uit 3D-acceleraties van de onderrug 
(gerelateerd aan loopsnelheid en de dynamica van het lopen). De ‘Loss of Complexity’ 
hypothese heeft gefungeerd als theoretisch kader. Multivariate analyses zijn vervolgens 
gebruikt om loopvariabelen te relateren aan cognitieve- en val-status (Hoofdstuk 1).
Volgend op de algemene introductie presenteert Hoofdstuk 2 een systematisch litera-
tuuronderzoek. Het review analyseerde 20 longitudinale studies welke de relatie tussen 
karakteristieken van het lopen en verandering in cognitieve functies over de tijd hebben 
onderzocht. Een lagere loopsnelheid tijdens de baseline meting werd geassocieerd met een 
achteruitgang in globale en specifieke cognitieve functies, en met een verhoogd risico op het 
ontwikkelen van MCI en dementie (met maximale odds en hazard ratio’s van respectievelijk 
10.4 en 11.1) over gemiddeld 4.5 jaar. Het review veronderstelde dat toekomstige studies de 
relatie tussen lopen en cognitieve achteruitgang wellicht verder kunnen specificeren door 
het lopen en cognitieve functies in meer detail te kwantificeren.
Voortbordurend op deze bevindingen is in Hoofdstuk 3 onderzocht of een meer gedetailleerde 
beschrijving van cognitie (globale cognitie, geheugen, en executief functioneren) en van het 
lopen (dynamische loopvariabelen) het voorspellen van vallen kon verbeteren ten opzichte 
van alleen een reguliere valrisico-screening. De classificatie-nauwkeurigheid van vallende 
en niet-vallende ouderen steeg van Area Under the Curve (AUC) =0.86 naar AUC =0.93. De 
specificiteit van het val-classificatiemodel steeg van 60% naar 72% wanneer cognitieve 
uitkomsten werden toegevoegd aan de reguliere screening, en van 72% naar 80% wanneer 
dynamische loopuitkomsten werden toegevoegd aan het model. De resultaten onderstrepen 
dat een accurate identificatie van val-gevaarlijke ouderen hoogstwaarschijnlijk een 
multivariate evaluatie aanpak vereist, waarbij cognitieve- en loopvariabelen toe kunnen 
voegen aan de huidige diagnostiek.
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In Hoofdstuk 4 is onderzocht welke loopvariabelen het sterkst gerelateerd zijn aan cog-
nitieve achteruitgang. Loopsnelheid, en variabelen gerelateerd aan de regelmatigheid, 
voorspelbaarheid, en stabiliteit van het looppatroon hadden het hoogste vermogen om 
groepen van elkaar te onderscheiden, aangeduid met de ‘Variable Importance in Projection’ 
(VIP)-waarden (met een gemiddelde VIP-waarde van 1.12, waarbij een VIP-waarde van >1 
een hoog discriminatief vermogen aanduidt). Geriatrische patiënten liepen langzamer, 
minder regelmatig en minder stabiel dan relatief jonge en gezonde ouderen. Echter, 
geriatrische patiënten met- en zonder cognitieve achteruitgang konden niet onderscheiden 
worden op basis van de loopvariabelen alleen, waarbij respectievelijk 57% en 64% van de 
geriatrische patiënten verkeerd werden geclassificeerd tijdens enkel- en dubbel-taak.
De loopvariabelen met het hoogste discriminatieve vermogen uit hoofdstuk 4 zijn vervolgens 
onderzocht in een longitudinale pilotstudie in Hoofdstuk 5. Significante cognitieve ach-
teruitgang (globale cognitie, geheugen, en executief functioneren) over gemiddeld 14.4 
maanden correleerde met een meer regelmatig (ρ=0.579*) en meer voorspelbaar (ρ=0.486*) 
looppatroon tijdens de basismeting. Deze hogere regelmatigheid en voorspelbaarheid van 
het looppatroon reflecteerde een afname van complexiteit, wat in dit hoofdstuk verklaard 
met behulp van de ‘Loss of Complexity’ hypothese. De afname van de complexiteit van het 
looppatroon kan daarom mogelijk dienen als voorspeller van cognitieve achteruitgang in 
geriatrische patiënten.  
De resultaten zijn samengevat en bediscussieerd in Hoofdstuk 6 van dit proefschrift. 
Cognitieve achteruitgang in geriatrische patiënten kenmerkt zich mogelijk door een 
verhoogde regelmatigheid en voorspelbaarheid van het looppatroon, wat verband houdt 
met een afname van complexiteit. Als toevoeging op veelgebruikte variabelen zoals de 
loopsnelheid, kunnen dynamische loopvariabelen (zoals uitkomsten gerelateerd aan de 
regelmatigheid, voorspelbaarheid, complexiteit, en stabiliteit van het lopen) de relatie 
tussen lopen en cognitie verder specificeren, en deze dynamische loopvariabelen kunnen 
daarom mogelijk dienen als indicator van cognitieve achteruitgang en vallen in geriatrische 
patiënten. Een uitgebreide analyse van het looppatroon is een niet-invasieve en goedkope 
diagnostische maat, en zou toegevoegd kunnen worden aan de huidige screening van 
geriatrische patiënten. Echter, geriaters en andere clinici moeten zich bewust zijn van de 
effecten van de vele comorbiditeiten en chronische condities in geriatrische patiënten, welke 
met elkaar en met het lopen interacteren. Een nauwkeurige identificatie van cognitieve 
achteruitgang en vallen in deze kwetsbare populatie vereist daarom hoogstwaarschijnlijk 
een multifactoriële aanpak, waaronder algemene patiënt karakteristieken, comorbiditeiten, 
en een uitgebreide analyse van het cognitief als wel het motorisch functioneren.
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